PCPC2016 Microbiology Guidelines
PCPC2016 Microbiology Guidelines
TECHNIC AL GUIDELINES
Microbiology
Guidelines
Microbiology
Guidelines
2016 EDITION
Editors
John F. Krowka, Ph.D.
Beth A. Jonas, Ph.D.
Production
Natasha Clover
Published by
Personal Care Products Council
1620 L Street, N.W., Suite 300
Washington, D.C. 20036
Phone: 202/331‑1770
Fax: 202/331‑1969
www.personalcarecouncil.org
In 1969, CTFA (now called the Personal Care Products Council (PCPC)) began publishing its
Technical Guidelines in the CTFA Cosmetic Journal. These guidelines were developed by the newly
organized CTFA Microbiology Committee and were concerned with microbiological issues. The
benefits of having the Guidelines available in a single volume, and presented in a standardized for‑
mat, were recognized, and in 1974, the first independent compilation of the Technical Guidelines
was published.
In 1993, after several major revisions and additions to the Guidelines, PCPC responded to requests
made by the users to split the Guidelines into separate volumes so that individuals might purchase
sets relating specifically to their areas of responsibility. The Guidelines are now published by PCPC
in three volumes: Microbiology, Quality Assurance, and Safety Evaluation.
The PCPC Technical Guidelines are dynamic documents that undergo extensive review and updat‑
ing to reflect best practices prior to publication by PCPC technical committees and staff, as well as
include input from PCPC members and nonmember companies, federal government agencies, and
scientific professional societies. Comments from individuals are welcome at any time. All guidelines
and methods were re-reviewed and updated for this edition of the Microbiology Guidelines.
While PCPC has sought to ensure that these Guidelines generally satisfy applicable U.S. federal stat‑
utory and regulatory requirements as of the date they were drafted, PCPC can assume no respon‑
sibility for their adequacy, nor does it purport to advise as to the necessity for their use in any par‑
ticular situation. In those Guidelines that address regulatory requirements, decisions such as when a
report must be filed and what information must be included in it can be made only by those indi‑
viduals responsible for making such submissions. With regard to all of the areas covered by PCPC
Guidelines, each company is responsible for making their own assessments and must independently
assume responsibility to ensure that their conduct is consistent with all current, applicable federal,
state and local laws and regulations.
It must be emphasized to the user that these Guidelines are intended only to aid manufacturers in
developing programs that meet their individual needs. The Guidelines must not be considered either
minimum or maximum requirements of effective programs. Alternative ways to reach the goals of
the Guidelines may well exist and may be equally useful. Guidelines on any topic must, of course,
be adapted to the particular operations of the manufacturer using them. We hope it proves to be an
especially valuable resource.
The Guidelines presented in this volume were developed by the PCPC Mi‑
crobiology Committee. As the development and updating effort has been an
iterative process, listing all of the experts involved from PCPC member com‑
panies would be beyond the capabilities of the current editors. Therefore, to
all who had a part, a very warm and sincere thank you. We are grateful to
Andress Johnson and Warren Holland-Recine who organized the efforts of the
Council’s Microbiology Committee to update these guidelines. We also wish
to thank Don English and Joyce Beauchamp for their invaluable assistance.
This edition is dedicated to the memory of Kimdra Smith-Webster and Scott
Sutton.
The editors also would like to thank Natasha Clover at PCPC for her assistance
in producing this volume.
The production of quality personal care products requires a commitment from the manufacturer to
establish and maintain a total quality program. The microbiological component of such a program
is designed to ensure: (1) that the product that reaches the consumer is free of microorganisms that
could affect the product quality and consumer health, and (2) that during normal product use, the
quality of the product will not be compromised by microbial activity.
The Personal Care Products Council Microbiology Guidelines are intended to provide manufacturers
with guidance regarding best practices as well as establishing and maintaining a microbiological
quality program within their companies. The Guidelines are also recommended for contract manu‑
facturers and packagers as well as suppliers of raw materials. Sections of the Guidelines will vary as
to applicability for different sectors of the industry and for individual companies.
The Guidelines are organized into separate sections. The major provisions for an effective micro‑
biological quality program are outlined in the first guideline “Microbiological Quality Assurance
for the Personal Care Products Industry.” More detailed information on cleaning and sanitization,
staff training, raw materials, sampling, process water and other topics is presented in subsequent
sections. “Cosmetic products are not expected to be aseptic; however, they must be completely free
of high-virulence microbial pathogens, and the total number of microorganisms per gram must be
low.”1 In addition, cosmetics should remain in this condition when used by consumers.
As an alternative to manufacturing sterile products, the consideration of limits to microbiological
content is based on the best available information. Microbiological limits for finished products as
well as raw materials are covered in separate guidelines. Sections 16-21 provide methods for micro‑
bial content and preservation effectiveness testing of a variety of product types. A glossary of mi‑
crobiological terms is provided in Section 25. All sections of the 2016 edition of the Microbiology
Guidelines were reviewed and revised.
These Guidelines are not intended to establish minimum industry standards for all personal care
products. Also, the Guidelines do not cover all areas that might be addressed under a specific cate‑
gory. The Personal Care Products Council intends to include additional topics in future updates to
the Guidelines. In the interim, cosmetic companies are encouraged to refer to other microbiology
resources. Also, while these Guidelines can help ensure that products are microbiologically accept‑
able, they cannot substitute for day‑to‑day familiarity with the principles of microbial control. The
Guidelines must never be taken to restrict additional activities when circumstances dictate.
1
US Food and Drug Administration, Compliance Program Guidance Manual, Chapter 29 – Colors and Cosmetics Technology
–Part V Page 1, available at: http://www.fda.gov/downloads/Cosmetics/GuidanceRegulation/GuidanceDocuments/
UCM208412.pdf (Accesssed June 1, 2016)
Microbiological Quality
Assurance for the Personal
Care Products Industry
1
QUALITY ASSURANCE
MICROBIOLOGICAL
INTRODUCTION
Adequate control of the microbiological quality of finished personal care products depends upon
the implementation of an effective microbiological quality assurance program. Although the appli‑
cability of some aspects of such a program will vary for different types of products, processes, and
facilities, the major areas described below should be reviewed.
The reader is directed to review the “Glossary of Microbiological Terms” that follows these guide‑
lines to ensure a proper understanding of the guidelines.
Note: These guidelines do not apply to Over-the-Counter (OTC) products and/or drugs as defined
by regulatory agencies. Food and Drug Administration (FDA) Current Good Manufacturing Pro‑
cedures (cGMPs) for Finished Pharmaceuticals should be consulted for the manufacture of drug
products.1
QUALITY ASSURANCE
Quality assurance is defined as the activity of providing the evidence needed to establish confidence
that the quality function is being performed adequately.2 The goal of an effective microbiological
quality assurance program is to assure that the finished product consistently meets established mi‑
crobiological standards.
The microbiological quality assurance program can be viewed as having several major components:
The PCPC Quality Assurance Guidelines offer general guidance in establishing quality assurance
programs within personal care manufacturing facilities.3 In addition, the “Personal Care Good Man‑
ufacturing Practices” offers guidance in establishing the control systems designed to assure product
quality and consumer safety.4
The personnel responsible for microbiological quality control should be of adequate number
MICROBIOLOGICAL
and have the necessary training and/or experience to ensure that personal care products meet
established specifications.
1. Microbiologist - Should have acquired by education and/or experience the expertise needed to
supervise operations and should be capable of:
B. Manufacturing/Operations
1. Supervisor - Should be qualified by training and/or experience to properly ensure maintenance
of the microbiological integrity of the product being manufactured.
2. Compounders, Filling Line Operators, etc. - Should have an understanding of causes of mi‑
crobiological contamination, common contamination sources, and their prevention.
C. Education Program
In order to maintain microbiological quality it is important to instill general microbiological
awareness and to train operating employees in hygienic practices. Examples of microbiological,
and hygiene training to be emphasized are listed below.
1. Potential sources for product contamination by the following avenues:
2. Training on proper cleaning and sanitizing procedures (See Section 3 – Cleaning and Sanitiza‑
tion).
3. Encouraging employees to report plant conditions that could affect product integrity.
1
4. Personal Hygiene:
QUALITY ASSURANCE
MICROBIOLOGICAL
• No person with any health condition that could adversely affect products should have direct
contact with raw materials, packaging products, or product contact surfaces.
• Personnel should store personal belongings, eat, drink, or use tobacco only in designated
areas.
• Personnel should be required to wear appropriate Personal Protective Equipment (PPE) and
clothing (hair net, booties, etc).
PHYSICAL ENVIRONMENT
A. Plant and Grounds
Buildings and equipment should be designed for ease of cleaning and sanitization. They should
be clean and maintained in an orderly manner.
The manufacturing area should be designed to minimize the risk of contaminating raw materials,
packaging components, or products. These areas should have walls and floors that are easy to
clean and sanitize. Overhead repositories for dust, such as piping and ductwork, should be kept to
a minimum and cleaned when necessary. Floor drains in manufacturing areas should be routinely
sanitized and properly maintained.
Building openings, including doors, should be designed, operated, and maintained to protect the
manufacturing areas and to minimize environmental contamination. Windows should be prop‑
erly screened and each manufacturing facility should have an effective rodent and insect control
system.
Ventilation systems should include, where appropriate, changeable filters properly maintained
to restrict entry of particulate matter, insects, microorganisms, and other contaminants. Positive
air pressure should be available in areas containing easily contaminated materials. Water used for
humidifying should be of acceptable microbiological quality.
Hand-washing and/or hand sanitizing facilities should be provided near the production area.
Signs reminding personnel to wash hands should be prominently displayed at the washing facili‑
ties. Hand cleansers and disposable towels should be available.
Eating and smoking should not be permitted in the manufacturing areas.
Clean containers, utensils and microbiologically acceptable water used with a disinfectant-type
cleaner should be available for general environmental cleaning. Clean containers appropriately
labeled should be provided for collecting waste and scrap materials.
Designated areas should be provided for storing raw materials and finished goods.
It is desirable that equipment be constructed for effective cleaning and sanitization and that it
MICROBIOLOGICAL
be designed to protect products from contamination. The PCPC Quality Assurance Guidelines
provide important information on construction, cleanability, and related items.6
Possible Sources of Contamination:
• Pipes - May contain crevices, pits, sharp turns, dead ends, connections, unsanitary welded
joints.
• Equipment - May contain pits, crevices, poorly sealed lids, leaking pump shaft seals, defective
1
sight glasses.
• Utensils - Plastic is difficult to clean. Wood is not acceptable for most personal care manufac‑
turing applications.
• Personnel - The human body is a reservoir of large numbers of microorganisms. Protective
apparel should be worn whenever appropriate. Infected cuts or abrasions on the hands should
be covered.
• Atmosphere - Dust is laden with airborne microorganisms.
• Other - General condensation, standing water, reused filter pads, cleaning rags, and com‑
pressed air can be sources of microbial contamination.
Recommendations:
• Pipes - Stainless steel, glass and plastic hose are the best materials; sanitary snap joint fittings
are preferred. Pipes should be graded to drain with no dead legs.
• Equipment - Lids on compounding tanks should be tight fitting and vented to minimize con‑
densate formation. Drains should be at the lowest point. Equipment should be designed to
minimize backwash contamination potential. Hard to clean equipment should be dismantled
and cleaned out of place between product changeovers.
• Utensils - Should be made of stainless steel; should be thoroughly cleaned, rinsed, air dried,
and properly protected from contamination between uses.
• Personnel - Should be properly trained in personal hygiene (e.g., Proper hand hygiene after re‑
stroom use, contact with food, use of proper clothing, etc., and prior to contact with product)
and the sanitary use of equipment.
• Atmosphere - Introduction of clean air and the exclusion of particulate matter.
• Other - Single-service towels should be used where possible. Compressed air lines associated
with product contact equipment should be protected with appropriate point of use filters.
SANITARY PROCEDURES
Cleaning and sanitization procedures are essential to ensure good microbial quality in the manu‑
facture of personal care products. Written cleaning and sanitizing procedures should be established,
distributed and implemented by responsible personnel. These procedures should be validated in
order to consistently meet hygienic manufacturing requirements. Refer to Section 3 (Cleaning and
Sanitization) for additional details.
1
QUALITY ASSURANCE
MICROBIOLOGICAL
STORAGE
Care should be taken to prevent introducing microbes when storing all materials. The following are
desirable conditions of storage: dry; protected from airborne contaminants; maintained within rea‑
sonable temperature limits; located within low traffic areas; and large enough to segregate incoming
materials from material already received and approved. Materials should be stored in a manner that
allows for sufficient cleaning and inspection.
Raw material containers, and storage areas should be protected from contamination by air, dust,
water, and personnel. Storage areas, and raw material containers should be cleaned on a schedule.
For more specific guidance for storing raw materials consult “Handling, Storage and Analysis of
Raw Materials” (Section 5).
Bulk storage of raw materials, process intermediates, and finished products should be protected
from microbial contamination. Bulk material should be properly labeled. Bulk subjected to extend‑
ed storage should be sampled and retested before use in accordance with established procedures.
A program should be established for cleaning and sanitizing bulk storage containers (Section 3 –
cleaning and Sanitization).
RAW MATERIALS
A. Specifications
Personal care manufacturers should evaluate the microbiological quality of their raw materials,
and establish appropriate specifications based on the best available scientific information. Micro‑
biological specifications should be established for all raw materials susceptible to contamination
(See Section 5 – Handling and Storage of Raw Materials and Section 11 – Raw Material Micro‑
bial Content). The microbiological quality assurance program should include provisions that:
B. Identifying Materials
All raw materials, intermediate, and finished product, should be clearly marked as to their iden‑
tity.7
C. Sampling Plan
For sampling plan see Section 6 (Microbiological Sampling) and the PCPC Quality Assurance
QUALITY ASSURANCE
Guidelines.8
MICROBIOLOGICAL
A program should be established to ensure that appropriate packing materials and product contain‑
ers conform with in-house microbiological specifications.
FINISHED GOODS
Finished goods should be sampled and tested to assure that products meet established microbiolog‑
ical specifications and should not be released for distribution until the satisfactory completion of
the testing. See Section 6 (Microbiological Sampling) and Section 11 (Establishing Microbiological
Quality of Personal Care Products) for guidance.
LABORATORY PRACTICES
A. Microbiological Quality Assurance Laboratory
Several key functions of the Microbiological Quality Assurance Laboratory are:
• Analyze raw materials for microbial content, and determine if microbiological specifications
are met;
• Check to ensure that plant hygiene procedures are implemented, and effective;
• Ensure that the microbial status of finished product meets established specifications;
• Investigate, and resolve contamination problems;
• Establish a program to routinely monitor critical control points, including cleaning, sanitiza‑
tion, and storage of processing and filling equipment;
• Establish appropriate documentation, and record-keeping procedures for laboratory testing;
Microbiological testing should be conducted in a laboratory specifically designed for this pur‑
pose. Alternatively, microbiological quality assurance may be subcontracted. For additional guid‑
ance see the Section 8 (Microbiology Laboratory Audit) guideline.
1
B. Procedures
QUALITY ASSURANCE
MICROBIOLOGICAL
The following are the main suggested procedures for the microbiological laboratory:
It is recommended that completed records be maintained for at least two years after distribution
of the batch of manufactured product.4
MONITORING
The PCPC Quality Assurance Guidelines recommends periodic self-audits.4 Periodic surveillance or
inspection of facilities, operations, practices, housekeeping and sanitation is an excellent adjunct to
a microbiological quality assurance program. Such monitoring helps to verify consistent compliance
with established procedures, to confirm that the systems continue to be adequate for provision of
safe and effective products, and to identify areas that may require improvement. Appropriate mea‑
sures should be taken where undesirable trends become evident or when conditions are noted that
may cast doubt on product or process integrity.
REFERENCES
1. “Current Good Manufacturing Procedures (cGMP’s) for Finished Pharmaceuticals,” Title 21,
Code of Federal Regulations, Part 211 (21 CFR 211).
2. Nikitakis, J.M. (ed.) 2014. “Glossary of Terms,” PCPC Quality Assurance Guidelines, The
Personal Care Products Association, Washington, DC 20036 (December 1992).
3. Nikitakis, J.M. (ed.) 2014. PCPC Quality Assurance Guidelines, The Personal Care, Products
Association, Washington, DC 20036 (December 1992).
QUALITY ASSURANCE
MICROBIOLOGICAL
4. Nikitakis, J.M. (ed.) 2014. ISO 22716 Cosmetic Good Manufacturing Practices. In PCPC
Quality Assurance Guidelines, The Personal Care Products Association, Washington, DC 20036.
5. Nikitakis, J.M. (ed.) 2014. Annex 1 Personnel and Training. In PCPC Quality Assurance
Guidelines, The Personal Care Products Association, Washington, DC 20036, pp (December
1992).
6. Nikitakis, J.M. (ed.) 2014. Annex 3 Equipment – Part 2 – Processing. In PCPC Quality
1
Assurance Guidelines, The Personal Care Products Association, Washington, DC 20036, pp. 21-31.
7. Nikitakis, J.M. (ed.) 2014. Annex 6 Finished Products/Lot Identification & Control. In PCPC
Quality Assurance Guidelines, The Personal Care Products Association, Washington, DC 20036, pp
55-58.
8. Nikitakis, J.M. (ed.) 2014. Annex 17 Sampling: Part I - General Provisions Sampling Plan. In
PCPC Quality Assurance Guidelines, The Personal Care Products Association, Washington, DC
20036, pp 103-106.
Microbiological
Evaluation of the
Plant Environment
INTRODUCTION
The personal care product manufacturing plant environment may directly or indirectly affect the
microbiological quality of personal care finished products. Environmental assessment of the plant
primarily employs air and surface monitoring techniques. Evaluation of monitoring results takes
into consideration the intrinsic factors that affect the microbial environmental quality within the
facility. Changes in environmental data (i.e., trend analysis) can serve as useful indicators of the need
2
for investigation and possible corrective actions.
PLANT ENVIRONMENT
EVALUATION OF THE
For facilities that manufacture products that are regulated as over-the-counter (OTC) drug products
in the United States, refer to the United States Pharmacopeia (USP),1 Parenteral Drug Association
(PDA),2 and Current Good Manufacturing Practices (cGMPs)3-5 for guidance in how to conduct
environmental monitoring for a manufacturing plant.
Manufacturers have the responsibility to determine what type of program is most suitable for their
facilities, since each manufacturing plant is unique. This guideline sets forth general and specific
information to aid manufacturers in designing environmental monitoring programs that are suited
to their own needs. Some information offered may not be directly applicable to the operations of
every facility. However, an established environmental monitoring program can provide the data,
tools, and procedures needed to maintain a well-functioning facility. An effective program can pro‑
vide information about areas of the plant that potentially may affect the microbial quality of the
finished product.
The Food and Drug Administration (FDA) has another approach that could be considered, which is
Hazard Analysis Critical Control Point (HACCP). HACCP is a systematic approach for evaluating
hazards and risks of various parts of a process and places controls and systems at critical points.6
Good communication between microbiologists and facility engineers is essential in maintaining
awareness of changing environmental factors that could alter the microbiological quality of the
plant environment.
MANUFACTURING ENVIRONMENT
The quality of the manufacturing plant environment is largely influenced by five basic factors: facili‑
ties, equipment, personnel, housekeeping, and cleaning and sanitization. Understanding these factors
is essential when developing an environmental control program. Additional guidance on these topics
is given in Section 3 (Cleaning and Sanitization) and the PCPC Quality Assurance Guidelines.7
A. Manufacturing Facility
1. Design
A well-designed, well-constructed manufacturing facility can contribute to a high-quality fin‑
ished product. Proper design can minimize cross-contamination and contamination from the
surrounding environment. Contamination of the plant environment by microorganisms, dust,
and dirt can be controlled by the use of vent filters, drain traps, and tight-fitting doors and
windows. Airborne dust contamination can be minimized by filtered air-handling systems that
provide adequate ventilation, temperature, and humidity controls to prevent cross-contamina‑
tion. Materials used for building interiors should be durable, designed to be easily cleaned, and
adequately maintained. Overhead utilities (pipe work) can be designed so as not to adversely
affect the manufacturing environments. Ductwork for these utility systems should be com‑
posed of nonporous and non-flaking material.
General building design includes suitable barriers for separating manufacturing and packaging
areas from warehouses, offices, locker rooms, and washrooms. In particular, a good building
PLANT ENVIRONMENT
design provides separate areas for material receipt, storage, weighing, compounding, filling,
EVALUATION OF THE
packaging etc. Traffic flow of both personnel and materials (e.g., raw ingredients, packaging
component, and finished stock) can be minimized in processing and packaging areas.
When considering building design concepts, some decisions on the desired level of control
may be based on present and anticipated requirements of products and manufacturing
2. Operational Influences
Both internal and external conditions are important factors that can affect the microbiological
2
quality of the plant environment. These diverse factors are taken into consideration when de‑
termining facility design as well as the frequency of microbiological monitoring.
Some examples of internal influences are:
• Construction
• Surrounding environment (farm lands, wet lands)
• Equipment drawings and/or schematics, which can provide helpful guidance for cleaning and
sanitization protocols (Refer to Section 3 - Cleaning and Sanitization).
• Equipment manufactured from smooth, nonporous materials, for example 316L stainless steel
• Valves and gauges that are easily disassembled for cleaning
• Equipment made from materials that are compatible with products and cleaning and sanitiza‑
tion solutions
2
In the PCPC Quality Assurance Guidelines, Annex 3 which covers packaging and processing
PLANT ENVIRONMENT
EVALUATION OF THE
equipment gives important direction on construction, cleanability, and related items.8,9
C. Personnel
Personnel are encouraged to practice good personal hygiene. Wearing clean uniforms and appro‑
priate clothing like, head covers, beard covers, clean gloves or finger cots will help prevent con‑
tamination. Adequate locker room facilities, washrooms, and eating areas should be physically
separated from the manufacturing, filling, and packaging areas of the plant.
It is recommended that employees responsible for sanitation and housekeeping be thorough‑
ly trained in all pertinent procedures as part of an ongoing training program. All employees
involved with manufacturing and packaging should be trained to follow Personal Care Good
Manufacturing Practices through a regular training program.10 Training programs are most effec‑
tive if documented and conducted periodically according to a pre-planned schedule. For more
information, refer to Section 3(Cleaning and Sanitization).
D. H ousekeeping
The general plant environment should be maintained in a clean and orderly state. For example,
cleaning and /or sanitization of floors, walls, ceilings, vents, pipes, fixtures and equipment exteri‑
ors should be conducted on a regular schedule according to written operating procedures. Equip‑
ment, hoses, tools, and other items not in use should be stored in a clean state and protected from
contamination. Personal Care facilities should have effective programs for control of rodents and
other pests, and for proper refuse disposal. For additional guidance, refer to Annex 2 - Premises
(Facility) in the PCPC Quality Assurance Guidelines.11
The following are among the elements to be considered when establishing an environmental mon‑
itoring (EM) plan.
A. Training
Personnel involved with environmental sampling should be properly trained according to a writ‑
2
ten procedure applicable to such testing, which includes at least the following:
B. Documentation
Documentation provides an organized record of the microbiological evaluation. It is recommend‑
ed that the following information be included for proper documentation of an environmental
monitoring program:
1. Procedural information
2. Reported Data
2
• Date and time
• Signature of investigator (a microbiologist or suitably trained individual)
PLANT ENVIRONMENT
EVALUATION OF THE
Additional information may be included based on in house needs or company policies.12
C. Baseline Data
Periodic microbiological monitoring of physical surfaces should be performed to determine the
baseline levels of the microbial flora within the different areas of the manufacturing environment.
Baseline variations in the microbial levels may be variable depending on internal and external
conditions. Operational influences are summarized previously in this section in the discussion of
the “Manufacturing Environment.”
Statistical analysis of environmental historical microbiological test data may be used to set the
alert and action level criteria for deciding when to investigate a shift in the trend. It is common
practice to periodically reevaluate the alert and action levels. There are several statistical methods
for evaluating the data.12,13
SURFACE SAMPLING
A. Surfaces14,15
The microbiological quality of physical surfaces within a manufacturing environment can direct‑
ly or indirectly affect the microbial quality of finished personal care products. Physical surfaces
coming into direct contact with finished product may include:
Surfaces not coming in direct contact with the product that could affect microbiological quality
PLANT ENVIRONMENT
may include:
EVALUATION OF THE
• Walls
• Floors
• Ceilings
• Overhead lighting and piping
• Vertical and horizontal support beams
2
• Overhead walkways
• External processing and filling equipment surfaces
• Pallets and forklift trucks
• External packaging materials
• Air handling systems
B. Monitoring Frequency
The type and frequency of microbiological monitoring of physical surfaces depend on the sus‑
ceptibility of the finished product to microbial contamination as well as other factors. Additional
factors to be considered are the scale of manufacturing, condition and design of plant, type of
process, local environmental factors, and company policies. Areas that are in direct contact with
finished product are usually monitored more frequently than areas that are not.
In areas directly contacting product, any increase from predetermined microbial alert and ac‑
tion levels may indicate a potential microbiological problem that could affect product quality.
Increased frequency of testing, adjustments to cleaning and sanitization protocols, or changes in
C. Methods
Sampling by means of swabs, direct contact devices, or contact plates are the most common
methods of monitoring surfaces for microbial contamination.16,17 Note that swabs and contact
plates will not recover total microbial bioburden from a surface.
Exit monitoring of rinse water can be used to evaluate interior surfaces of manufacturing and
filling equipment. However, rinse water testing may not be useful in detecting the presence of
biofilm bacteria.18 See Table 2-1 for different surface sampling methods.
1. Swabbing: Sterile swabs can be used to sample environmental surfaces for the presence of
microbial contamination. The sterile swab is wetted in sterile buffer, saline solution, or broth
and rubbed over a measured portion of the surface to be monitored. The swab is then either
streaked across an agar plate or placed into a sterile broth tube. The plate or tube is incubated
for the appropriate length of time.
2
a. Swabs: Swabs can be used on flat, irregular surfaces and on hard-to-reach areas. The three
PLANT ENVIRONMENT
EVALUATION OF THE
most common composition materials for swabs are dacron, cotton wool, and calcium al‑
ginate. Calcium alginate is a fibrous material that dissolves in sodium citrate or sodium
hexametaphosphate, a characteristic that facilitates the total release of microorganisms that
have been recovered on the swab from the surface. This allows for a quantitative analysis.19
Leachables from cotton wool swabs, such as fatty acids, may be inhibitory or detrimental
to microbial growth.20 Whichever type of swab is used, all on-going testing should be per‑
formed with the same type of swab and be processed as soon after collection as feasible.
In cases where there is a delay (e.g., swab samples need to be shipped to a laboratory for
processing and analysis), transport swabs may be used. Transport swabs are designed to
maintain the viability and numbers of microbes present at the time of sampling until the
time of processing. The swab manufacturer should be consulted for storage and temperature
conditions to determine how long after use a transport swab can maintain the viability of
microorganisms.21
b. Sampling: Using aseptic technique, the sample site is sampled by rubbing a pre-moistened
swab over the surface. Moistened swabs are essential for recovery of the highest possible
numbers of bacteria, molds or yeasts. Solutions used to wet the swab may be, but are not
limited to, the following: sterile buffer, saline solution, or broth.
If sanitizer or disinfectant residues are present on the surfaces being sampled, they may
interfere with the test results. All of the solutions used to wet swabs should contain a neu‑
tralizer if disinfectant or sanitizer residues are expected.
An appropriate cleaner such as 70% alcohol should be used after sampling to remove swab
residue. A sterile template (e.g., 2 x 2in. area) may be used to standardize the amount of
surface area sampled.
c. Processing Swabs: Three basic techniques are commonly used to process swabs after sampling
a surface.
i. Direct Swab Methods. After a swab has been used to sample a test surface, it can either be
streaked directly onto an agar surface in a Petri dish or it can be added to an enrichment
broth as described below. A variety of media both general and selective, may be used, e.g.,
Trypticase Soy Agar, Pseudomonas Isolation Agar, MacConkey, Sabouraud Dextrose, etc.
If general and selective media are used, inoculate the general media first. If the selective
media is inoculated first, inhibitory ingredients may be carried over to the general media
and prevent growth. Include a neutralizer in the media if the sanitizer/disinfectant resi‑
dues on the sampled surface may interfere with the test results.
This technique may be used for testing those surface areas on which low numbers of mi‑
croorganisms are expected and for which a quantifiable result is needed. Streaked Petri
dishes or enrichment broth are incubated for the appropriate period and temperature.
Note: The use of selective agars when directly plating swabs can be inhibitory to injured
microorganisms. The results, either microbial growth or no growth, may not be repre‑
sentative of the types of microorganisms that are actually present on the surface. Unless
looking for specific types of microorganisms, the use of general microbial growth media
or enrichment techniques may give more useful information in an environmental moni‑
PLANT ENVIRONMENT
toring plan.
EVALUATION OF THE
ii. Swab Enrichment Methods. This technique may be used in areas where low numbers of
microorganisms are expected. After sampling a test surface, aseptically transfer the used
swab directly into a test tube of enrichment broth. Include a neutralizer in the enrich‑
ment broth if there is a concern that sanitizer/disinfectant residues on the sampled surface
may interfere with the test results. Incubate the test tube with swab for the appropriate
period and temperature.
Test results may be recorded as:
• Growth or no growth per swab, based on the presence or absence of turbidity in a gen‑
eral enrichment broth or
• Growth or no growth per unit area (e.g., per square inch or square centimeter)
iii.Standard Plate Count Methods. This technique can be used in those areas in which there
could be either high or low numbers of microorganisms. After sampling the test surface,
aseptically transfer the swab into a sterile test tube containing 10 milliliters of enrichment
broth. Enrichment broth may include neutralizer(s) for sanitizer/disinfectant residues.
Vortex the test tube to release microorganisms from the swab into the broth. If sampling
with calcium alginate swabs, sodium citrate or sodium hexametaphosphate may be used
to dissolve the swab and aid in releasing recovered microorganisms from the swab. Re‑
move aliquot(s) of the broth and plate onto a general microbial growth agar medium
and/or onto selective / differential agar media. Agar media may include a neutralizer(s)
for sanitizer/disinfectant residues that may have been picked up by the swab in sampling
test surfaces. If high numbers of microorganisms are expected, further dilute the original
swab dilution sample and plate these aliquots.
To record results, count the colonies on countable plates, multiply by the dilution factor
and record as number of microorganisms per swab, or per unit area (e.g., per square inch
or square centimeter).
2. Contact Sampling: Contact sampling may be performed by using either modified Petri dishes
(i.e., RODAC plates), paddles, or flexible films, which contain a solid agar culture medium
whose convex surface extends above the carrier. Selective and non-selective agar media may be
used. The sterile agar surface is applied to the test surface so that the agar makes total contact
with the area being sampled. An appropriate cleaner such as 70% alcohol is used after sampling
to remove any remaining agar residue. The sampling devices are incubated, after which the
degree of microbial contamination per unit area can be determined. Factors to be considered
when choosing one of these methods are:
2
• Suitability for flat surfaces only
PLANT ENVIRONMENT
EVALUATION OF THE
• Usefulness in remote areas under field conditions
• Commercial availability of disposable units
• Suitability for qualitative/quantitative analysis of environmental cleaning and sanitization
procedures
• Limited shelf life
• Cost
• Problem of confluence, with certain microorganisms, especially if agar surface is wet
3. Rinse Water Method This technique is generally used to sample either equipment interior
surfaces (e.g., kettles, tanks etc.) that cannot be reached using a swab technique or other hard
to access surfaces that come into direct contact with finished product. The rinse water meth‑
od consists of flushing the selected surface with a suitable volume of sterile rinse water, next
collecting a sample of the rinse water, and then quantitatively determining the number of mi‑
croorganisms in the sample. Membrane filtration, pour plates, spread plates or Most Probable
Number (MPN) procedures can be used to quantify the microbial recovery. Advantages of
rinse water method include:
D. General Applications
Physical surfaces coming into direct contact with the product should be examined for the pres‑
ence of bacteria and fungi that are known to cause product spoilage, or harm to the consumer.
Indirect surfaces such as walls and floors should also be monitored to determine background
levels of microorganisms that are intrinsic to the manufacturing environment.
In general, all equipment (processing and filling), valves, traps and working surfaces should be
monitored on a defined and periodic basis. Transfer lines should be taken apart and tested. Viable
microbial counts should be performed to determine the levels of microorganisms that are present
in these areas.6
AIR SAMPLING
The selection of sites for air sampling is based primarily on the potential for adverse microbiological
effects on the finished product. Routine air monitoring may include selected environmental sites
within the facility as well as sources of compressed air used in manufacturing. Factors to take into
consideration when developing an environmental air monitoring program include room design,
airflow pattern, proximity to vents, and potential for product exposure.19-22
PLANT ENVIRONMENT
EVALUATION OF THE
A. Monitoring Frequency
The air-monitoring program establishes the frequency of routine sampling at each location based
on in-house needs, with the areas of greater microbiological concern being monitored more fre‑
quently. The schedule for air monitoring in each designated area is based upon previously de‑
termined microbial baseline levels. Monitoring frequency is determined in part by the type of
activities in each area, such as machine operation, personnel, physical cleaning, construction, etc.
2
Seasonal changes and climate are also important considerations when establishing an air-sam‑
pling program. Areas of greater microbiological concern, such as exposed product and raw mate‑
rials are usually monitored more frequently.
Supervisory personnel, the plant microbiologist, or other or suitably trained individual should
review and analyze the microbial test data generated during air sampling. These data can be used
for trend analysis and provide a history of the plant environment, which can be used to evaluate
sampling frequency or investigate shifts in microbiological quality.
B. Methods
A variety of methods may be employed for environmental and compressed air sampling. Each is
designed to meet specific needs.23-25 Some sampling methods measure all particulates, including
viable and non-viable microorganisms. Others only measure viable organisms. Consider the fol‑
lowing factors when choosing an air-sampling method:
• Collection medium
• Quantitative vs. qualitative measurement
• Ability to determine the number of colony-forming units per unit of time or volume sampled
The monitoring method(s) chosen will be influenced by the requirements of the individual facil‑
ity. The requirement or need to measure only viable microorganisms versus all other particulate
matter should be determined.
1. Viable Methods The most commonly used methods for measuring viable organisms, many of
which are available commercially, are listed below. Also see Table 2-2.
a. Settling Plate A Petri dish containing Trypticase Soy Agar or other suitable general microbial
growth agar is directly exposed in the sampling area (i.e., placed upright in the area with
the lid off). Particles in the air settle out on the agar surface. After a specified exposure time,
the Petri dish is collected, covered with the lid, and incubated. The number of microbial
colonies is counted directly from the plate.
b. Centrifugal Air Sample Air is collected via centrifugation through impeller blades and micro‑
organisms are deposited onto the surface of a nutrient agar medium in a strip. The growth
agar strip is incubated and the number of organisms per volume of air is calculated.
2
c. Sieve Impaction Sampler Air is drawn into the unit through a sieve and over the surface of an
PLANT ENVIRONMENT
EVALUATION OF THE
agar plate. After incubation of the plate, the number of viable microorganisms per unit of
time or volume of air may be determined.
d. Slit-To-Agar Sampler Microorganisms are impinged directly onto a microbial growth agar
surface in a Petri dish that rotates beneath a slit opening. Air is drawn through this slit by
the use of a vacuum. The speed of the Petri dish rotation and the volume of air sampled can
be adjusted. After incubation of the plate, the number of viable microorganisms per unit of
time or volume of air can be calculated.
e. Liquid Impinger Air is drawn through a sampler tube, and particles are collected in liquid
medium. The air rises and is removed from the system. Serial dilutions of the liquid medium
are made, and duplicate aliquots are plated into empty Petri dishes to which a sterile melted
microbial growth agar is then added. The Petri dishes are allowed to solidify and are incu‑
bated. After incubation, the number of microbial colonies is counted per Petri dish, and an
average is calculated for each duplicate serial dilution.
f. Multi- Stage Particle Sizing Sampler The sampler contains up to six plates, arranged vertically.
A measured volume of air is drawn through successively smaller holes in the sieve plates,
resulting in acceleration of the particles at each stage. Viable particle size distribution is then
calculated from the plate counts at each stage.
g. Membrane Filter Air to be sampled is impinged on a gelatin membrane filter, which is then
removed from the filter holder and placed in a dish containing a general microbial growth
medium. After an appropriate incubation period, the number of microbial colonies on the
membrane surface is counted.
EVALUATION OF RESULTS
There are no set criteria for microbiological monitoring of the environment in plants manufactur‑
ing personal care products. Trend analysis performed on the data from microbiological monitoring
PLANT ENVIRONMENT
of surfaces and air in the plant offers a useful evaluation tool. Shifts from established data patterns
EVALUATION OF THE
may indicate changes in the environment or work practices that may have the potential to affect the
microbial quality of the finished product.
In the evaluation of environmental test results, alert and action levels should be established for each
manufacturing area. Levels set will depend on the areas monitored, the historical trend data from
the area, the type of monitoring, and potential effects on finished product quality.
2
B. Documentation
Documentation is important in establishing the historical trend data in the plant. The trend anal‑
ysis of microbial recovery levels in the environmental may be useful when
Once a program is in place, results generated should be documented by keeping an organized record
system. Records of environmental monitoring should be maintained for appropriate length of time.
These data can be used to establish a normal range of results. Supervisory personnel, a microbi‑
ologist, or other qualified individual should routinely review all results. Based on these results, a
feedback mechanism can be established whereby all departments involved are informed when the
environmental quality is outside of the normal range. The responsibility for documentation and
communication should be addressed by internal standard operating procedures.
2
Refer to “Microbiological Documentation and Validation” (Section 9) and to “Production and
PLANT ENVIRONMENT
EVALUATION OF THE
Control Documentation.”27
C. Interpretation
Once all the data have been collected, consideration of the following information will help in
their interpretation:
• Retesting of the affected areas (Depending on the extent of the problem, manufacturing or
filling may be delayed until all environmental testing is complete.)
• Recleaning and resanitization of equipment, floors, walls, etc.
• Additional testing of finished product to ensure its quality
• Retraining/reinforcement of cleaning and sanitization procedures
• Modification of engineering controls
• Modification of practices or processes
• Documentation of corrective action taken
PLANT ENVIRONMENT
EVALUATION OF THE
CONCLUSION
A microbiological monitoring program for the plant environment is a tool to help assure the mi‑
crobiological quality of products manufactured for the Personal Care industry. An environmental
monitoring program includes the microbiological monitoring of surfaces, air, raw materials, and
product. The value of the program depends on adequately trained testing personnel, documentation
of test data, assessment of results, and appropriate response. Once a microbiological profile of the
plant has been established, trend analysis can be used to develop alert and action criteria. Changes
2
in the trend may indicate the need for an investigation, after which a correction action plan may
be implemented. Each step of the process should be accompanied by appropriate documentation.
Table 2-1
SURFACE-SAMPLING METHODS
Method Description Advantages Disadvantages
Contact A contact plate may be • Can be used in remote areas • Short shelf life under field
Plating modified Petri dishes, paddles • Samples the same size area conditions
or flexible films containing each time as defined by the • Not suitable for irregular
a solid microbial growth size of the device surfaces
agar whose convex surface • Can be qualitative or • Microbial overgrowth may
2
extends above the carrier. quantitative be a problem
The sampling device may • May leave a residue or
contain any of a number of microbial growth agar on
PLANT ENVIRONMENT
EVALUATION OF THE
various types of microbial the surface after being
growth agar with or without sampled; the agar media
a disinfectant/sanitizer residue needs to be
neutralizing agent. removed.
Rinse Water The rinse water technique • Can be used to test • May not detect the presence
consists of flushing the otherwise inaccessible of biofilm bacteria.
surface to be tested with a areas such as the interior • Not suitable for many
sterile rinse solution such as equipment surfaces of applications.
water. manufacturing equipment. • Extensive manipulation may
• Larger surface areas may be be required.
sampled. • Sample processing may
• Quantitative affect test results
Table 2-2
AIR-SAMPLING METHODS28
Method Description Advantages Disadvantages
Centrifugal Lightweight, portable • High recovery efficiency • Requires special agar strips that
Impactor unit that measures a • Portable are expensive and available only
quantifiable volume • Speed and ease of operation from the manufacturer
of air (1 to 1,000 liters). • Excellent for areas that are • Strips have a limited shelf life
The sampling media difficult to access • Overgrowth of strips in heavily
are agar strips. • Measures concentration of contaminated areas
viable particles as function of
time and unit volume of air
PLANT ENVIRONMENT
EVALUATION OF THE
• Selective/differential agar
strips are available.
Sieve Air is drawn through a • Colony overlapping minimal • May be cumbersome if used
Impaction uniformly perforated • Large air volumes possible with a vacuum
Sampler surface and is • Portable
distributed over an • Air flow can be calibrated
agar surface. • May be used to sample
compresses air when used
with a vacuum
• Choice of agar dish size and
2
media is flexible
Slit to Agar Air is pulled through • Measures concentration of • Vacuum source required
Sampler a slit over a revolving viable particles as function of • Not easily portable
plate. volume of air • Large numbers of sampling
• No serial dilution or plating areas are needed, very time
required consuming.
• Wide application in • Electrical connection required.
surveillance of ambient air • Best suited for clean rooms
contamination • Some systems require 150 mm
• Volume and speed adjustable agar plates
• Constant surveillance not
necessary
• Remote sampling probe can
be used
Liquid Air is drawn through • Samples with high viable • Low sampling rate
Impingement a sampler tube and counts can be diluted for • Vacuum source required
particles are collected enumeration • Time consuming
in liquid medium. • Quantitation is good for • Requires dilution and plating
Microbial counts are spores and vegetative cells • Breaks up bacterial particles
determined in the • Inexpensive • Device may consist of breakable
liquid. glass components
Table 2-2
Sieve A specific volume of • Determines size of particles • Limited sampling duration does
Multistage air is drawn through a • Portable not provide entire picture
Particle Sizing series of sieve plates, • Measures concentration of • Requires many plates
Sampler resulting in particle viable particles as a function • Vacuum required
size separation. This of time • Not well adapted for heavily
allows plate counts at • No serial dilution or plating contaminated areas.
each stage. required • Agar desiccation
• Comparable to the impingers
2
PLANT ENVIRONMENT
EVALUATION OF THE
REFERENCES
1. United States Pharmacopeia and the National Formulary (USP39-NF34) 2016 (U.S.
Pharmacopeia, 1260 Twinbrook Parkway, Rockville, MD 20852).
2. Parenteral Drug Association. 2014. “Technical Report No. 13 (Revised) Fundamentals of
Environmental Monitoring Program,” PDA. Parenteral Drug Association, Bethesda, MD.
www.pda.org
3. U.S. Food & Drug Administration. 2015. FDA 21 CFR, Part 210 Current Good
Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General.
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=210
4. U.S. Food & Drug Administration. 2015. FDA 21 CFR, Part 211 Current Good
Manufacturing Practice for Finished Pharmaceuticals. https://www.accessdata.fda.gov/scripts/
cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=211
5. U.S. Food & Drug Administration. 2001. Guidance for Industry, Q7A Good Manufacturing
Practice Guidance for Active Pharmaceutical Ingredients. http://www.fda.gov/ICECI/
ComplianceManuals/CompliancePolicyGuidanceManual/ucm200364.htm
6. Mortimore, S., and Wallace, C. (eds.) 2013. HAACP: A Practical Approach. Third Edition,
PLANT ENVIRONMENT
7. Nikitakis, J.M., ed. 2014. PCPC Quality Assurance Guidelines, The Personal Care Products
Council, Washington, DC 20036
8. Nikitakis, J.M., ed. 2014. Annex 3 – Equipment – Part 1: Packaging, In PCPC Quality
Assurance Guidelines, The Personal Care Products Council, Washington, DC 20036, pp 17-20.
9. Nikitakis, J.M., ed. 2014. “Annex 3 - Equipment: Part 2 – Processing., In PCPC Quality
Assurance Guidelines, The Personal Care Products Council, Washington, DC 20036, pp. 21-30.
2
10. Nikitakis, J.M., ed. 2014. Annex 1 Personnel and Training. In PCPC Quality Assurance
Guidelines, The Personal Care Products Council, Washington, DC 20036, pp1-6
11. Nikitakis, J.M., ed. 2014. Annex 2- Premises(Facility) , In PCPC Quality Assurance Guidelines,
The Personal Care Products Council, Washington, DC 20036, pp. 7-16.
12. Parenteral Drug Association. 2014. Fundamentals of Environmental Monitoring Program
Technical Report No. 13 (Revised). Parenteral Drug Association, Bethesda, MD 20814.
www.pda.org
13. Ibid., p. 8-9
13. Reich, R.R., Miller, M.J. 2003. Developing a Viable Environmental Monitoring Program for
Nonsterile Pharmaceutical Operations. Pharmaceutical Technology 27: 92-100.
14. American Society for Testing Materials. 2015. ASTM Standards on Materials and
Environmental Microbiology. ASTM, West Conshohocken, PA 19428-2959
15. Block, S.S., ed. 2000. Disinfection, Sterilization, and Preservation, 5th Edition, Lippincott
Williams & Wilkins, Philadelphia, PA.
16. Dyer, R.L., Frank, J.F., Johnson. B., Hickey, P., and Fitts, J. 2004. Microbiological Tests for
Equipment, Containers, Water, and Air, In: Standard Methods, For the Examination of Dairy
Products, 17th Edition, Wehr HM and Frank, JF (Eds.), American Public Health Association,
Washington, DC.
17. Lemmen, S.W., Hafner, H., Zolldan, D. Amedick, G., Lutticken, R. 2001. Comparison of
two sampling methods for the detection of Gram-positive and Gram-negative bacteria in the
environment: moistened swabs versus Rodac plates, Int. Journal of Hygiene and Environmental
Health 203: 245-248.
18. U.S. Food and Drug Administration, 2014. Guide to Inspections - Validation of Cleaning
Processes (7/93) www.fda.gov/ICECI/inspections/inspectionguides/ucm074922 p. 5.
19. Parenteral Drug Association. 2014. Fundamentals of Environmental Monitoring Program
Technical Report No. 13 (Revised)., sec. 4.4.3.2.3, p. 20. Parenteral Drug Association, Bethesda,
MD 20814, p. 20.
20. Tille, P. (ed). 2013. Bailey and Scott’s Diagnostic Microbiology, Thirteenth Edition, Mosby/
2
Elsevier, Philadelphia, PA.
PLANT ENVIRONMENT
EVALUATION OF THE
21. Hindiyeh, M., Acevedo, V. and Carroll, K.C. 2001. Comparison of Three Transport Systems
(Starplex StarSwab II, the New Copan Vi-Pak Amies Agar Gel Collection and Transport Swabs,
and BBL Port-A-Cul) for Maintenance of Anaerobic and Fastidious Aerobic Organisms. J. Clin
Microbiol. 39:277-380.
22. Powitz, R. W. 2002. ASampling of Airborne Biological Contaminants: A Rational Approach.
http://www.cemag.us/articles/2002/01/sampling-airborne-biological-contaminants-rational-
approach
23. Mehta, S., Bell-Robinson, D., Groves, T., Stetzenbach L., Pierson, D. 2000. “Evaluation of
Portable Air Samplers for Monitoring Airborne Culturable Bacteria. AIHA Journal 61:850-4.
24. Shelby, S., Grinshpun, S., Willeke, K., Terzieva S., Ulevicius V., Donnelly, J. 1995. Effect
of Impact Stress on Microbial Recovery on an Agar Surface@ Applied and Environmental
Microbiology. 61:1232-1239.
25. ISO 2015. ISO 14644-2 Cleanrooms and associated controlled environments — Part 1:
Classification of air. cleanlinesswww.iso.org.
26. ISO 2015. ISO 14644-2 Cleanrooms and associated controlled environments — Part 2:
Specifications for testing and monitoring to prove continued compliance with ISO 14644-1, ISO,
Geneva, Switzerland (2000). http://www.iso.org.
27. Nikitakis, J.M., ed. 2014. Annnex 5- Production Control In: PCPC Quality Assurance
Guidelines, The Personal Care Products Councilt, Washington, DC 20036, pp. 35-44 (December
1992).
28. Hess, K. 1996. Environmental Sampling for Unknowns, CRC Press, Boca Raton, FL.
INTRODUCTION
Effective cleaning and sanitization programs are essential to ensure microbial quality in the manu‑
facture of personal care products. Cleaning procedures and sanitization procedures should be val‑
idated in order to consistently meet hygienic manufacturing requirements. The design of cleaning
and sanitization procedures should take into account the product formulation, engineering design
of equipment, and all aspects of manufacturing.
GENERAL CONSIDERATIONS
Specific internal programs for cleaning and sanitization should be established. These programs are
essential to:
3
• Minimize the microbial load contributed by processing, filling, and storage equipment
• Avoid the time and resources associated with microbial failures
SANITIZATION
CLEANING AND
• Maintain integrity and condition of the equipment
If cosmetics and drug products are manufactured with the same equipment, refer to FDA guide‑
lines for the manufacture of Over-the counter (OTC) drugs.1-3 Factors such as active ingredient and
cleaner residues are important areas of cleaning and sanitization but are beyond the intended scope
of this document. For the purpose of this document, the following definitions apply:
• Cleaning - the process of removing product residue and contaminants such as dirt, dust,
and grease from surfaces. Cleaning is an essential step that needs to be performed before the
performance of a sanitization procedure. It is important that personnel involved in cleaning
have a working understanding of the nature of different types of soils and the chemicals
required for their removal.
• Sanitization - the process utilized to reduce viable microbial contaminants to an acceptable
level such as the microbial count specification of the finished product. All surfaces must be
clean for the sanitization procedure to be effective.
PCPC MICROBIOLOGY GUIDELINES | 31
SECTION 3 CLEANING AND SANITIZATION
• Validation - the process of substantiating that the process does what it purports to do.
• Documentation - the process of organizing all relevant information in an orderly and easily
understood format. This documentation is required to support the validation of a process
and to maintain a historical record of the process and equipment usage.
Guidance for the development of operating procedures is addressed in each section below, as ap‑
propriate. Written protocols are required prior to attempting to validate any process. For more
information, see the “Microbial Validation and Documentation” (Section 9) and “Microbiologi‑
cal Evaluation of the Plant Environment”(Section 2). Additional information on cosmetics Good
Manufacturing Practices can be found in the Personal Care Product Council’s “Quality Assurance
Guidelines.”4 In addition, an understanding of the importance of biofilms5-7 and application of haz‑
ard analysis of critical control points (HACCP)7-9 should also be considered.
Biofilms
A biofilm5-7 is a community of mixed microorganisms encased in an extracellular polymer matrix,
which they produce and secrete. Bacteria living in a biofilm may behave as a unit or multicellular
organism. Biofilms have the potential to develop in most aqueous systems including process water
systems and on those areas of manufacturing equipment that is difficult to clean and sanitize. Bio‑
films can be also be present on equipment surfaces that appear to be visually clean.
Biofilm Characteristics
• Once formed, biofilms become continuous sources of microbial contamination as microor‑
ganism clumps or aggregates will break from the biofilm and surfaces are colonized down‑
stream and potentially contaminate finished product.
• Although thermal methods (e.g., 65 to 85°C hot water or steam) kill microorganisms within
a biofilm, they are not effective in removing an established biofilm. Killed but intact biofilm
can become a nutrient source for rapid biofilm regrowth.
• Routine microbial sampling of water systems or equipment surfaces may not be able to de‑
tect the presence of biofilms because they are not dispersed homogeneously.
Microorganisms living in a biofilm on equipment are more difficult to kill and subsequently remove
CLEANING AND
SANITIZATION
than free floating organisms because they are protected by the polysaccharide matrix structure of the
biofilm. For chemical sanitization to be effective against biofilms, it must be performed frequently
in order to minimize the amount of biofilm development.
• The less developed and thinner the biofilm, the more effective the biocidal action.
• Compounds such as hydrogen peroxide, peracetic acid or peroxyacetic acid, and ozone oxi‑
3
dize microorganisms and kill biofilm organisms by the formation of reactive peroxides and
hydroxyl free radicals.
• Microorganisms growing in a biofilm can exhibit reduced susceptibility to antimicrobial
agents including disinfectants and sanitizers.
• Microorganisms in a well-developed biofilm can be extremely difficult to kill, even by ag‑
gressive oxidizing biocides due to protection by the polysaccharide layer of the biofilm.
HACCP
Hazard analysis critical control point (HACCP8-10) is a systematic preventive approach that address‑
es physical, chemical and biological hazards. HACCP is a risk assessment process that may be used
to identify the critical control points (CCP) of the system. CCP may include areas that are most
difficult to reach for cleaning and sanitization and that are keys to monitoring contamination in
order to maintain microbial control.
HACCP typically consists of 7 steps:
TRAINING
Personnel should be properly trained in the cleaning and sanitization of the facility and equipment.
3
A training program should be appropriate to the roles and responsibilities of the employee and
SANITIZATION
CLEANING AND
impart an understanding of the elements of cleaning and sanitization and their effect on product
quality. Training should include:
For further information on training, see “Microbiology Staff Training” (Section 4) and “Microbial
Validation and Documentation” (Section 9).
VALIDATION
All procedures used for cleaning and sanitization should be validated. For protocol and additional
information, see “Microbial Validation and Documentation (Section 9).
RECORD KEEPING
Ongoing documentation includes routine logs that are necessary to maintain a history of the equip‑
ment usage and cleaning and sanitization practices. This information can also serve as part of a
validation information package. It can be used for trend analysis and evaluating cycle reduction. A
cleaning and sanitizing record should be prepared, maintained, and made readily available for each
piece of equipment.
Equipment Records
Equipment records should include the following information:
Equipment Status
The current status of the equipment should be clearly displayed. Examples of status designation
labels may include:
• Needs Cleaning
• Clean Needs Sanitizing
• Sanitized*
• Out of Service
*Sanitization date and expiration time should be included on the label. If expiration time is exceed‑
ed, the equipment should be re-sanitized before being put back into service.
MANUFACTURING FACILITY
The environment of the manufacturing facility strongly influences the microbial quality of the fin‑
ished product. Appropriate building design and maintenance are critical. Standard procedures for
facility cleaning should be written and a record of their implementation should be maintained.11,12
For additional information, see “Microbiological Evaluation of the Plant Environment.” (Section 2)
Floors
Clean floors on a scheduled basis and include the following:
3
lavatory cleaning should be stored separately from cleaning supplies and equipment used in manu‑
facturing areas.
SANITIZATION
CLEANING AND
Warehouse Areas
General guidance for the warehouse area includes the following:
• Aisles should be kept neat and clean by sweeping, damp mopping or machine scrubbing. An
appropriate, freshly prepared cleaner should be used.
• An established, monitored, and documented insect and rodent control program should be
in place. For additional information, see “Quality Assurance Guidelines.”4
• Stored materials and containers should be kept clean, orderly, protected and correctly iden‑
tified.
Equipment design
The following guidance on overall equipment design is intended to minimize conditions that may
lead to microbial growth in the equipment. It also offers suggestions to reduce the potential degra‑
dation of the equipment by the effects of the cleaners and sanitizers used. It is essential to work with
your engineering department in choosing the appropriate equipment design and specifications for
your facility.
• Design manufacturing and filling equipment to minimize retention of residual product and/
or wash water. Where equipment is not self-draining, the installation of sanitary drain valves
or valves that can be completely disassembled may be of value. Residual water in equipment
will dilute product and/or sanitizer which can lead to microbial growth and the develop‑
ment of adaptable microorganisms.
• Minimize condensation in equipment. Condensation can dilute product and create an en‑
vironment for microbial growth.
• Design equipment so that during cleaning, all internal surfaces are in contact with the clean‑
ing solution. All internal surfaces should be as free as possible of crevices that can harbor
product or microorganisms.
• External surfaces should be easily cleanable.
• Choose materials of construction that are not easily degraded, etched, or reacted when in
contact with the product, cleaners or sanitizers such as 316L stainless steel.
• Choose equipment with a surface finish that is easily cleanable, durable, capable of being
derouged and passivated; e.g., 316L stainless steel with a surface finish of ≤25 Roughness
CLEANING AND
SANITIZATION
• Routinely inspect and replace gaskets when necessary, as the gasket interface is readily con‑
taminated when gasket integrity is not maintained.
• Use of sanitary welding techniques such as orbital welding or gas tungsten orbital arc weld‑
ing is recommended to avoid creating crevices or rough surfaces that are difficult to clean.
Chemically welded joints of plastic piping should be checked and be smooth to facilitate
cleaning.
Common sanitary design practices for specific types of equipment are listed in the following sec‑
tions.
Tanks/Vessels
• Minimize sharp corners because they are difficult to clean.
• Avoid narrow recesses that could trap product and water.
• Design tanks with a domed head to minimize condensation.
• Choose tanks and vessels with conical or dish shaped bases, with a center drain, as they allow
for complete draining.
• Design vessel openings and surfaces to be easily cleaned.
• Design and maintain covers to fit well and close easily.
• Design vents to minimize debris.
• Eliminate pipes with dead legs.
• Design tanks with spray ball devices that cover the entire surface area and all shadows creat‑
ed by internal components.
• Tanks with mixing capability should be equipped with welded or singe piece mixer blades
and shaft.
Transfer Pipes
• Minimize the length of pipe runs to make cleaning easier and slope the pipe runs to be
self-draining (>1%) to reduce the risk of biofilm formation.
• Choose a pipe diameter that is appropriate to maintain the required flow rate for the clean‑
ing solution.
• In-line filters should be designed for easy cleaning, sanitization and inspection.
• Design piping systems to have a minimal number of T’s.
• Use sanitary welding techniques to avoid the creation of difficult-to-clean crevices and rough
3
surfaces.
• Use sanitary fittings for all connections.
SANITIZATION
CLEANING AND
• Avoid flange and screw-threaded piping that comes in contact with the product.
Valves
Valves should be easily cleanable with no dead spaces to collect product residue or water. Examples
of sanitary valves are diaphragm valves and butterfly valves. The use of valves that can collect prod‑
uct residue or water, such as ball valves, is not recommended due to dead spaces resulting from their
design.
Pumps
Sanitary pumps are recommended. Sanitary pumps are oriented with a vertical inlet and outlet and
passes and pressure relief valves are designed to prevent water and/or product retention. Examples of
sanitary pumps are diaphragm pumps and peristaltic or lobe pumps. Examples of non-sanitary pumps
for moving finished product are centrifugal pumps, gear pumps, or mono pumps. It should be noted
that centrifugal pumps are commonly used in process water systems without having microbial con‑
tamination issues. Pumps should be easily accessible for inspection, cleaning, and sanitization.
Filling Equipment
Fillers should be designed to be easily cleaned and sanitized. Avoid drip pans and water-lubricated
belts. If compressed air is used in filling equipment, the lines should be equipped with microbial
retentive filters and air-line dryers which should be monitored to prevent air-line condensate from
contaminating finished product.
Gaskets
Gasket interfaces are potential sites for contamination. Gasket materials should be compatible with
the product as well as the cleaning and sanitizing solutions. Non-porous, chemically inert materials
such as ethylene propylene diene monomer (EPDM), silicone, and polytetrafluoroethylene (PTFE)
are recommended. Care should be taken to assure that gaskets are properly installed, inspected,
and replaced at a preventative maintenance frequency that is performed prior to wear and damage
causing loss of integrity.
Hoses
Transfer hoses should be of a material that is compatible with product, cleaners and sanitizers to be
used. Common hose materials are:
They should have flush mounted sanitary fittings composed of 316L stainless steel with rounded
edges and a minimum grit of 180 to prevent migration of product between the fitting and the hose
material. Cleaned and sanitized hoses should be hung in such a manner that they completely drain
CLEANING AND
to dry and visually inspected. Hoses should be capped after drying or stored in a protected area. If
SANITIZATION
The frequency of equipment cleaning and sanitization should be determined during validation and
is typically based on several factors including:
Expiration limit
An expiration limit for cleaning procedures and sanitization procedures should be set for each piece
of manufacturing equipment. This expiration limit reflects the allowable time a piece of equipment
can stand before requiring recleaning and/or resanitization. This will depend on the equipment, the
environment in which the equipment is stored, and methods used for cleaning and sanitization.
Once the cleaning and sanitization procedures have been validated, periodic monitoring of equip‑
ment is essential. For additional information, see “Microbiological Evaluation of the Plant Environ‑
ment (Section 2).
General Procedures
General Housekeeping Practices
• Clean spills immediately and remove debris from the manufacturing areas.
• Use disposable towels and discard immediately after single use. Non-disposable cleaning
cloths should not be used.
• Container exteriors should be cleaned before transferring material into manufacturing areas.
Water
• The water used to make up cleaners and sanitizers should have a low microbial bioburden to
avoid contaminating the cleaner and to avoid consuming the sanitizer.
• Water used to rinse cleansers from cleaned equipment should be fresh, potable water that
has a microbiological quality that meets EPA or equivalent potable water quality standards.15
• Water used to rinse chemical sanitizers from sanitized equipment must have no higher mi‑
crobial bioburden then the microbial specifications of the product to be made in that equip‑
ment.16
• Water hardness should be considered when diluting sanitizers and cleaners because hardness
3
may affect the efficacy of the chemicals used. If an alkaline cleaning agent is used, hardness
ions in the water may precipitate out as calcium carbonate and may cause a white residue on
SANITIZATION
CLEANING AND
the surface. For sanitizer preparation, utilize the water hardness and instructions provided
on the EPA approved sanitizer label.
• The pH of the water may affect the cleaning ability of some cleaners and the antimicrobial
activity of sanitizers/disinfectants.
• Remove product residue from all contact surfaces by thoroughly rinsing with water or a
water/detergent solution. Rinse water for sanitized equipment should not contain higher
microbial content than the limits that have been established for the finished product. Tem‑
perature of the rinse solution is dependent on product type, equipment compatibility, and
Equipment should be cleaned as soon after use as possible in order to facilitate product removal.
Product that has dried and hardened onto equipment surfaces can be difficult to remove thoroughly.
Ideally, clean equipment should be sanitized as close to the next use as possible. Cleaned/sanitized
equipment should be properly stored before use to prevent recontamination. In general, equipment
should be drained dry with open ends covered to prevent recontamination. Validated clean hold
times and sanitized hold times should be established for all equipment to be stored prior to re-use.
• Manual
Manual methods involve the preparation of cleaning solution and the scrubbing of equip‑
ment or parts using a brush, singleuse cloth or pad. Proper training and appropriate proce‑
dures are critical to obtaining reproducible results.
• Soak
3
This method involves the immersing of utensils or equipment parts in containers of deter‑
gent or sanitizing solution for extended periods of time. Parts should be completely im‑
mersed in the solution with no air bubbles.
• Spray
Low or highpressure sprays are used to remove soil. In most cases, the cleaning action of the
pressure spray is enhanced by the use of detergents. Highpressure spray devices such as spray
balls or injectors may be installed in mixing or storage tanks. Piping that delivers solutions
to the spray ball should be sloped to allow adequate drainage. Spray balls or injectors may
become clogged with product residue or debris and should be removed, if possible, and
cleaned periodically. If spray balls or injectors are removed after cleaning and sanitization,
they should be stored in a clean area in a self-draining position.
Highpressure spray wand equipment is also widely used. This type of equipment may be
movable. It is used for general surface cleaning. Spray pressures developed should range
from 200 to 1000 p.s.i.. These devices should not be used in an area or in a manner that
creates an overspray contaminating nearby clean equipment.
• Fog
Fogging is a method of generating a mist for the application of sanitizers. Large areas of
equipment surfaces can be treated by fogging in a very short time using small amounts of
sanitizers. This method of application should only be used when the EPA product label
clearly provides instructions for fogging of hard surfaces. The labeling may only allow fog‑
ging as an adjunct to traditional surface sanitization. Fogging should only be used in closed
systems by properly trained personnel using the appropriate personal protective equipment.
• Clean In Place (CIP)
CIP is a semi or fully automated, self-contained system for the cleaning and sanitizing of
equipment. Cleaning and sanitizing solutions are circulated for a specific time at specified
temperatures. Little or no disassembly of equipment is necessary. Unless properly designed,
installed and maintained, CIP systems can become contaminated. Each system is unique
and to work well it should be properly designed, evaluated and controlled. Factors to con‑
sider when using CIP are: detergent/sanitizer type; detergent/sanitizer concentration; tem‑
perature; and design of equipment. Some equipment design factors include type, number,
positioning of spray devices, pressure to spray device, velocity rates in flow paths, type of
pump, and shadows in tanks created by internal components such as baffles, etc. Portable
and fixed CIP skids should be of sanitary design and have the same validation requirements
as the equipment being cleaned.
• Steam in Place (SIP)
Steam in Place is a semi or fully automated system for the disinfection of equipment. Steam
3
is flushed into the equipment for a specified time at a specified temperature. It is a suitable
system for large volume equipment such as storage tanks, manufacturing vessels, transfer
SANITIZATION
CLEANING AND
pipes, etc. because the elevated temperature can treat complex internal geometries which
may not be reached by sanitizer solutions. Disinfection cycles should be determined for each
piece of equipment in order to take into account their complexity and drainability.
Acceptance Criteria
Prior to validation of the cleaning and sanitization processes for equipment, the acceptance criteria
for each process should be determined. Criteria should take into account the types of finished prod‑
ucts that are being processed by the equipment. Criteria for cleaning include no product residue
and no standing water. Criteria for sanitization typically include no standing water and microbial
bioburden that meet specific requirements or microbial release limits of the finished product. If
chemical sanitizers are being used, analytical specification for detecting the presence of an allowable
limit of sanitizer residue may also be included as part of the acceptance criteria. In general, these are
the minimal criteria that should be considered.
Alert and action levels for microorganisms should be established by quality assurance based on fin‑
ished product microbial content specifications.
CLEANERS
A cleaner can be defined as a chemical or blend of chemicals formulated to remove soils from a con‑
tact surface. These chemicals may be solvents, acids, bases, oxidizers, detergents, and/or water-based
chemical blends.
Aqueous cleaners are defined as blends of water-soluble chemicals designed to remove soils into a
waterbased solution with a water continuous phase during cleaning. These consist of surface active
ingredients and other cleaning chemicals that use detergents to lift soils from surfaces.17
Table 3-1 gives examples of various types of cleaners. For additional information, see References 13,
14, and 17.
3
type (organic, inorganic, oils, heavy soils, light soils, etc) and the desired cleaning method (manual,
soaking, CIP, power spray wand, etc.). Information on the level of cleanliness required (acceptance
criteria) should also be known. For difficult to clean materials, use of more than one cleaner in a
specific order or regimen may be considered. Several questions can be asked prior to the selection
of a cleaning system:
• Does the cleaner have good detergency on the type of soil to be removed?
• Is the cleaner recommended for the cleaning process to be used?
• Is the cleaner easily rinsed without leaving residuals?
• Does the cleaner have to be treated before being flushed to drain?
Cleaner Concentration
The concentration of the cleaner and process optimization should be selected through consultation
with the supplier of the material followed by inhouse validation.
Temperature
Temperature should be optimized for the soil being removed as well as the equipment and cleaner
being used. The process should be validated using an appropriate method. Safety considerations
should be addressed if risk of personnel exposure exists. Cleaners efficient at lower temperatures are
now available and may be considered to reduce energy consumption.
Time
3
Cleaning time is dependent on several factors of the process. These factors include mechanical ac‑
tion, temperature, cleaner effectiveness, type of equipment being cleaned, and degree and nature of
SANITIZATION
CLEANING AND
the soil to be removed. For example, the mechanical action of highpressure sprays may require from
seconds to minutes while soaking may require a substantially longer time. Cleaning time should be
determined during the validation of the entire cleaning process/system.
Rinsing
It is important that the rinse procedure removes any residue left during cleaning. The specified
volume of rinse water should be optimized and validated for each particular rinse program. Ensure
there is no cleaner residue remaining.
Drying
To reduce the potential for corrosion, inhibit microbial growth and biofilm formation, and prevent
dilution of chemical sanitizers, it is essential that the equipment be completely drained and dried
after rinsing. Evaporation is the simplest and least-expensive drying method. It is most appropriate
when used after hot water rinses on equipment that can be easily drained such as tanks. Drying by
evaporation is not appropriate for equipment that cannot be completely drained such as filling lines.
Drying by evaporation after ambient water rinses can require longer dry times and may lead to high‑
er risk of microbial contamination. Other methods include circulated hot air, vacuum-drying, and
forced-air blow drying. For these methods, high quality air must be used for drying. The air source
may be filtered (particulate, hydrocarbon, and microbial retentive) to provide high-quality air for
drying. This type of mechanical drying is especially useful for equipment that is used for anhydrous
products where it is essential that no moisture remain in the equipment. Use of alcohol that is free
from spore forming organisms as a finishing step can aid in the evaporation of water. Alcohol can be
used as a dryer/sanitizer although it is not as effective as mechanical drying and is most appropriate
on small pieces of equipment. Caution should always be used when using alcohol on equipment as
it could present a fire and explosion hazard.
SANITIZERS
CLEANING AND
SANITIZATION
Definition
A sanitizer is either a chemical or physical agent that is effective in reducing microbial contami‑
nation on hard, nonporous contact surfaces. A sanitizer may be considered effective if it reduces
microorganisms to levels established by company standards, with no detectable objectionable mi‑
3
Chemical Sanitizers
Combined cleaner/sanitizer agents are available. These “one-step” products are registered by EPA to
be effective in the presence of light to moderate soil; however, heavy soil must be removed prior to
use. When using a “two-step” process where a cleaning agent is used prior to application of a sani‑
tizer, surfaces should be free of residue prior to sanitization since residues can interfere with activity
of chemical sanitization.
Some useful chemical sanitizing agents are chlorine, hydrogen peroxide, peracetic acid, alcohols,
phenolic compounds, and quaternary ammonium compounds. See Table 3-2 for information on
frequently used chemical sanitizers for processing and filling equipment. Chemical sanitizers should
be used according to the manufacturer’s directions and must be shown to be effective for the intend‑
ed use.
For sanitization of process water and process water systems, see “Microbiological Quality for Process
Water” (Section 7). See references #19 and 20 for additional information on chemical sanitizers.
Physical Sanitizers
The most common physical sanitizers are steam or hot water. A major advantage of heat is its ability
to penetrate into small cracks and crevices. Heat is also non-corrosive, cost-effective, measurable
3
with recording devices or thermal strips, efficient, effective against a broad range of microorganisms,
SANITIZATION
CLEANING AND
and leaves no residue.
Surfaces should be cleaned and free of residue prior to sanitization since residues can interfere with
activity of thermal sanitization.
See Table 3-3 for information on frequently used physical sanitization methods for processing and
filling equipment.
that inactivates or reduces the efficacy of the sanitizing agent. Operators should be properly trained.
Improper use may give ineffective results, release toxic fumes, or corrode equipment.
The following process variables should be considered, specified, and controlled to ensure consistent
sanitizer performance:
Rotation of Sanitizers
While rotation of the active ingredients used in sanitizers has been suggested to reduce the potential
for development of bacterial resistance, the published literature has not yet substantiated this recom‑
mendation.21,22 It is critical to assure that the sanitizers are used at the labeled strength through prop‑
er dilution and preparation. Rotation of sanitizers is not a common practice in the manufacture of
personal care products. Where rotation is desired, review the active ingredients listed on the chemi‑
cal sanitizer label to assure that a rotation of active ingredients is achieved when changing products.
SUMMARY
The selection and effective use of a cleaning or sanitizing agent and/or method is dependent on the
manufacturing facility, the type of product processed, and the design and layout of the equipment.
All cleaning and sanitizing procedures should be properly designed and their use documented and
validated. Personnel should receive adequate instruction and training in these areas. With attention
to these details, a cleaning and sanitizing program will ensure a sanitary manufacturing facility.
CLEANING AND
SANITIZATION
3
Table 3-1
3
SANITIZATION
CLEANING AND
Table 3-2
Table 3-3
a
Heat may cause equipment damage by expansion of close-fitting and/or moving parts.
b
Heat must be used with thermally stable materials.
c
Steam and scalding water pose a potential hazard.
3
SANITIZATION
CLEANING AND
REFERENCES
1. U.S. Food and Drug Administration. 2015. “Current Good Manufacturing Practice in
Manufacturing, Processing, Packing, or Holding of Drugs; General,” FDA 21 CFR, Part 210.
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=210
2. U.S. Food and Drug Administration. 2015. “Current Good Manufacturing Practice for
Finished Pharmaceuticals” FDA 21 CFR, Part 211. https://www.accessdata.fda.gov/scripts/cdrh/
cfdocs/cfCFR/CFRSearch.cfm?CFRPart=211
3. U.S. Food and Drug Administration. 2001. Guidance for Industry – Q7A Good
Manufacturing Practice Guide for Active Pharmaceutical Ingredients. http://www.fda.gov/ICECI/
ComplianceManuals/CompliancePolicyGuidanceManual/ucm200364.htm
http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129098.pdf
4. Nikitakis, J.M. (Ed.) 2014. Personal Care Products Council Quality Assurance Guidelines,
Personal Care Products Council, Washington, D.C.
5. Ghannoum, M., and O’Toole, G.A. (Ed.) 2004. Microbial Biofilms. ASM Press, Washington,
DC.
6. Murthy, P.S. and R. Venkatesan, R. 2009. Industrial Biofilms and Their Control. In: Marine
and Industrial Biofouling (H.C. Flemming, P.S. Murthy R. Venkatesan, K. Cooksey eds.),
Springer, NY, pp. 65-102.
7. Clontz, L. and C.M. Wagner (Eds.). 2012. Biofilm Control in Drug Manufacturing, Parenteral
Drug Association, Bethesda, MD.
8. U.S. Food & Drug Administration. 1997. HACCP Principles and Application Guidelines
http://www.fda.gov/Food/GuidanceRegulation/HACCP/ucm2006801.htm, (Updated 2014).
9. Van Scothorst, M. 2004. A Simple Guide to Understanding and Applying Hazard the Hazard
Analysis and Critical Contol Point. ILSI Press, Washington, DC.
10. World Health Organization. 2003. WHO Technical Report Series, No. 908, Annex
7 “Application of Hazard Analysis and Critical Control Point (HACCP) methodology to
pharmaceuticals.”
CLEANING AND
SANITIZATION
13. Block, S.S., 2000. Disinfection, Sterilization, and Preservation, 5th Edition, Lippincott
Williams & Wilkins, Philadelphia, PA.
14. Fraise, A., Maillard, J.Y., and Sattar, S. 2013. In Principles and Practices of Disinfection,
Preservation and Sterilization, Wiley-Blackwell, Hoboken, NJ.
15. U.S. Environmental Protection Agency. 2015. Surface Water Treatment Rules
https://www.epa.gov/dwreginfo/surface-water-treatment-rules
16. Geis, P.A. (ed.) 2006. Cosmetic Microbiology: A Practical Handbook, Taylor & Francis, New
York, NY.
17. McLaughlin, M.C., and Zisman, A.S. 1998. The Aqueous Cleaning Handbook: A Guide to
Critical Cleaning Procedures, Techniques and Validation, Morris-Lee Publishing Group, Rosemont,
NJ.
18. AS TM International 2014. “E1153143 (2010) Standard Test Method for Efficacy of
Sanitizers Recommended for Inanimate Non-Food Contact Surfaces” ASTM International West
Conshohocken, PA. www.astm.org
19. Centers for Disease Control. 2009. Biosafety in Microbiological and Biomedical Laboratories
(BMBL) 5th Edition. Appendix B. (Decontamination and Disinfection). http://www.cdc.gov/
biosafety/publications/bmbl5/
20. United States Pharmacopeia. 2016.USP 39- NF 34 USP <1072> Disinfectants and
Antiseptics. United States Pharmacopeia and National Formulary. Rockville, MD. Pp. 517-520.
21. Martinez, Jose E. 2009. The Rotation of Disinfectants Principle: True or False? Pharmaceutical
Technology, Vol 33, No. 2, p 58-71.
22. Sutton, Scott. 2005. Disinfectant Rotation: A Microbiologist’s View. http://www.microbiol.org/
wp-content/uploads/2010/07/sutton.Controlled.Environ.2005.8.7.9.pdf. Contolled
Environments July 2005: 9-14.
23. Sirtes, G., Waltimo, T., Scaetzle, M., Zehnder, M. 2005. The effects of temperature on sodium
hypochlorite short-term stability, pulp dissolution capacity and antimicrobial efficacy. J Endod.
31:669-71.
24. Dychdala, G. 2001. Chlorine and Chlorine Compunds – Chapter 7. In. Block, S.S
Disinfection, Sterilization, and Preservation – 5th Ed. Lippincott, Williams, & Wilkins,
Philadelphia, PA, pp. 135-158.
25. Sundheim, G., Langsrud, S., Heir, E., Holck, A. L. 1998. Bacterial resistance to disinfectants
3
containing quaternary ammonium compounds. International Biodeterioration & Biodegradation,
41: 235-239.
SANITIZATION
CLEANING AND
26. Rorvik, L.M., Aase, B., Langsrud, S., and Sundheim, G. 2000. Occurrence of and a possible
mechanism for resistance to a quaternary ammonium compound in Listeria monocytogenes.
International Journal of Food Microbiology, 62: 57-63.
27. Parenteral Drug Association. 2007. PDA Technical Report 1(TR 1) Validation of Moist
Heat Sterilization Processes Cycle Design, Development, Qualification and Ongoing Control.
Parenteral Drug Association, Bethesda, MD
28. Parenteral Drug Association. 2013. Technical Report. No 61. Steam in Place Parenteral Drug
Association, Bethesda, MD.
Microbiology
Staff Training
INTRODUCTION
The staff of the microbiology department has an essential role in maintaining product quality that
meets development specifications, marketing design, and customer expectations. The knowledge
and skills of this group are crucial. Microbial test results must be accurate and reliable so that deci‑
sions based on the test data can be made with confidence.
Training of the microbiology laboratory staff should cover the following general areas:
This training provides confidence that test results are accurate and can be relied upon during the
decision-making process.
Many different types of microbiological tests may be performed in a personal care microbiology
laboratory. These can include content testing of microbiologically susceptible raw ingredients and
finished products, preservative challenge testing of product formulations, and the analysis of envi‑
ronmental test samples such as cleaning and sanitization swabs, air, or water samples from a cosmet‑
ic manufacturing facility. If OTC drugs such as sunscreens are being tested, refer to FDA guidelines
for the manufacture of OTC drugs1,2 and to relevant chapters in the USP.3
There are two goals in having a training program for the employees in a personal care microbi‑
ology laboratory: First, to provide an in-depth, well-rounded program in how and why a certain
microbiological test is to be conducted on a particular test sample; and second, to insure that the
microbiological testing for a particular type of sample will be performed exactly the same way by
4
each employee every time a sample is received for testing. The purpose of this guideline is to provide
information regarding requirements for a microbiology staff training program.
STAFF TRAINING
MICROBIOLOGY
ESTABLISHING A PROGRAM
The establishment of a training program should include, but not be limited to, the understanding
of microbiological concepts, review of Standard Operating Procedures (SOPs), and review of test
methods or procedures. It is important that the individual have full understanding of the principles
of aseptic technique. Internal or external training classes can be provided as part of the training
program for an employee. It is recommended that hands-on training be included to demonstrate
proficiency in using laboratory equipment and conducting microbiological test methods. It is rec‑
ommended that a knowledgeable, qualified individual possessing appropriate academic and work
experience should train new employees to the laboratory.
A. Training Frequency
All new laboratory employees should receive training prior to beginning work in the laboratory.
In addition, it is recommended that all current staff employees receive periodic re-training at
intervals most appropriate for keeping them current and proficient in performing the various
procedures for which they are responsible. It is the responsibility of the management to ensure
that each staff member is updated or trained according to the company’s policy or Standard Op‑
erating Procedures.
B. Documentation
For each employee in a personal care microbiology laboratory, a training record or log should be
established. The documentation should include, but not be limited to, training and dates when
proficiency has been demonstrated for each particular test method, technique, policy, or proce‑
dure used by that individual during a workday. It is important that no laboratory staff member
be allowed to perform any laboratory task until documentation is established indicating sufficient
training was received and proficiency was demonstrated.
The trainer should either initial or sign and date the training record or log to verify that the train‑
ing was received and completed for that task. Each training record or log should be periodically
reviewed and initialed or signed and dated by the supervisor of the testing laboratory. Records
should be kept for an appropriate length of time.
It is also important that proper documentation exists that the trainer has the necessary experience
and knowledge for conducting a particular microbial test method, or use of a particular piece of
laboratory equipment.
C. Topics
The training topics will often depend upon the laboratory equipment utilized, testing methods
performed, laboratory function, and individual job responsibilities. The tables in the sections
that follow suggest topics and elements that should be included in a microbiology staff training
program.
STAFF TRAINING
MICROBIOLOGY
LABORATORY ORIENTATION
A general orientation should be given to any new individual as an introduction for entering the mi‑
crobiology laboratory. The topics covered during orientation should remain general in scope, give an
overview of SOPs, and cover guidelines within the laboratory as an introduction. The topics listed in
Table I may be included in a general orientation. Other topics may be added at the discretion of the
person developing the training. More specific topics are discussed in detail in sections that follow.
MICROBIOLOGY LABORATORY
A. Equipment
Equipment availability and usage will vary depending on the testing performed in each labora‑
tory. Most laboratories will contain many of the instruments listed below. Employees should be
trained in the safe and effective use of each piece of equipment needed to fulfill their job function.
The list below is not exhaustive; however, it does contain many of the basic pieces of equipment
that may require calibration. Each laboratory will need a customized list depending on their par‑
ticular testing requirements. Common microbiology laboratory equipment includes:
• Balances
• Sterilizers/Autoclaves
• pH Meter
• Water Baths
• Incubators
• Refrigerators
• Low Temperature Freezers
• Automatic Pipetting/Dispensing Devices (e.g., pipettors, micropipettors,
dispensing pumps, etc.)
• Laminar Flow Hoods/Biological Safety Cabinets
• Microscopes
• Stereoscopes
• Laboratory Water System
• Bunsen Burners
• Colony Counters
• Sample Mixing Devices (e.g., vortexes, Waring® Blenders, etc.)
• Laboratory Shakers
• Centrifuges
4
• Laboratory Ovens
• Air Samplers
STAFF TRAINING
MICROBIOLOGY
• Stopwatches
• Spectrophotometers
• Lyophilizers
• Automated Microbial Identification Systems
• Automated Microbial Counting Devices
• Water Activity Instrument
• Dishwasher
• Automated Data Collection System
• Stomacher
• Spril Plater
LABORATORY TECHNIQUES
A. Common Techniques
Table 4-2 contains common key elements that should be included in a training program for an
individual responsible for conducting tests in a microbiology laboratory. The list contains key
microbiological techniques that may be employed in the laboratory; however, it is not inclusive
of all the different types of techniques that might be used in every laboratory. Additional tech‑
niques performed in your laboratory should be added to your training program. Specific tests are
discussed in detail in sections that follow.
ENVIRONMENTAL MONITORING
A. General
To effectively monitor the quality of the personal care product manufacturing and pilot plant
environment, laboratory employees with the responsibility for conducting environmental mon‑
itoring should be trained in all methods currently in use. Environmental testing comprises three
major categories: surface sampling, air sampling, and water analysis. Refer to “Microbiological
Evaluation of the Plant Environment” (Section 2) in these guidelines for information on con‑
ducting environmental monitoring in a manufacturing plant.
Training should be based on written procedures which include:
• Communication of results
• Corrective action procedures
• Swab
• Contact Plate (e.g., Rodac Plates)
• Flexible Films or Contact Slides
• Final Rinse Water
2. Air
For monitoring the microbial content of air in different locations of a manufacturing plant, a
laboratory employee should be trained in how to use one or more of the following air sampling
methods:
3. Water
For determining the microbial content of water samples in a manufacturing plant, a laboratory
employee should be trained on how to perform the activities listed in one or more of the areas
in Table 4-4.
necessary educational background and proper training to correctly identify a microbial isolate to the
genus or species. It is strongly recommended that this individual demonstrate proficiency in per‑
forming microbial identifications. The following table contains key microbiological tests that may
be employed to identify microbial isolates. The list may not be all inclusive. Additional microbial
identification tests performed on isolates in different laboratories should be added to the laboratory
training program.
The microbiology department is, by function, an integral part of the cleaning and sanitization pro‑
gram. It is recommended that training include the following:
• Aseptic Sampling
• Testing Methods such as:
– Swabbing
– Direct contact
– Final rinse water
• Validation Protocol
• On-Going Environmental Monitoring Procedures
• Documentation
– Documentation of validation and qualification of cleaning and sanitization procedures
– Logs for equipment cleaning and sanitization history
• Basic Understanding of:
– Cleaning
4
> Chemicals
> Physical methods
STAFF TRAINING
MICROBIOLOGY
– Sanitizers
> Physical methods
> Chemical (including pH range, soil effects, concentration, and contact time)
PCPC MICROBIOLOGY GUIDELINES | 59
SECTION 4 MICROBIOLOGY STAFF TRAINING
CONCLUSION
It must be realized that the topics listed above and the suggested elements for a training program for
a microbiology laboratory cannot be all-inclusive. These elements are only for guidance on the com‑
ponents of a microbiology staff training program. If a microbial technique, procedure, or a piece of
laboratory equipment is not listed here and is being performed or used in a microbiology laboratory,
then it should be included in the training record or log for each employee whose job duties include
using the equipment or performing the procedure.
Proficiency testing, as a means of demonstrating competence, is an integral part of a training pro‑
gram.
STAFF TRAINING
MICROBIOLOGY
Table 4-1
4
STAFF TRAINING
MICROBIOLOGY
Table 4-2
Table 4-3
Table 4-4
Table 4-5
REFERENCES
1. U.S. Food and Drug Administration. 2015. “Current Good Manufacturing Practice in
Manufacturing, Processing, Packing, or Holding of Drugs; General,” FDA 21 CFR, Part 210.
www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=210
2. U.S. Food and Drug Administration. 2001. Guidance for Industry – Q7A Good
Manufacturing Practice Guide for Active Pharmaceutical Ingredients.
www.fda.gov/ICECI/ComplianceManuals/CompliancePolicyGuidanceManual/ucm200364.htm
3. United States Pharmacopeia and the National Formulary. 2016. (USP39-NF34), U.S.
Pharmacopeia, 1260 Twinbrook Parkway, Rockville, MD
4. Centers for Disease control and Prevention. 2009. Biosafety in Microbiological and Biomedical
Laboratories (BMBL) 5th Edition. http://www.cdc.gov/biosafety/publications/bmbl5/
5. Occupational Safety & Health Administration. 2016. Draft Safety and Health Program
Management Guidelines Document. https://www.osha.gov/shpmguidelines/
6. Nikitakis, J.M. (Ed.) 2014. Personal Care Product Council Quality Assurance Guidelines, Personal
Care Product Council, Washington, D.C.
ADDITIONAL RESOURCES
Akers, M. 1993. cGMP Education and Instruction: A Corporate Approach to Employee Training
Worldwide. Pharmaceutical Technology, 17: 51-60.
Beauchemin, K., Gallup, D., and Gillis, M. 2001. Read and Understand vs. A Competency-Based
Approach to Designing, Evaluation, and Validating SOP Training. PDA Journal of Pharmaceutical
Science and Technology, 55 (1): 10-15.
Deluca, P.P. 1983. Microcontamination Control: A Summary of an Approach to Training. PDA
Journal of Pharmaceutical Science and Technology, 37(6): 218-224.
Gallup, D., Beauchemin, K., and Gillis, M. 1999. A Comprehensive Approach to Compliance
Training in a Pharmaceutical Manufacturing Facility. PDA Journal of Pharmaceutical Science and
Technology, 53(4): 163-167.
Gallup, D., Beauchemin, K., and Gillis, M. 1999. Competency-Based Training Program Design.
PDA Journal of Pharmaceutical Science and Technology, 53(5): 240-246.
Levechck, J.W. 1991. Training for GMPs. Journal of Parenteral Science and Technology, 45(6):
270-275.
Parenteral Drug Association, Inc. 2001.“Technical Report No. 35, A Proposed Training Model
4
for the Microbiological Function in the Pharmaceutical Industry.” 2001. PDA Journal of
Pharmaceutical Science and Technology, 55(6).
STAFF TRAINING
MICROBIOLOGY
INTRODUCTION
Raw materials used by the personal care products industry are not expected to be sterile as received.
Some commodities, especially those of natural origin, may contain large microbial populations. The
incorporation of such raw materials into product formulations is undesirable because the organisms
introduced could:
CATEGORIES
A program to control organisms in raw materials should consider the physical and chemical nature
of the raw materials as well as the subsequent processing involved in the manufacture of quality
products. In general, raw materials may be categorized as:
• Hostile - A raw material that will not support and may inhibit the growth of microorgan‑
isms.
• Inert - A raw material that may act as a carrier of microorganisms but ordinarily will not
promote microbial proliferation.
• Supportive - A raw material that serves as a nutritional substrate and supports microbial
growth.
• Preserved - A raw material to which antimicrobial preservative have been added to control
microbial growth.
STABILITY
The stability of raw materials may be affected by the presence of microorganisms. To monitor chang‑
es in microbial content, raw materials should be examined upon receipt and on a regular basis
throughout their shelf life by acceptable microbiological procedures.
5
EXPIRATION
Expiration dates should be established for raw material by product category, history, in‑house ex‑
perience, and manufacturer’s recommendations. An appreciable change from the normal microbial
profile indicates a possible problem, and should be investigated.
RECEIPT
Raw materials received should be properly labeled, placed on quarantine status, and held until re‑
leased by Quality Assurance. For further guidance, refer to “Sampling: Part I: General Provisions
Sampling Plan” in the PCPC Quality Assurance Guidelines.1
STORAGE
Raw materials should be stored under conditions that minimize the possibility for microbial con‑
tamination. Factors to be considered are:
Procedures for the control of raw materials should be documented and assigned to a responsible
department. Storage conditions should be periodically monitored by appropriate personnel. Once
established, the procedures should be reviewed on a periodic basis.
TRANSFER
Transfer systems for raw materials include sterilized containers, transfer lines, pumps, and related
equipment. These systems should be evaluated on an individual basis depending on the specific raw
material involved. The raw material categories listed above will aid in this evaluation. For example,
a supportive raw material will require greater consideration (i.e., stringent, sanitary handling) and
more monitoring than a hostile one.
SAMPLING
Appropriate control procedures are required for sampling raw materials.2
• Personnel - Personnel responsible for sampling raw materials should be trained in aseptic
sampling techniques, preferably by a qualified microbiologist. Individuals with contagious
illnesses or open lesions should not touch or otherwise contact materials being sampled.3
• Containers - All sampling containers should be sterile and of suitable size.
• Utensils - All sampling utensils should be sterile and suited to the particular raw material.
Long‑handled dippers, syringes, sampling tubes, “thieves,” spatulas, spoons, and pipettes are
all examples of sampling utensils. Some of these are commercially available as pre-sterilized
items.
• Techniques - To ensure that samples are representative of the lot or batch, a logical sampling
plan should be developed.1
When samples are obtained for microbiological analysis the following procedures should be ob‑
served.
TESTING
Microbiological testing of raw materials can be accomplished according to “Determination of the
Microbial Content of Personal Care Products” (Section 17) or other appropriate method. The na‑
ture of the raw material will determine the method used.
REFERENCES
1. Nikitakis, J.M., ed. 2014. Annex 17, Part 1 – General Provisions Sampling Plan. In: PCPC
Quality Assurance Guidelines, The Personal Care Products Council, Washington, DC 20036, pp
103-106.
2. Nikitakis, J.M., ed. 2014. Annex 17, Part 2 – Sampling and Control Techniques. In: PCPC
Quality Assurance Guidelines, The Personal Care Products Council, Washington, DC 20036, pp
107-110.
3. Nikitakis, J.M., ed. 2014. Annex 1, Part 1 – Personnel and Training. In: PCPC Quality
Assurance Guidelines, The Personal Care Products Council, Washington, DC 20036, pp 1-6.
Microbiological Sampling
6
SAMPLING
MICROBIOLOGICAL
INTRODUCTION
Appropriate microbiological techniques are needed for sampling raw materials, bulk in‑process,
packaging components, and finished goods to ensure personal care product quality. Although each
area has its own specific needs, there are basic similarities that are vital to all. From the time raw
materials arrive until the finished product emerges, product history and proper identification are
essential. In general, aseptic techniques should be followed for valid evaluations of samples. The
frequency, sampling and screening methods may vary, but the need for monitoring by qualified
personnel is of utmost importance.
CATEGORIES OF SUSCEPTIBILITY
All raw materials, packaging components, bulk in‑process, and finished goods differ in susceptibility
to microbial growth. In order to assess the risk of growth occurring in a material, it is helpful to es‑
tablish categories of susceptibility. These categories of susceptibility influence the extent of sampling
and testing required for each material.
Category 1 (High Susceptibility)
High-susceptibility materials include:
• Bath salts.
• Many aerosol products.
• Raw materials with antimicrobial activity.
Category 4: (Nonsusceptible)
A nonsusceptible material is one that by nature of its components, exclusive of preservatives, will not
support the survival of vegetative organisms.
NOTE: The susceptibility of packaging components and other raw materials should be evaluated
based on their composition and the nature of the product with which they are used.
The above categories are based on the following:
• History - Necessity and frequency of testing a material are based on past microbiological
profiles. Determining the microbial content of a designated number of batches over a period
of time helps to establish the susceptibility category.
• Susceptibility Tests - Materials may be challenged with microorganisms and tested for sus‑
ceptibility.
SAMPLING DEVICES
The following devices for sampling, available from scientific supply houses, may be used:
PERSONNEL
The individual(s) responsible for sampling should be trained in aseptic sampling technique by a mi‑
crobiologist or other qualified person and should be familiar with visual characteristics of containers
and/or materials to be sampled.
6
RAW MATERIALS
SAMPLING
MICROBIOLOGICAL
Designated personnel should be notified of the receipt of each shipment of raw materials. The ship‑
ment should be inspected for physical damage as indicated by leakage of liquids or powders, rusty
or dented containers, and broken or torn containers that expose the contents to outside contamina‑
tion. Tank car shipments may be inspected through the top for gross contamination. Any container
damaged in such a manner that the contents could be contaminated should be rejected and the
supplier notified.1 Each container should be properly labeled.2
Sampling Technique
Aseptic technique should be followed at all times by trained personnel. Sampling should be per‑
formed with sterile equipment, which can be of stainless steel, plastic, or any other microbiologi‑
cally acceptable material. Devices for sampling include ladles, cups, spatulas, scoops, and spoons.
In general, glass devices should be avoided because of danger of breakage. Each container should be
sampled with a separate sterile device.
3. Transfer the sample to a sterile, properly labeled container and cap the container.
4. Identify each container sampled (label, initial and date).2
Sample Properties
6
The intrinsic properties and microbiological history (internal monographs developed from previous
microbiological assessments) of a raw material are of prime importance in ascertaining sampling
frequency. The type and homogeneity of the material will also play a role in this determination. A
microbiologically nonhomogeneous material generally requires a greater number of samples.
Raw material lots, depending on the type of material, amount ordered, and/or the supplier, are re‑
ceived in various forms: boxcars, truckloads, bags, boxes and drums. A determination of the number
of samples per lot to be taken (whether the lot is in the form of a single boxcar or in the form of
many bags) should be made. Typical sampling plans can be found in the Personal Care Products
Council Quality Assurance Guidelines.2
In most cases, 30‑100 grams of sample are aseptically taken from each container or area of the con‑
tainer chosen by one of the above methods. It is also feasible and practical to test composite sam‑
ples of the same lot number of certain raw materials, which are by previous analysis and/or nature
considered microbiologically homogeneous. If composites of a lot are shown to be unacceptable
by in‑house standards, then all previously sampled containers should be reassayed.1 More extensive
sampling and testing may also be necessary.
Stability
Raw materials should be investigated to determine susceptibility to microbial proliferation, includ‑
ing the effect of storage conditions. Retest intervals should be scheduled to determine the continued
adherence to microbial content specifications.
PACKAGING COMPONENTS
6
Components should be inspected before shipment by the supplier. The burden of correcting prob‑
lems and minimizing defects should be the responsibility of the supplier; however, it is still the
SAMPLING
MICROBIOLOGICAL
personal care product manufacturer’s responsibility to have an acceptable component to give the
consumer.
Sampling
Upon receipt of a shipment of components, a trained quality-assurance sampler should check for
proper identification.
The quality-assurance sampler randomly samples the shipment. The shipment is then sent to a
designated area until it has been released. A visual examination should be done for obvious defects,
such as mold, dust, dirt, insects, or other extraneous materials. If there is any evidence of these, a
microbiological examination should be done. As a rule most components are considered microbi‑
ologically safe and are not routinely tested except for product applicators, brushes and puffs and,
in predetermined cases, those that are in direct contact with “highly susceptible” products. Only
surface areas that come in direct contact with the product are tested.
Sampling Techniques
Storage
When the sampling of components meets all inspecting criteria, the shipment is then accepted. The
warehouse is notified so that the balance of the shipment can be stored in the proper place. Com‑
ponents should be kept elevated from the ground in a relatively clean dust‑free area with a good
rotation system.
BULK IN PROCESS
MICROBIOLOGICAL
Bulk products should be sampled and tested to ensure acceptability of the product before filling, as a
secondary check on sanitary manufacturing practices, to build a product profile, and as an economic
SAMPLING
Types of Mixes
1. Cold Mix - No heat applied at any time during manufacture. Sample in accordance with the
procedures stated previously.
2. Hot Mix - Sample after cooling.
3. Aerosols - Sample the concentrate in the same manner as for hot and cold mixes.
In the above three types of mixes, approximately the same sample size should be obtained.
NOTE: If composites of a lot of bulk mixed products are shown to be unacceptable by in‑house
standards, then all samples should be retested individually and if necessary all previously sampled
containers should be reassayed. More extensive sampling and testing may also be necessary. Tanks
should be sampled from the top and bottom before mixing or stirring the contents. Special attention
should be given to the interface of the possible moisture layer on the top of the material. “Low-sus‑
ceptibility” materials (Category 3) should be sampled on a defined periodic basis or prior to use.
• Inasmuch as bulk products are usually stored in tanks, drums, carboys and cartons, a repre‑
sentative sample should be taken regardless of the container size and shape.
• A representative sample may be 50‑100 grams of a well‑mixed product collected in a sterile
container.
• These samples should be sufficient in size to perform all necessary tests, including confirma‑
tory tests.
• Drums and all sub‑units of a manufactured batch of high- and medium- susceptibility ma‑
terials may be sampled according to typical plans as outlined in Personal Care Products
Council Quality Assurance Guidelines, Sampling.2
• Stored bulk material should be resampled and retested on a defined periodic basis or prior
to use.
FINISHED GOODS
Sampling Intervals and Quantities
6
Samples for testing should be taken at the beginning, middle and end of each shift. If more than
SAMPLING
MICROBIOLOGICAL
one shift fills a batch, samples from each shift should be submitted. In determining the number of
samples taken, consideration should be given to multiple filling lines, container size and extended
downtime and product susceptibility. It is suggested that for possible future reference at least two
unopened samples per batch and/or lot be retained. Retention time should be comparable to that
normally required for other quality control purposes.2
Composites
Composite samples of products from each sampling time may be made; i.e., equal portions of sam‑
ples at the beginning, at the middle, and at the end of the run would be combined to provide three
composite samples.
Frequency of Testing
Samples should be tested as soon as possible after manufacture. In general, the frequency of testing
is determined by the nature of the preparation, efficacy of any antimicrobial agent present, manufac‑
turing process, and experience gained as a result of previous microbiological evaluation. In practice,
it is recommended that, with few exceptions, all susceptible finished products be tested with the
same frequency. This will permit the detection of microbiological problems resulting from formula
changes, errors in compounding or failure of good manufacturing practices.
Microbial Limits
The microbial content for products should follow Establishing Microbiological Quality of Personal
Care Products (Section 12), in‑house specifications, or other appropriate criteria.
Product Release
Finished products should not be released for consumer use until all microbiological testing has been
completed and they are approved for release.
REFERENCES
1. Nikitakis, J.M. (ed.) 2014. Annex 8 – Treatment of Product that is Out of Specification In
Personal Care Products Council Quality Assurance Guidelines, Personal Care Products Council,
Washington, DC 20036, pp. 55-58.
2. Nikitakis, J.M. (ed.) 2014. Annex 17 – Sampling. In Personal Care Products Council Quality
Assurance Guidelines, Personal Care Products Council, Washington, DC 20036, pp. 103-110.
MICROBIOLOGICAL
SAMPLING
6
Microbiological Quality
for Process Water
INTRODUCTION
This section is an overview of process water system design and maintenance. It is intended for use by
microbiologists and other technical personnel involved with the design, installation, qualification,
and maintenance of a process water system for the manufacture of personal care products.
Process water systems used in the manufacture of personal care product formulations are typically
comprised of multiple stages. Source water for the system is exposed to various treatments intended
7
to remove chemical, physical, and microbiological impurities and contaminants. The end product
PROCESS WATER
QUALITY FOR
of the system is purified process water in compliance with the manufacturing facilities specifications.
The microbial content of process water should be defined by each company and controlled because:
During the design process, complete and detailed blueprints, diagrams, and/or flow charts of the
process water system should be prepared and kept on file for reference purposes.7 Any changes to the
system should be similarly documented.
The microbiological quality of process water may vary and can be influenced by conditions of man‑
ufacture such as pH, temperature, equipment, and the presence of chemicals. Seasonal variations
in the feed or source water for a process water system may also have an effect on the process water
quality. Although a particular source of water may appear to be suitable for production purposes,
the number and type of microorganisms present may serve as a source of microbiological contam‑
7
ination for the entire manufacturing facility. It is the responsibility of the manufacturer to control
the microbiological and chemical quality of the process water.
In order to help insure the microbial quality of the process water the following must be taken into
consideration during the system’s design: 5,6, and 8
• U-bends should be avoided unless they are inverted so as not to form a pocket of water that
can stagnate. Pressure sensors should not be mounted directly in line with the piping; a
separator should be used.
• Unused valves or branch lines (dead legs) should be removed from the system as they are a
microbial contamination risk.
• Sanitary type unions and valves should be used to ensure that they may be properly cleaned.
• 316L Stainless steel surface finishes of the water storage tank and distribution loop should
be greater than150 grit or have a roughness average less than 0.8 to be considered sanitary.6
• When 316L stainless steel is used, passivation is recommended to prevent chemical attack
by deionized water. If the system is modified and new stainless steel is installed, the system
needs to be re-passivated.6
• While less expensive than stainless steel, plastic piping is not generally recommended for use
in process water systems. If plastic is used or being considered for use, the following must be
taken into account:
– Where plastic piping is used, 316L stainless steel is still recommended for use in the dis‑
tribution loop.
– With the exception of polyvinylidene fluoride (PVDF) or polytetrafluoroethylene (PT‑
7
FE),plastic piping is known to be intolerant to the use of high heat and ozone as a sani‑
tizer.8
PROCESS WATER
QUALITY FOR
– In the case where PVDF and/or PTFE piping is planned for use to distribute heated wa‑
ter:
> The piping will need more structural support than stainless steel.
> Expansion sections will be needed (PVDF and PTFE expand when heated)
> Insulation will be needed to maintain temperature.
– Polyvinyl chloride (PVC) piping is incompatible with most chemical sanitizers.8
– Plasticizers (phthalates) can be leached from PVC piping and are able to serve as micro‑
bial food source by microbial biofilms.8
• The PVC piping joints cannot be heat welded together. They must be joined with cou‑
plings that use a solvent to partially dissolve the joints. This process forms rough welds that
are known to be favorable sites for the development of microbial biofilms.8 Stainless steel,
PVDF, and PTFE are not known to have this issue. 316L stainless steel is the ideal material
for use in process water system piping as it is compatible with most sanitizing systems and
chemistries, is tolerant over a wide range of temperature, and may be easily cleaned. When
properly designed and maintained, 316L stainless steel is highly effective for minimizing
microbial growth.
half-life degradation of ozone into oxygen due to high water temperatures, it is recom‑
mended to control the temperature of the ozonated water to be <25°C.6 and 10
– Ozone must be inactivated by ultraviolet light at either the point of use or after a storage
tank in which the ozone is injected. Ozonated water should not be re-circulated back to
the generation portion of a process water system.
7
– Use of ozone is not suitable in water that contains more than 0.5 parts per million (ppm)
of Manganese (Mn) as: ozone converts soluble Mn to an insoluble form.12
• Other Oxidizing Biocides
– Besides chlorination and ozone, other oxidizers like bromine, iodine, chlorine dioxide,
hydrogen peroxide, hypobromus acid, or sodium bromide may be used.
– It is recommended that oxidizing biocides only be used with piping and storage tanks
comprised of 316L stainless steel since oxidizing biocides have been known to cause cor‑
rosion of some other materials.
– Effective addition levels must be found and validated before use.
– Materials used in formulations produced using water which was treated with these bio‑
cides must be compatible.
• Ultraviolet Light (UV), at 254-265 nanometers wavelength
– Disinfection ultraviolet radiation intensity is typically between 30,000 to 35,000µW-sec/
cm2 5 and 8
– Energy output of the UV lamp(s) must be monitored for the system to maintain antibac‑
terial efficacy. When the bulb drops below 50%, output it must be replaced.
– The UV cell housing must be periodically cleaned to ensure that UV light is able to pen‑
etrate into the flowing water.
– The absorbed UV dose is dependent upon the depth and turbidity of the water, flow rate,
lamp intensity, and temperature.
– It is recommended that micro-filtration be used in conjunction with UV light since UV
light by itself is only 90% effective under ideal conditions at killing microorganisms that
are present in water.
• Heat, at ≥ 80°C 6 and 8
– Process water may be heated to a temperature ≥ 80°C in the storage tank or by passing it
through a heat exchanger.2
– Best practice is to continuously re-circulate hot water in a distribution loop.
• Microbial Filtration, with 0.45 micron or smaller pore size
– If used in conjunction with ozone, the microbial filtration cartridge should be composed
of PTFE and PVDF to prevent degradation.6
The individual microbial control methods listed above are recommended to be used in combination
with other microbiological control methods for broad spectrum activity.
7
PROCESS WATER
QUALITY FOR
PROCESS WATER SYSTEM MAINTENANCE
A program of regular maintenance should be devised in order to ensure proper performance of the
process water system. In-line microbial filters, ultraviolet lamps, chlorinating equipment or any
other equipment requiring special attention should be serviced and/or replaced according to the
supplier’s specifications and recommended intervals.8 In addition, regular cleaning of filters, storage
tanks, valves, pumps, piping, meters, and points of use should be implemented. Routine preventa‑
tive maintenance checks should be performed to minimize leaks, ensure pumps are functional, flow
rates are adequate for recirculation, meters are calibrated, and points of use are kept clean and well
maintained.
Maintenance frequency is established during validation of the process water system. A log or elec‑
tronic record should be kept as documentation. Alert and action levels established using historical
data and process water system specifications should be included as part of the plan.
Treatment components of the process water system intended to remove impurities may become a
source of microbial contamination if not properly maintained. Regular microbial maintenance of
these systems should be included in the overall plan in order to guarantee process water quality.
• Deep-Bed Filtration (Multimedia/Sand Filters) units have a high surface area in which
microbial nutrients and microorganisms will be either desorbed or absorbed. Microbial
biofilms may form in these units and shedding can occur. As a microbial control measure,
a periodic back purge of the units is recommended to reduce microbial nutrients and to
prevent the formation of microbial biofilms.5
• Activated Carbon Beds have a high degree of bacteria adherence and shedding due to the
presence of a high surface area. When present, chlorine is removed in the upper portion
of the Carbon Beds which may allow bacterial growth in these units. Periodic water back
flushes, a 90°C hot water flush, or a steam flush can be used for microbial control.5
• Regenerating brine (NaCl) solutions for water softeners should not be relied on for an‑
timicrobial control; it is recommended that these units be periodically back flushed to
remove microorganisms.1
For microbial maintenance of a process water system alert and action levels are particularly import‑
ant. Each manufacturer must establish their own alert and action levels for the process water system
sample points based upon historical microbiological test data. Specifications including number and
type of organism appropriate to the product being manufactured should be generated. It is recom‑
mended that the microbial quality of process water contain a limit that is no higher than the micro‑
bial limits that a manufacturer has established for finished products.
7
Microbial alert levels are microbiological count recoveries for process water that are within the test
specifications but which are higher than normal recoveries from a specific sample point. Microbi‑
al action levels are microbiological count recoveries for process water that are not within the test
specifications from a specific sample point. For example: Historical microbiological test data might
indicate the establishment of an alert level of 25 Colony Forming Units (CFU) per milliliter sample
and an action level of 75 CFU per 1 milliliter sample. Sanitization of the process water system must
be considered when microbial count recoveries have approached an alert or action level. Sanitization
of a process water system should follow the instructions of internal SOPs.
WATER SAMPLING
Best practice for building historical data on the microbiological environment in a process water
system or for pinpointing sources of microbial contamination is to obtain microbiological test data
from various locations in the system.1 The following areas of the generation and supply distribution
system are important and should be considered when taking microbiological samples:1
Each process water sampling point must be aseptically sampled and tested for microbial content
in a manner consistent with actual use in manufacturing. For example, if a hose is used with the
process water in production, a sample should be taken from the hose. Also, if the process water use
point is sanitized and flushed before use in production, the same sanitize and flush process should
7
be completed before a sample is taken.
PROCESS WATER
QUALITY FOR
Microbiological test results of the process water system should be routinely monitored for trends
which will indicate if there are increasing microbial counts at each use point. If chemical treatment
is being used as a microbial control method, then daily tests for checking chemical levels are strongly
recommended. Microbiological water test results are typically determined after the process water has
been used for production purposes; therefore it is critical that the process water system be validated
to ensure that the microbial quality of process water that is used in production is satisfactory.
WATER TESTING
There is no single method capable of detecting all the potential microbial contaminants in a water
system.1 The methods used for microbial monitoring should be capable of isolating the number and
type of organisms that have been deemed significant for in process system control and finished prod‑
uct release. When selecting a method to monitor the microbial content of a process water system,
method detection sensitivity, range of detectable microorganisms and types and species or organisms
should be considered.1
Identification of recovered microbial isolates from a process water use point may be important in in‑
stances where specific waterborne microorganisms could potentially be detrimental to the products
or processes in which the water is used.1 This information may also be useful when identifying the
source of microbial contamination in a product or process. However, it is up to the manufacturer to
decide whether or not a particular type of microorganism that is recovered in a process water system
sample is objectionable or not.
Corrective action in accordance with the manufacturing facilities’ maintenance plan must be taken
when objectionable organism(s) or unacceptable microbiological counts are found at alert and/or
action levels at a use point.
• Verification of utilities.
QUALITY FOR
• System description
• Verification that each piece of equipment ordered and received is identical to those specified
in the system drawings.
• Verification of sanitary design and materials of construction.
• Examination and documentation of welds.
7
Operational Qualification (OQ) verifies the capability of the equipment to perform within opera‑
tional requirements. The following components are part of the OQ:
Performance Qualification (PQ) is a process of rigorous testing which demonstrates the effectiveness
and reproducibility of the process water system. The PQ provides documentation that a system is
consistently performing as designed when it is operated under normal conditions. Performance
Qualification for a process water system consists of three validation phases: prospective, concurrent,
and retrospective.
Phase one (prospective validation): The purpose of this phase is to develop a data set for establishing
standard operating procedures (SOPs) and confirming that these SOPs are adequate. Prospective
validation includes:
• Daily sampling of the water and chemical and microbiological analysis for each component
at each point of use.
• Analysis of the data set to determine system performance against acceptance criteria.
• Determination of the sampling and testing schedule for concurrent phase (Phase Two).
• Development of SOPs for the water system.
Phase two (concurrent validation): The purpose of this phase is to establish the short-term consis‑
tency of the water system when it is operated according to the SOP’s developed during the prospec‑
tive phase. During this phase, water from the process water system may be used for production or
7
cleaning/sanitization. Concurrent validation includes:
PROCESS WATER
QUALITY FOR
• Sampling done according to the schedule/SOP decided upon in the prospective phase.
• Testing and documentation of conformance to microbial limits (Action/Alert levels).
• Testing and documentation of conformance to analytical specifications.
Phase three (retrospective validation): The purpose of this phase is to establish the long-term consis‑
tency of the water system. Long term testing will determine the variability of the feed water supply,
water system operation, and the effect of deterioration on system components. Retrospective vali‑
dation includes:
REFERENCES:
1. United States Pharmacopeia. 2015. <1231> Water for Pharmaceutical Purposes. USP 38-NF-
33. Rockville, Md.
2. U.S. Food & Drug Administration. 2014 “ Guide to Inspection of High Purity Water Systems.”
http://www.fda.gov/ICECI/Inspections/InspectionGuides/ucm074905.htm
3. U.S. Environmental Protection Agency. 1998 “National Primary Drinking Water Regulations:
Disinfection and Disinfection Byproducts.” 40 CFR Parts, 9, 141, and 142.
http://www.epa.gov/safewater/mdbp/dbpfr.pdf. http://www.fda.gov/ICECI/Inspections/
InspectionGuides/ucm074905.htm
4. United States Pharmacopeia. 2016.<1231> Water for Pharmaceutical Purposes. USP 39-NF 34.
Rockville, Md.
5. Collentro, W.V. 1999. Pharmaceutical Water: System Design, Operation and Validation.
Interpharm/CPC, New York, New York.
6. Meltzer, T.H. 1997. Pharmaceutical Water Systems. Tall Oaks Publishing, Inc. Littleton,
Colorado.
7. International Society for Pharmaceutical Engineering (ISPE). 2014. Approaches to
Commissioning and Qualification of Pharmaceutical Water and Steam Systems. ISPE, Tampa,
Florida.
PROCESS WATER
QUALITY FOR
8. Soli, T.C. “Design and sanitization of Water Systems to Prevent Contamination.” In Madsen
R.E, and Moldenhauer, J. Editors. Designing and Controlling Water Systems. 2014. Parenteral Drug
Association, Bethesda, Md.
9. Dychdala, G.R. “Chlorine and Chlorine Compounds.” In: Block, S.S. 2001. Disinfection,
Sterilization and Preservation. Lippincott, Williams & Wilkens. Philadephia, Pa.
7
10. International Society of Pharmaceutical Engineering [ISPE] 2012. Good Practice Guide:
Ozone Sanitization of Pharmaceutical Water Systems. ISPE, Tampa, Florida.
11. Nebel, C. and Nenel, T. 1984. “Ozone: The Process water Sterilant.” Pharmaceutical
Manufacturing 1 (2), pp 16-22.
12. Rice, R.G., Robson, G., Miller, W.M. and Hill, A.G. 1981 Uses of Ozone in Drinking Water
Treatment. American Water Works Association 73 (1), pp 49-57.
ADDITIONAL READING
Cruver, J.E. “Water Disinfection-A Comparison of Chlorine, Ozone, UV Lights, and Membrane
Filtration” Eight Annual Membrane Technology/Planning Conference & First High-Tech
Separations Symposium, Newton, Ma. (October 15-17, 1990).
Huttquist, A. 2007. Practical Guidelines for Qualifying and Purified Water System.
Pharmaceutical Technology Europe, Vol. 19, Issue 12.
International Society for Pharmaceutical Engineering (ISPE). 2011. ISPE Baseline Guide: Water
and Steam Systems, 2nd. Edition, ISPE, Tampa, Florida.
Maltias, J.B. et al. 1990. An Evaluation of Various Biocides for Disinfection of Reverse Osmosis
Membranes and Water Distribution Systems. Ultrapure Water 7(3): 37-40.
Soli, T.C. 2008. “Pharmaceutical Water, Microbiology” In Pharmaceutical Manufacturing, Vol. 1,
2nd Edition, Prince, E.R. (ed.), DHI Publishing, LLC., Bethesda, Md.
Soli, T.C. 2012. Sanitization Approaches for Biofilm Control. In Biofilm Control in Drug
Manufacturing. Clontz, L. and Wagner, C.M. (eds.). Parenteral Drug Association. Bethesda. Md.
U.S. Food and Drug Administration 2015. , Reverse Osmosis, http://www.fda.gov/ICECI/
7
Inspections/InspectionGuides/InspectionTechnicalGuides/ucm072913.htm
PROCESS WATER
QUALITY FOR
U.S. Food and Drug Administration. 2015. “Water for Pharmaceutical Use. http://www.fda.gov/
ICECI/Inspections/InspectionGuides/InspectionTechnicalGuides/ucm072925.htm
U.S. Environmental Protection Agency. 1989. Drinking Water; National Primary Drinking Water
Regulation; Total Coliform (Including Fecal Coliform and E. coli, Federal Register, Vol. 54, No.
124, 40 CFR Parts 141 and 142.
Microbiology
Laboratory Audit
INTRODUCTION
Within the personal care industry, quality assurance, development, and contract microbiology te‑
sting laboratories provide supportive microbiological data related to product safety and quality.
Microbiological aspects of formula development, from product conception to finished goods, need
to be addressed to determine if microbiological standards are met. Examples include the develop‑
ment and evaluation of preservative systems and the examination of the microbial content in raw
materials, intermediates, finished goods, and the manufacturing environment.
Laboratory practices should be evaluated at regular intervals to ensure that the generation of data
is reproducible, accurate, and reliable. An audit serves to review existing practices, systems, and
equipment to ensure that they perform as expected. Microbiology lab audits should be conducted
by individuals familiar with the functions and processes that typically occur in a microbiology la‑
boratory. This document provides guidance for conducting an audit of both in-house and contract
personal care microbiology testing laboratories. If personal care and over-the-counter (OTC) drugs
are tested in the same laboratory, refer to FDA guidelines for the manufacture of OTC drugs and to
relevant chapters in the US Pharacopeia.1-3
Based on the information presented in this document, an example of a personal care Microbiology
8
Laboratory Audit Checklist can be found in Table 8-1.
LABORATORY AUDIT
MICROBIOLOGY
PERSONNEL
Supervisory personnel have the responsibility to ensure that operating systems are consistent with
existing personal care regulations and Cosmetic Good Manufacturing Practices (GMPs).4 Labora‑
tory supervisors are to be familiar with applicable regulations and current industry practices. Initial
and continuing training programs are valuable means to ensure that employees are qualified for
their roles and responsibilities and are informed about all laboratory procedures. The following do‑
cumentation may be considered in recording an employee’s qualifications and is most useful when
maintained on file for reference:
• Job descriptions for all laboratory positions, which may describe the qualifications, primary
and secondary responsibilities, and job functions
• Organizational chart showing each staff position and each incumbent identified by position,
name and reporting relationship
• Skills checklist or applicable training documentation for each employee detailing the mi‑
crobiological techniques and procedures that an individual has been trained and certified to
perform on a routine basis (See, for example, Table 8-2)
• Records of initial and continuing training for each employee
LABORATORY FACILITIES
Adequate laboratory facilities should be provided to minimize errors in test results due to contami‑
nation, inaccuracy in data interpretation, equipment failure, or sampling mistakes. It is recommen‑
ded that rooms used for microbiological testing be of suitable size, construction, and location to
facilitate proper operation. In general, the attributes of an adequate microbiology laboratory facility
include, but are not limited to the following:
• The laboratory contains separate areas for microbiological analysis, support functions (e.g.,
media prep, sample prep, sample login, clerical work), and storage of personal belongings.
• The area for microbiological analysis is used exclusively for testing aspects such as sample
handling, performing procedures, transfer of cultures, counting of colonies, etc.
• All surfaces in the laboratory are nonporous, cleanable, and sanitizable.
• The facility design minimizes exposure of laboratory areas to air currents.
• Laboratory access is restricted to minimize foot traffic by non-laboratory personnel.
• Microbiological quality of the laboratory environment is controlled by appropriate me‑
chanical and physical means such as use of positive-pressure room air, germicidal lamps,
high-efficiency particulate air filters, and/or laminar flow stations.
• Workspaces such as laboratory benches and laminar flow hoods are sanitized at the begin‑
ning and end of the workday, as well as between individual procedures.
• Adequate ventilation and lighting is provided, especially over work areas.
LABORATORY AUDIT
• Electrical service is appropriate for the equipment used in the laboratory and associated
areas to avoid power outages and equipment failure.
MICROBIOLOGY
• Adequate sink areas with hot and cold water service are provided.
• Sufficient counter and shelf space are available so that all procedures can be performed while
preventing overcrowding, safety hazards, or any cross contamination.
• Clean uniforms or lab coats are provided.
• Microbiologically contaminated materials are decontaminated prior to disposal.
8
• Floors are kept clean by regular mopping and be sanitized by using a disinfectant detergent.
• Adequate containers that are appropriately labeled are provided for microbiological waste,
non-hazardous waste, and general trash disposal. General trash is removed from the labora‑
tory each working day.
SAFETY
A written safety policy that addresses laboratory personnel, equipment and processes should be
readily available. This policy should reference a published laboratory safety manual.5,6
LABORATORY EQUIPMENT
It is recommended that standard operating procedures as well as supporting documentation (e.g.,
equipment manuals, calibration data) be readily available to personnel for each piece of equipment.
Equipment is to be maintained in accordance with the manufacturer’s guidelines and routinely
calibrated, with clearly visible calibration stickers or logs containing calibration date, calibrators
name, and next scheduled calibration date. Personnel should be adequately trained on each piece of
equipment necessary to their function prior to their routine use of that equipment. A summary of
calibration recommendations can be found in Table 8-3. The following specific attributes for some
types of common laboratory equipment are recommended as a minimum guideline:
Incubators
Incubators should maintain a uniform and constant temperature within predetermined limits;
±2.0°C is recommended for most laboratory applications. An accurate thermometer with a bulb
continuously immersed in liquid (water, mineral oil or propylene glycol) is maintained at appro‑
priate location(s) (e.g., hot and cold spots detected through temperature mapping) in the incu‑
bator. Daily temperature readings are recorded on laboratory workdays. Daily humidity readings
are recorded for humidity-controlled incubators. Temperature recording devices or maximum and
minimum registering thermometers within the incubator are recommended to record temperature
variations. Provision is made for humidity control (e.g., placing a beaker of water in the incubator).
The temperature setting is appropriate for the types of organisms being incubated.
Autoclaves
8
Laboratory autoclaves are capable of maintaining a uniform and constant temperature of 121° -
123°C and reach target temperature within 30 minutes. In order to allow sufficient heat distribu‑
LABORATORY AUDIT
MICROBIOLOGY
tion and penetration for sterilization, autoclaves are properly sized and loaded to prevent crowding
of items. Autoclaves are equipped with accurate thermometers or temperature recorders, pressure
gauges, and properly adjusted safety valves. If a time-temperature recorder is not available, an alter‑
native temperature monitoring device or bioindicator is used. Autoclave tape is not an indicator of
sterility. A maintenance program is in place, which includes an annual certification of temperature
and pressure gauges, timers, and temperature recording devices. In addition, individual run records
(e.g., time-temperature recording) are maintained. Records are routinely reviewed for deviation. An
autoclave log is maintained detailing run conditions and allowing traceability of autoclave run doc‑
umentation with specific loads. Temperature controllers, temperature recording devices, pressure
gauges, and timers must be certified for accuracy to insure proper operation.
Colony Counters
A standard colony counter or comparable instrument may be used. Automated colony counters may
be used where accuracy and reliability have been validated. Automated colony counter accuracy is
checked each day of use and a log-in book is maintained.
pH Meter
pH meters are capable of accurately measuring the hydrogen ion concentration to 0.1 pH units. The
pH meter should be calibrated each day of use by using at least two certified pH buffer solutions
that bracket the pH range of the sample. Buffers should not be used past their expiration dates.
Probes for taking the pH of a sample should be appropriate for the material being analyzed.
Balances
Balances used for routine weighing (e.g., media, samples, etc.) are accurate for the utilized task.
Balances and weights are calibrated according to a regular preventative maintenance schedule with
weight (mass) standards traceable to NIST Reference standards.7 Weight checks should be per‑
formed with calibrated weights.
Labware
Disposable or reusable labware is inert to the materials with which it may be used. For glassware
items, borosilicate glass is recommended because of its ability to withstand high temperatures. The
following are recommendations for selected examples of commonly used labware:
• Pipettes - sterile glass or disposable plastic pipettes may be used. The accuracy of the pi‑
pettes will depend on the volume (i.e., 50-1,000ul pipette accuracy ±0.6%). If used, micro‑
pipettors should be calibrated annually.
• Dilution bottles and tubes - bottles and tubes are single use or are made of autoclav‑
able material. Screw caps are equipped with inert liners. All reusable items are thoroughly
cleaned and rinsed using a protocol that assures no detectable detergent residue.
• Media preparation utensils - clean borosilicate glass, stainless steel, or other suitable inert
labware are recommended.
• Petri dishes - sterile borosilicate glass or disposable plastic Petri dishes are recommended.
Microscopes
A monocular or binocular microscope suitable for the intended purpose is recommended. The
microscope should be capable of a minimum total magnification (combined ocular and objective
LABORATORY AUDIT
lenses) of 1000x. A dissecting scope may be used for lower magnification. An annual maintenance
check is recommended by which lenses, alignment and mechanism aspects are checked.
MICROBIOLOGY
Refrigerator/Freezers
Commercially available refrigerators are suitable unless there is a need for an explosion-proof model.
Refrigerator temperature should be maintained at 2-8°C and routinely checked. No food should be
stored in laboratory refrigerators or freezers. Standard freezers have autodefrost. Ultra-freezers (e.g.,
-80°C) are maintained within 5°C of the desired temperature.
8
Water Baths
Water baths have thermostatic controls to deliver temperatures from ambient to 100°C ±2.0°C. An
accurate, calibrated thermometer should be placed in the water bath to monitor the temperature.
Temperature readings are recorded daily when in use and also after equilibrium has been reached
following any adjustment of the temperature controls. Biocide may be added to the water to pre‑
vent/control microbial growth.
Water Treatment
The laboratory has an appropriate system for producing the desired grade of water (e.g., deionized,
distilled) for use in microbial growth media and other applications. The water treatment unit is
maintained and operated consistent with manufacturer’s recommendations. Water is periodically
monitored to ensure it meets chemical and microbiological quality. If a UV light is part of the water
system, it should be maintained and operated according to the manufacturer’s directions.
Note: If personal care and over-the-counter (OTC) drugs are tested in the same laboratory, refer to
FDA reference materials and the USP Guidelines for Water.1,2,3
8
Thermometers
LABORATORY AUDIT
MICROBIOLOGY
Thermometers are of appropriate range for the application. Measurement accuracy is initially estab‑
lished and rechecked at least annually by using a NIST certified thermometer.8
Spectrophotometers
Calibration is performed against standard solutions every six months or as recommended by the
manufacturer.
Centrifuge
Centrifuges are calibrated for temperature and rotor speed annually.
Media Dispensers
The dispensing volume should be verified on a regularly scheduled basis.
Chemical Storage
Appropriate storage should be used for chemicals used in laboratory (i.e., flammable cabinets for
flammable material).
For more guidance on calibration of microbiological equipment; see PCPC Quality Assurance Guide-
lines.9
DOCUMENTATION
The purpose of documentation is to provide the written record of a laboratory operation. A history
of operation is maintained through the retention of documents (e.g., logbooks, worksheets, cali‑
bration records, etc.). Establishment of a document retention program is highly recommended; it
defines the policy of the company, retention time, form place of storage, etc.
Any documentation should describe the function of the laboratory operation with properly prepa‑
red and regularly updated procedures. Scheduled review of laboratory procedures is made to ensure
that procedures are as described. Discrepancies are corrected and procedures amended when appro‑
priate. The investigation and procedure change are documented. See “Microbiological Validation
and Documentation” (Section 9).
Documentation of the following quality control checks is recommended as part of laboratory pro‑
cedures:
• Methods Validation
All microbiological methods are validated and documented to ensure the accuracy of the
test response.
• Media
Media performance is documented via positive and negative controls on each prepared
LABORATORY AUDIT
batch of media.
MICROBIOLOGY
to conform to signatures that are issued in the laboratory is maintained. Retraining docu‑
mentation is maintained.
• Forms
Forms used to document test results are periodically reviewed and updated as necessary to
reflect current procedures.
• Procedures
Written standard operating procedures and test methods reviewed and updated on a regular
basis to document changes. All procedures include an effective-date and supercedes-date to
identify the current version. All changes are communicated to laboratory personnel.
• Investigation and Discrepancies
An out of specification investigation procedure exists that includes the steps outlining the
process, detailing the findings, and reporting the results. Any discrepancies in the microbio‑
logical test results and/or procedures are investigated, documented and evaluated by appro‑
priate personnel.
8
LABORATORY AUDIT
MICROBIOLOGY
Table 8-1
General
1. Is there an organizational chart present showing each employee and reporting relationship?
2. Is the signature list up-to-date?
3. Are there written job descriptions for each laboratory position?
4. Is there a training and development program for laboratory members?
5. Is there formal training documentation?
6. Are individual qualifications for laboratory members on file and updated regularly?
Laboratory Facilities
1. Is access to the microbiology laboratory controlled?
2. Are laboratory facilities clean and orderly?
3. Does the laboratory have adequate workspace, ventilation, and light?
4. Is the laboratory free of dust, drafts and temperature extremes?
5. Are there adequate facilities for cold storage, microbial media, and storage of samples?
6. Review records for sanitization and cleaning?
Laboratory Safety
1. Are laboratory coats worn only in laboratory areas?
2. Are proper shoes and clothing worn in laboratory areas?
3. Is a safety committee and/or advisor established and functional?
4. Are all laboratory members provided with or have access to the laboratory safety manual?
5. Are the members of the janitorial staff provided appropriate training suited to the microbiology area?
6. Does the laboratory provide for the following:
a. Designated containers for broken glass, sharp objects, etc.?
b. First aid kits accessible and maintained?
c. Operational eyewash and deluge shower stations conveniently located?
d. Are fire extinguishers and blankets maintained up-to-date and readily accessible?
e. Are emergency exits clearly marked?
f. Are emergency telephone numbers widely and conveniently located?
7. Is microbiologically contaminated waste decontaminated before disposal?
Laboratory Equipment
1. Review records for equipment calibration and preventative maintenance.
2. Review records for calibration of standards and equipment daily calibration check logs (evaluate where
corrective actions where taken when calibration failed).
3. Review cleaning log records (e.g., incubators, water baths, etc.).
LABORATORY AUDIT
6. Is each piece of laboratory equipment properly identified and tagged with its calibration, preventative
maintenance, and operational status?
7. Review temperature monitoring log records for incubators, refrigerators, and controlled areas.
8. Review laminar flow hood HEPA filter certification records.
9. Are up-to-date equipment operating instructions available?
10. Is appropriate laboratory/instrumentation available for use in accordance with required methodology?
11. Are there service contracts for maintaining equipment?
a. For what types of laboratory equipment?
8
Culture Maintenance
1. Are ATCC or standard culture collections microbial cultures verified upon receipt (prior to use)?
2. Is record keeping and traceability of microorganisms used in testing in place?
3. Is the (e.g., not more than five passages from original) source culture reculturing being monitored.
Water
1. Is there a source of distilled or deionized water?
2. Is water monitored routinely for chemical and microbiological quality?
3. Review data generated to include evaluation of corrective action plans when test results are aberrant.
4. Review sanitization and preventative maintenance log records for laboratory water system.
5. Review procedure for taking microbiological test samples of water.
6. Are representative water isolates identified?
8
Sample Handling
1. Are there adequate written procedures for receipt, storage and handling of test samples?
LABORATORY AUDIT
MICROBIOLOGY
2. Are there established sample turnaround times/targets?
3. Are sample submission forms stamped with date/time upon receipt?
4. Are samples given an unambiguous sample number when logged?
5. Does a permanent record exist for sample log-in data?
6. Are appropriate chain-of-custody procedures documented and followed, when required?
7. Are there established operating procedures available for disposal of samples?
Records Management
1. Is a system in place that provides for retrievability and traceability of sample source, methodology of analyses,
results, person performing analysis, and date?
2. Are records and reports adequately secured and retained for the required length of time to ensure their
integrity?
3. Are all laboratory notebooks, when completed, filed in a secure, controlled archive area and from which they can
be easily retrieved?
4. Are all laboratory equipment/instrument maintenance logs uniquely identified and stored for easy retrieval?
5. If the laboratory operates a computerized data/information management system (LIMS), are there backups to
ensure integrity and availability of data/information in the event of a system/power failure?
Test Reports
1. Do the laboratory’s reports accurately and clearly present test results and all other relevant information?
2. Does each test report include the following:
a. Identification of laboratory issuing the report?
b. Identification of client. if applicable?
c. Sample identification and description (e.g., sample name and lot number)?
d. Dates/times of sample collection or receipt. Receipt and types of testing performed?
e. Identification of microbiological test methods used in the analysis?
f. Description of sampling procedure, where relevant?
g. Any deviations, additions, or exclusions from a test method?
h. Disclosure of any subcontractor used?
i. Results and any failures identified?
j. Identity of person accepting responsibility for the testing?
k. Is the laboratory report format understandable?
l. Are corrections or additions made to test reports after being issued?
m. Is there a policy/protocol to handle inquires and complaints about test reports and results?
n. Is there a policy/protocol in place outlining the checking and authorization for data release to clients?
LABORATORY AUDIT
MICROBIOLOGY
8
Table 8-2
SKILL
Media
• Preparation and storage
• Media quality control
• Media remelt in autoclave/microwave
• Use of differential media
Microorganisms
• Inoculum preparation
8
• Organism maintenance techniques
LABORATORY AUDIT
MICROBIOLOGY
Table 8-3
Weekly
Six Months
Balances Calibration
Spectrophotometers Calibration
Annually
Stomachers Efficacy
Sonicators Efficacy
REFERENCES
1. U.S. Food and Drug Administration 2015. FDA 21 CFR, Part 210 - Current Good
Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General.
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=210
2. U.S. Food and Drug Administration 200 Guidance for Industry, Q7A Good Manufacturing
Practice Guidance for Active Pharmaceutical Ingredients. http://www.fda.gov/ICECI/
ComplianceManuals/CompliancePolicyGuidanceManual/ucm200364.htm
3. United States Pharmacopeia and the National Formulary 2016. (USP39-NF34) Pharmacopeia,
1260 Twinbrook Parkway, Rockville, MD 20852).
4. Nikitakis, J.M. (ed.) 2014. ISO 22716. Cosmetics good Manufacturing Processes. In PCPC
Quality Assurance Guidelines, The Personal Care Products Council, Washington, DC 20036
5. Fleming, D.O. and Hunt, D.L., Eds. 2006. Biological Safety: Principles and Practices, Fourth
Edition ASM Press, Washington, D.C.
6. Department of Health and Human Services, Centers for Disease Control and Prevention and
National Institutes of Health, 2009. Biosafety in Microbiological and Biomedical Laboratories
(BMBL) 5th Edition, U, US Government Printing Office Washington: http://www.cdc.gov/
biosafety/publications/bmbl5/bmbl.pdf
7. National Institute of Standard and Technology 2016. Specifications, Tolerances, and Other
Technical Requirements for Weighing and Measuring Devices. http://www.nist.gov/pml/wmd/
pubs/hb44.cfm
8. National Institute of Standard and Technology 1996. Specifications and Tolerances for
Thermometers. www.nist.gov/pml/wmd/upload/105-6.pdf
9. Nikitakis, J.M. (ed.) 2014. Annex 16 Calibration Systems. In PCPC Quality Assurance
Guidelines, The Personal Care Products Council, Washington, DC 20036, pp. 99-102.
8
LABORATORY AUDIT
MICROBIOLOGY
Microbiological Validation
and Documentation
INTRODUCTION
Validation assures that the methods and procedures used by the personal care microbiology labora‑
tory are accurate and reproducible. Documentation provides the record of the validation.
In order for results to be meaningful, methods and procedures must be validated. Otherwise, the
conclusions drawn could be erroneous. For example, failure to properly neutralize the preservative
system during testing can result in false negative results where lack of organism recovery may be due
to inhibition of the organism.
A variety of techniques for validating and documenting methods and procedures is available. In
addition to the test methods and procedures used in the laboratory, the microbiological aspects of
process water systems and of cleaning and sanitizing procedures can also be validated by the micro‑
biologist. The results of a validation should then be documented in an organized record keeping
system.
Once these methods and procedures are validated and documented, there is a high degree of confi‑
dence that they can consistently produce accurate and reliable results. This completes the full circle
of quality assurance and is necessary to assure product quality.
Personnel responsible for any aspect of the validation must be adequately trained by education and/
or experience.
GENERAL CONSIDERATIONS
Validation is a process designed to establish documented evidence that a method or procedure does
what it purports to do. A validation or revalidation should be performed:
A. Validation Format
The validation format should contain the following elements:
1. Scope
The scope identifies the area being validated, describes the purpose of the validation, and tells
what it encompasses. This should include the types of validation that will be performed. Three
types of validation include:
a. Prospective
Prospective validation establishes documented evidence that a process does what it purports
to do based on a preplanned validation protocol. All information and results are gathered
before implementation.
b. Concurrent
Concurrent validation establishes documented evidence that a process does what it purports
to do based on information generated during actual implementation of the process. The test
methods, procedures (such as cleaning and sanitizing), systems (such as deionized water sys‑
tem) and equipment are being used while data are being gathered to support the validation.
c. Retrospective
Retrospective validation consists of presenting documented evidence that, based on a review
and analysis of historical data and information, a process does what it was meant to do and
that, all things being equal, can be expected to continue performing properly.
It should be noted, concurrent and retrospective validation can be performed simultaneously.
2. Description
A detailed step by step description of the procedure or method is provided.
3. Requirements
The requirements and acceptance criteria for the areas to be validated are described. For example:
a. Equipment cleaning and sanitization requirements include specific sites, number of swabs
before and after, and defined performance criteria.
b. Laboratory autoclave requirements include number of heat penetration studies, defined ac‑
ceptable results, and negative controls acceptability criteria.
c. Test methods criteria include the number of replicate platings and the allowable variance.
4. Protocol
A written protocol for each method or procedure to be validated should be included.
5. Documentation
DOCUMENTATION
VALIDATION AND
6. Conclusion
Each validation protocol should include a conclusion that indicates the results of the valida‑
tion. If the results are satisfactory, a statement may be made that the validation is satisfactory
and that the method or procedure can produce accurate and reliable results. If the results are
unsatisfactory, the next steps or modification required to complete a satisfactory validation
should be indicated.
A final written report should be prepared once the validation has been completed. Any revali‑
dation information can be added as it is generated.
B. Documentation
Once a procedure or method is validated, all results generated during its use should be document‑
ed by keeping an organized record system. They can be organized by product or type of test and
can include:
• Material identification/description
• Identification/code number
• Vendor/in‑house lot number
• Reference to the validated procedure used
• Acceptance criteria
• Tested by
• Date tested
• Reviewed and approved by.
All results should be routinely reviewed by supervisory personnel. Records should be kept for
an appropriate length of time. Refer to the PCPC Quality Assurance Guidelines, Production and
Control Documentation.1
Documented results can be maintained as part of a product or raw material profile in the devel‑
opment of an historical data base. Validation procedure results should be included as part of this
data base. Results which were compiled in an historical data base prior to validation may be useful
as part of a retrospective validation. The data base can also be used as a guide in interpreting test
results and establishing test guidelines and requirements.
LABORATORY AUTOCLAVE
An autoclave is an instrument that uses moist heat supplied by steam under pressure to sterilize
9
materials. The contents, whether liquid or solid, are exposed to saturated steam at the required tem‑
perature and period of time. Pressure serves as a mechanism for obtaining higher temperatures than
DOCUMENTATION
VALIDATION AND
A. Validation
1. Preliminary Considerations
The accurate measurement of both time and temperature are necessary to confirm the steriliza‑
tion of the autoclave chamber contents. Before an autoclave cycle can be validated, tempera‑
ture controllers, temperature recording devices, pressure gauges, and timers of the autoclave
must be certified for accuracy to insure proper operation.
The autoclave load configuration and contents are important elements. The autoclave cycle will
vary based on volume of containers, number of containers, container type, media type, etc.
2. Heat Measuring Devices
Biological indicators and/or chemical and/or mechanical heat measuring devices can be used
to validate an autoclave cycle. The use of biological indicators (BIs) for certain media cycles
may be problematic if minimal sterilization cycles are required. BIs are available with different
populations. Select the most appropriate population.
a. Mechanical Devices
These include calibrated autoclave thermometers or thermocouples.
b. Biological Indicators
Due to their high resistance to moist heat, Bacillus stearothermophilus spores on a paper strip
or as a spore suspension in a glass ampule are the most commonly used biological indicator
used for monitoring autoclave performance.
At the end of the autoclave cycle, the Bacillus stearothermophilus biological indicators
are removed and incubated per manufacturer’s directions. These are usually incubated at
56.0‑60.0°C for 7 days to account for the possibility of slower growth following exposure to
sublethal heat. Use appropriate media if spore strips are used. If BIs are used, they should be
certified against the label claim.
Negative and positive controls should be incubated along with the autoclaved biological
indicator samples. An unautoclaved biological indicator should be incubated as a positive
control. If spore strips are used, a negative media control should be also included.
c. Chemical/Physical Indicators
Chemical and physical indicators are used as a secondary check to monitor a validated cycle.
They are not intended to be used as primary indicators to validate a cycle. Autoclave tape
indicates it has been exposed to an autoclave cycle when, for example, black stripes or the
word “autoclaved” appear on the tape. Ampules which contain a material that melts and
changes color when exposed to the proper temperature may also be used to monitor an
autoclave cycle.
3. Heat Distribution and Penetration
DOCUMENTATION
VALIDATION AND
Heat penetration and/or distribution studies should be performed on empty (or minimum)
and maximum load configurations of the autoclave chamber by using temperature measuring
devices and biological/chemical indicators. The biological/chemical indicators and/or the heat
measuring devices should be evenly distributed throughout the autoclave chamber for the
monitoring of representative areas. At minimum, the monitoring devices should be placed at
the four corners and center of the autoclave. The actual number may vary based on the size of
the chamber and the load pattern.
a. Heat Distribution
The purpose of a heat distribution study of an autoclave is to determine the uniformity of
temperature in the load. Heat distribution studies should be performed on load configu‑
rations of the autoclave chamber by using temperature measuring devices. It is suggested
that a minimum of three heat distribution studies be done on the load configuration being
validated.
A mean chamber temperature is taken from all the distributed temperature readings. Cham‑
ber temperature uniformity can be considered acceptable if individual temperature readings
deviate less than 1.0°C from the mean chamber temperature. A mean temperature devia‑
tion greater than 2.5°C versus the set temperature may indicate equipment malfunction.
Chamber uniformity range should be based on the manufacturer’s recommendation for the
autoclave capability.
b. Heat Penetration
The purpose of a heat penetration study is to assure that all the containers within a loading
pattern will consistently be exposed to a sufficient amount of heat for sterilization. A mini‑
mum of three heat penetration studies is suggested.
Heat penetration studies may be performed by placing chemical/biological indicators in
containers of media distributed in a load pattern throughout the autoclave. Biological and/
or chemical indicators should be placed throughout the chamber including areas considered
to be the most difficult to sterilize.
4. Documentation
The following information should be recorded for each validation run:
a. Date of validation
b. Autoclave identification or number
c. Run number
d. Sterilization time
e. Sterilization temperature
f. Load contents (media, broth or agar)
g. Number of containers, configuration
9
B. Routine Monitoring
Each autoclave cycle should be monitored for the following:
• Temperature and time - Confirm temperature and length of cycle on recording charts or
cycle printouts.
• Pressure - Observe pressure on gauge and confirm if recorded on cycle printouts.
• Biological indicators - Monitor using BIs at least quarterly where applicable for monitoring
a validated cycle.
• Chemical/Physical indicators - Temperature-sensitive indicators, such as autoclave tape,
should be used with each load.
MEDIA
A. General
Microbiological culture media contain growth-promoting substances such as available sources of
carbon, nitrogen and inorganic salts. The quality of the growth characteristics of microorganisms
in culture media depends upon the care taken in the preparation of the medium. To insure satis‑
factory microbial culture media for use in the microbiology laboratory, a validation and quality
control program should be established for freshly prepared or received media as well as for estab‑
lishing the shelf life of the media.
This applies whether the culture media are prepared from commercially dehydrated products or
purchased from a supplier in prepared form. This program is needed to ensure that the media can
consistently perform as expected over its shelf life. This program should include the identification
and control of those factors which affect the performance of the media. Some of these factors
include:
• Preparation of media
• Temperature
• pH
DOCUMENTATION
VALIDATION AND
• Storage conditions
• Shelf life
• pH - The pH of the microbial culture media is critical. There should be a laboratory pro‑
cedure that lists the acceptable pH ranges for a liquid or agar medium. In general, the pH
reading should be taken after autoclaving and subsequent cooling to room temperature
and should meet established requirements.
b. Media Records
Establish a batch record for each lot of culture medium that is prepared in the laboratory.
The following information should be included on the batch sheet:
• Medium name
• Date of preparation
• Manufacturer’s lot or batch number
• Quantity prepared
• Signature of preparer
• Method of preparation
• pH after autoclaving
• pH adjustment, if required
• Sterilization time and temperature
• Volume dispensed
• Number of units dispensed
• General comments (e.g., appearance of the medium during preparation)
• Performance test results and disposition (acceptable/unacceptable).
Where available and/or appropriate obtain a certificate of analysis the supplier of prepared
media.
3. Labeling and Storage of Prepared Media
a. Labeling
Label all microbial culture media, whether commercially prepared or prepared in the labo‑
ratory. Include the following information:
b. Storage
Establish a shelf life, an expiration date for the culture media. In general, the shelf life of a
particular medium is dependent upon how well that medium will continue to support the
growth of test microorganisms. The shelf life can be determined by growth promotion stud‑
ies over time and storage conditions. This can be accomplished by comparing the growth
promotion abilities of the stored versus freshly prepared microbial culture media. Factors
which affect the shelf life of prepared media include:
• Form - The formulation and packaging of the medium will decide its basic susceptibility
to deterioration during storage. In most cases, the shelf life of an agar medium in a Petri
DOCUMENTATION
VALIDATION AND
dish will be shorter than the same dehydrated agar in a sealed container or bottle.
• Storage temperature - The optimum storage temperature for the majority of prepared mi‑
crobial culture media is about 2‑8°C. Most liquid media will keep for many months at
2‑8°C, but have a tendency to form deposits. This is especially true for culture media at
double strength. If stored at room temperature, shelf life may be shortened.
• Light exposure - Dye‑containing media may fade if exposed to light.
• Evaporation - A volume check on liquid media should be made on older stocks which may
change due to evaporation.
• Dehydration and contamination - Prepared solid media can be stored for many months
in an airtight container. The storage of agar Petri dishes presents two main problems:
dehydration and contamination. The length of storage time that agar Petri dishes can be
kept for use will depend upon the ability to avoid microbial contamination and the loss
of moisture. To prevent moisture loss, agar Petri dishes can be wrapped in plastic bags for
storage at 2‑8°C.
4. Performance Testing of Microbial Culture Media
Performance testing is conducted to confirm that a given media yields expected results when
inoculated with applicable microorganisms.
Usually on the same batch preparation sheet or on a separate coordinated sheet, the following
performance testing details are listed:
• Medium
• Batch/preparation date
• Date tested
• Sterility evaluation
• Specific microorganisms
• Growth promoting, differential, and inhibitory ability
• Pass/Fail
• Operator’s signature and date.
A sterility check should be performed for each lot of prepared microbial culture medium. In‑
cubate a sufficient number of units at the temperature and time for which the medium is going
to be used in the laboratory testing. The sterility test for each lot of prepared medium will
document that it was sterilized properly. This test will ensure that any microbial contamination
detected during a test procedure using this lot of prepared medium was not caused by a lot of
improperly sterilized media.
Each lot of dehydrated microbial culture medium or commercial or laboratory-prepared lot should
be tested, as appropriate, for its ability to support, differentiate, or inhibit the growth of microor‑
9
ganisms. For general selection media, the choice of which microorganisms should be used to vali‑
date the ability of that medium to support growth is up to the individual laboratory. It is preferable
DOCUMENTATION
VALIDATION AND
to use representative strains of different types of organisms. However, selective or differential media
should utilize microorganisms that will demonstrate the characteristics of that medium. A negative
control organism may be included to determine that there are no false positive reactions.
If all control parameters of the preparation process are validated and monitored, testing may
be done less frequently, but on a regularly scheduled basis.
Two methods used by industry to validate the growth promotion ability of a microbial culture
medium are described below.
• One method involves inoculating a culture medium by streaking solid media or pipetting
into liquid media with a dilution yielding 10‑100 colony forming units (CFU) prepared
from a 24-hour culture of a known microbiological strain.
• The second method consists of inoculating by streaking or pipetting and spreading a solid
culture medium surface with a 10‑3 dilution of a 24-hour culture of a known microor‑
ganism(s).
The choice of method is up to the individual laboratory. There are many factors to consider
including the type of test and the sensitivity and/or detection limits of the test procedures for
which the media will be used. The known microbiological strains used may be American Type
Culture Collection (ATCC) strains of a particular microorganism. In either case, the inoculat‑
ed media should be incubated at the same temperature and time for which it will be used in
laboratory testing. After incubation, the inoculated liquid media is examined for the presence
of turbidity and general solid media for the presence of growth. Selective and enrichment agars
are examined for typical color and colony morphology of the strain used to inoculate them.
If the lot is within the correct pH range, passes the sterility test, and passes the growth promo‑
tion test, it can be used for testing in the microbiology laboratory. If the medium’s pH is out
of range, if the medium does not pass the sterility test, or if it fails to support the growth of the
test microorganism(s), the medium fails the criteria for use in the laboratory.
There may be times when performance testing is conducted concurrently with the use of the
media for laboratory testing. If a lot of media fails the performance test and was used in the
laboratory, all laboratory testing should be repeated with acceptable media.
Results of performance testing should be documented and reviewed for accuracy.
TEST METHODS
A. General Considerations
Validation of a microbiological method is the process by which it is established through labora‑
tory studies that the performance characteristics of the method meet the requirements for the in‑
tended application. Protocols should be designed to generate reliable, accurate and reproducible
results. Microbiological methods are designed to detect and/or identify microorganisms when
present. These methods include conventional plate count/streak plate procedures, as well as rapid
or automated methods. These methods are intended to perform within a wide range of variables,
some of which are:
DOCUMENTATION
VALIDATION AND
• Incubation conditions
• Organisms
• Detection limits
• Microbial content testing may be performed on raw materials, components, bulk product,
in-process material and finished goods.
• Microbial limit guidelines, sample size and frequency of testing should be established.
• The established testing guidelines should have appropriate documentation.
Refer to “M-1 Determination of the Microbial Content of Personal Care Products”(Section 18),
“Raw Material Microbial Content” (Section 11), and “Establishing Microbiological Quality of
Personal Care Products” (Section 12)
Refer to “M‑3 A Method for the Preservation Efficacy Testing of Water‑Miscible Personal Care
Products” (Section 20) and “M‑4 Method for the Preservation Testing of Eye Area Personal Cares”
(Section 21).
DOCUMENTATION
VALIDATION AND
E. Environmental
Ambient air, compressed air, and equipment surfaces in the manufacturing plant are monitored
for the presence of microorganisms using apparatus such as settling plates, air samplers, swabs,
and contact plates. Equipment should be evaluated by reviewing manufacturer’s technical infor‑
mation.
Surface monitoring procedures can be validated in the laboratory by applying known types and
levels of organisms to sample surfaces simulating production surface materials. Recovery using
the various surface monitoring techniques can then be compared to initial types and levels of
organisms to determine the acceptability of the procedure.
ORGANISM IDENTIFICATION
A. Identification systems
Microorganisms may be identified using classical methods. Identification via commercial identi‑
fication kits and/or automated systems is common practice in personal care microbiology labo‑
ratories. Systems used for microbial identification should be validated to ensure they consistently
and accurately identify microorganisms tested.
A validated system should show equivalence with a known method. Introduction of an alternate
identification system requires a validation vs. the current system to ensure performance is compa‑
rable or better than the current system(s). Some of the factors to include:
• Side-by-side comparison testing of the standard routine cultures used in the laboratory and/
or ATCC cultures.
• Side-by-side comparison testing of unknown organisms such as those isolated from the
plant product.
series of QA microorganisms to test reliability and accuracy. QA test organisms should be chosen
to give a positive response to each of the tests. Organisms used for the QC test should include
DOCUMENTATION
VALIDATION AND
the following:
• Positive Control
Inoculate with organisms the manufacturer claims are identifiable by the kit.
• Negative Control/Identification System Control
If applicable, inoculate with sterile saline or appropriate diluent. Do not inoculate with any
organisms. Follow manufacturer’s recommendations.
A system can be considered valid if the known organisms are properly and consistently identified
and the negative controls/identification system controls, as applicable, do not demonstrate any
reactions.
Records should be kept specifying the following:
• System tested
• Manufacturer
• Lot number
• Date tested
• Organisms tested
• Results
• Acceptance criteria ‑ action taken if system or performance check not valid
• Initials or signature of test performer
• Initials or signature of reviewer, as appropriate.
Refer to AM‑2 Examination for Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa,
and Candida albicans (Section 19).
• Determining requirements
• Writing a protocol
• Following the written protocol
• Testing and documenting the results.
Results should consistently demonstrate that the process is in control and all steps should be
DOCUMENTATION
VALIDATION AND
carefully documented. The protocol should be approved by the appropriate personnel including
the Microbiology Department. Performing the tests and evaluating the results should be the re‑
sponsibility of the Microbiology Department. This activity should be coordinated with analytical
chemistry, manufacturing, engineering and key personnel in other departments.
B. Validation Protocol
Components of the validation protocol include:
1. Determine specification or outcome desired.
• What results are required to indicate that the procedure will result in equipment that meets
requirements?
• Tank #XXX and associated pipes, pumps & lines ‑ identify them.
• Rinse with hot DI (deionized) water for XXX minutes to remove product residue. Disas‑
semble pumps/equipment when necessary to remove product residue.
• Drain rinse water.
• Fill tank with ?% solution XX.
• Recirculate/mix for XXX minutes.
• Drain wash solution.
• Rinse to remove wash solution.
• Sanitize (follow directions for use of sanitizing agent).
4. Determine test methods used to provide the data and acceptance criteria required in item
3 (previous page) to confirm the efficacy of the cleaning and sanitizing procedures. Sever-
al types of methods include:
• Visual examination
Visual inspection to detect product residue.
• Examination for odor
Inspect to detect the odor of residual perfume or sanitizer.
• Swabs
Swabs are used to detect microorganisms.
• Rodac plate
Contact plates are used to detect microorganisms.
• Rinse water
Tests on rinse water to detect microorganisms and/or chemical residue.
5. Compare results of tests performed before and after the cleaning and sanitizing proce-
dures to confirm the efficacy of the process.
6. Validation testing should be performed a minimum of three times.
Once the validation for a piece of equipment is completed, it need only be repeated if there is
a change in process, equipment or any parameter that may affect the outcome of the process,
such as product type. To remain aware of any changes, a Process Audit should be routinely
done and communication with key personnel maintained. There should be a routine review,
for example, annually, to insure and document that there have been no changes.
After a process is validated, routine testing, such as equipment monitoring, can be used to
monitor the process.
Refer to “Processing Equipment” and “Packaging Equipment” in the PCPC Quality Assurance
Guidelines.1
Describe the system and give an explanation of the purpose of each element. These should
include:
• Type of piping
• Number of outlets
• Points of use
• Recirculation route if applicable.
• Micron size
• Prefilter
• Final filter.
solutions
DOCUMENTATION
VALIDATION AND
• Prospective
• Concurrent
• Retrospective
• Combination.
b. The conditions under which a revalidation will be performed should be listed, whether
periodically, after a significant system change, or under other circumstances. Suggested re‑
validation requirements include:
A periodic revalidation may also be accomplished by a formal review of the data and system
to document that there are no significant changes, and that the system continues to perform
as intended.
c. Time period covered
Samples should be tested more frequently, a minimum of two or three times per week
during this period. Time period covered should include seasonal changes so that all variables
are part of the validation.
d. Test methods
Include a detailed step‑by‑step description of the methods used or a reference to established
test methods. For example, tests commonly performed are:
e. Test criteria
Include the criteria used and any action limits that are established. Also specify what actions
are to be taken.
f. Results
The validation protocol should include copies of all test results during the validation test
period.
DOCUMENTATION
VALIDATION AND
4. Discussion of Results
A discussion of the test results should include any investigations or actions taken if results do
not meet expected criteria.
5. Conclusion
A determination based on an analysis of the results of whether or not the system can consis‑
tently produce water which meets requirements if the key parameters are followed.
B. Documentation
Once established as part of the validation, critical system parameters, such as frequency of regen‑
eration, frequency of cleaning/sanitizing, names and concentrations of cleaners/sanitizers used,
and filter changes, should also be checked on a routine basis and documented to ensure the prop‑
er operation of the system. This information is usually recorded as part of the system maintenance
record. This record should include:
These parameters should be reviewed as part of an investigation if results do not conform to the
guidelines.
After the water system has been validated, samples should be tested on a routine basis to monitor
its performance. These results should be recorded and trends noted. This information should
include:
• Sampling points
• Reference to the validated test procedure/method
• Acceptance guidelines
• Any investigation results and/or actions taken if results do not conform to guidelines
• Tested by and date tested
• Reviewed and approved by.
A record tracing the use of the water (batch numbers, product) should also be maintained. This
is usually maintained as part of the manufacturing record. Refer to Microbiological Quality for
Process Water. (Section 7)
9
DOCUMENTATION
VALIDATION AND
• Name of instrument
• Model number
• Serial number
• Purchase date
• Manufacturer and/or distributor
• Maintenance and operational manuals
• Service representative information.
A list of suggested equipment and instrumentation to be monitored includes but is not limited to:
- Standard pH buffers
• Spectrophotometers
- Standard solution
• Water activity devices
• Standardized salt solution
• Thermometers
Information pertaining to proper control steps for carrying out performance checks and preven‑
tive maintenance should be found in the operator’s manual. To maintain equipment accuracy and
reliability, these tests and maintenance should be performed at regularly scheduled intervals. The
documentation for such testing should include the following:
During the validation of standard operation, all results should be recorded accurately including
deviations and corrective action initiated, if necessary. Records should be reviewed periodically by
supervisory personnel.
All equipment should receive regular preventative maintenance. Specialized checks, such as auto‑
clave servicing, centrifuge calibration and laminar flow hood maintenance should be performed by
trained personnel or an authorized representative of the equipment manufacturer.
Refer to Calibration Systems, PCPC Quality Assurance Guidelines.1
REFERENCES
1. Nikitakis, J.M. (ed.) 2014. In PCPC Quality Assurance Guidelines, 2014 The Personal Care
Products Council Washington, DC 20036
2. PharmOut. 2016. Top 10 Considerations when Validating an Autoclave,
http://www.pharmout.net/downloads/white-paper-autoclave-validation.pdf
9
3. United States Environmental Protection Agency 2016. EPA 40 CFR Part 141.
http://www.ecfr.gov/cgi-bin/text-idx?tpl=/ecfrbrowse/Title40/40cfr141_main_02.tpl
DOCUMENTATION
VALIDATION AND
4. U.S. Pharmacopeia. 2016. Water for Pharmaceutical Purposes, United States Pharmacopeia
and the National Formulary (USP 39 – NF 34) (U.S. Pharmacopeia, 1260 Twinbrook Parkway,
Rockville, MD 20852.
5. U.S. Food and Drug Agency 2014. Guide to Inspections of High Purity Water Systems,
@ July 1993, U.S. Food & Drug Administration. http://www.fda.gov/ICECI/Inspections/
InspectionGuides/ucm074905.htm
Note: Title 40, U.S. Code of Federal Regulations (40 CFR) and other U.S. Government publica‑
tions are available from Superintendent of Documents, U.S. Government Printing Office, Wash‑
ington, D.C. 20402.
DOCUMENTATION
VALIDATION AND
INTRODUCTION
Personal care product microbiological laboratories have an ongoing need to maintain and to pre‑
serve cultures for research, bioassays, training, and industrial testing purposes. Cultures may be
used in challenge testing, efficacy and stability testing, growth promotion testing, quality control
evaluations, etc. Microbial cultures that are used for the conductance of compendial microbial
testing should be sourced from either a national culture collection or a qualified secondary supplier
of microbial cultures that is in a form such as frozen, freeze dried, on microbial growth agar slants,
ready-to-use, or that which is most appropriate for use in the laboratory.
The major goals for a maintenance and preservation program of microbial cultures are to ensure:
• Culture Viability
• Culture Purity
• Retention and consistency of genotypic and phenotypic characteristics of a microbial strain
Some important considerations with regards to the maintenance and preservation program for mi‑
crobial cultures include:
• Understanding the advantages and disadvantages of the method(s) chosen and their appli‑
cability
• Matching the laboratory expectations to the method(s) chosen for factors such as ease of use,
laboratory expertise needed, overall value, etc.
• While a number of methods are applicable to a broad array of microorganisms, no method
is ideal for all microbial species. The practitioner is encouraged to consult the scientific liter‑
ature to help in providing understanding of the specific requirements for having a successful
maintenance and preservation program, especially when there is question as to the applica‑
bility of a preservation method for a given microbial strain.
For the purposes of this guideline, methods are divided into long and short term categories. Long
term methods are considered those which routinely ensure culture viability of greater than 3 years.
Short term methods include those methods which routinely ensure a varying degree of culture via‑
bility, from as little as 1 week up to 3 years. Not every method is represented in this chapter but any
validated methods are acceptable.
SHORT-TERM METHODS
Subculturing
Maintaining microorganisms on or in a microbial growth media with periodic transfer of pure mi‑
crobial colonies is the most common and simplest method of preserving a microbial culture line. It
10
has the advantage of not requiring special equipment. However, it is also the method that has the
greatest possibility in having the accidental introduction of contamination with other microbial
strains as well as causing strain variation. By using a fluorescent amplified fragment length polymor‑
phism analysis, Cross, Russel, and Desai showed that years-old microbial working control cultures
from several accredited microbial food testing laboratories were indeed genetically different from the
original strains that had been obtained from the National Culture Type Collection.1
Storage Conditions
Store cultures for up to four weeks at 2-8°C or at a temperature appropriate for the microorganism.2,3
A few fastidious microbial strains, such as Streptococcus pneumoniae, will require shorter intervals be‑
tween subcultures to maintain viability. In general, length of storage should be the maximum time
that ensures a viable, unaltered culture.
In order to prevent drying, cultures grown on agar plates can be wrapped with sealing film. Alter‑
natively, microbial cultures may be stored on a microbial growth agar slant or as a stab in microbial
growth agar that is present in a screw-top test tube with a rubber lined cap.
Special considerations
The rate of microbial mutation will vary from strain to strain with subculturing. Some strains easily
lose plasmids, which confer properties such as antimicrobial resistance.3 In order to avoid genetic
drift, passages or transfers should be tracked to prevent excessive subculturing for a working mi‑
crobial culture. The United States Pharmacopeia (USP) recommends that the number of passages
from the reference culture be five or less for certain compendial tests such as the Antimicrobial
Effectiveness Test.4
Conditions required for microbial survival will vary from species to species. Sometimes, microbial
survival will also vary from strain to strain. Each microbial testing laboratory will need to determine
the maintenance conditions that are necessary for those microbial strains that are used routinely for
testing.
Frequent check for maintaining the unique characteristics for a microorganism such as pigment
color, colonial morphology, biochemical or other traits should be performed to ensure variations or
contamination with other strains has not occurred.
Advantages
• Expensive equipment is not required.
• No special training is needed.
Disadvantages
• There is a risk of mutation and contamination with every transfer.
• Most bacterial cultures survive only a few months. Some fungal species may survive longer.
• Requires extensive refrigeration space.
• Need appropriate back-ups and contingencies to ensure refrigerator does not fail.
Overlay Techniques
As an extension of common short-term subculture methods, an overlay of mineral oil can be used.
By overlaying with mineral oil, it reduces the availability of air to those microorganisms that have
been overlayed which causes the slowing of their metabolic rate. After microbial growth for a cul‑
ture on either a microbial growth agar slant or as a stab in microbial growth agar, medicinal-grade
mineral oil is added to a depth of at least 1-2 centimeters (cm) above the highest point of growth.
Overlayed microbial cultures may then be stored at either room temperature (20 to 25°C) or under
refrigeration (2 to 8°C).
A common source for causing microbial contamination of overlayed cultures is by using mineral
oil that is not sterile. To prevent microbial contamination of cultures that have been overlayed with
mineral oil, mineral oil can be heated to 170°C for 1 to 2 hours for sterilization.5
Recovery of an organism that has been overlayed with mineral oil can be accomplished by removing
the mineral oil layer and aseptically removing a small amount of microbial growth by using a sterile
inoculating needle or loop and transferring it to an appropriate microbial growth medium.
Advantages
• This technique has been used extensively for many years because it has been very successful
in maintaining fungal cultures.
• Bacterial cultures can be maintained by this technique for 1 to 2 years, but fungi may sur‑
vive longer.
Disadvantages
• It is a messy procedure.
• This method may not be suitable for some microbial species.
Freezing
In culture preservation by freezing, water is made unavailable to the cell, and the dehydrated cells are
stored at low temperatures. Several factors may affect the viability of a preserved microbial culture
that has been frozen. They include:
The two primary factors affecting cell viability for freezing techniques are solute concentration and
ice crystal formation. During freezing, extracellular water freezes first. As this happens, solutes ex‑
ternal to the cell begin to concentrate. As a result, water begins to migrate out of the cell to balance
osmotic pressure. However, excessive removal of water from the interior of the cell may result in
harmful concentrations of solutes within the cell. If excessive intracellular water is present in a cell, it
10
can result in the formation of ice crystals that can further damage the interior of the cell. While all of
the above factors play a role, freezing rate and the use of cryoprotectants are of particular importance
in minimizing damage from intracellular solute concentration and ice crystal formation.
Advantages
• Cost
• Minimal expertise
Disadvantages
• Poor culture viability
• Freezer requires power back up, generally little time to respond to power outage before cul‑
tures would thaw
• Temperature cycling may cause ongoing cell damage
• Not amenable for routine culture resuscitation
Cryoprotectants
The incorporation of cryoprotectants as part of the freezing process helps maintain viability of the
cells by minimizing:
The most common cryoprotectants used for bacteria and fungi are dimethylsulfoxide (DMSO) and
glycerol. While a range of DMSO concentrations have been reported depending on the specific
organism, DMSO concentrations (v/v) in the range of 5-10% are most frequently used. Higher
DMSO concentrations can be toxic to microorganisms resulting in a decrease in the viability of a
frozen microbial culture. A wide range of glycerol concentrations (v/v) have also been reported with
the most common concentration being in the range of 10-15%. Glycerol is used most often as a
cryoprotectant for fungi. Other commonly used cryoprotectants include skim milk (used primarily
for bacteria) and blood serum. The practitioner is encouraged to consult the scientific literature to
help understand specific cryoprotectant approaches can be used to have a successful maintenance
and preservation of a given microorganism.6
Basic Method
A cell suspension of the microorganism is prepared in the appropriate media, routinely as an overnight
broth culture. After centrifugation, the pellet is resuspended in fresh sterile broth, supplemented with
an appropriate type and level of cryoprotectants (see above). If microbial growth agar slants are used
as the source of cells, growth is washed from the slant by using a sterile microbial growth broth con‑
taining a cryoprotectant. The selection of cryoprotectant and its concentration may be determined in
advance by examining for any toxic effects on the microorganism. The choice in the type of cryopro‑
tectant being used may vary depending upon the species of the microorganism being preserved.
Aliquots of the resuspended cells (e.g. 0.5 to 5.0 ml) are aseptically placed into sterile vials with suf‑
ficient space for expansion of the liquid during freezing. If using glass beads as part of this method,
refer to guidance below. The vials are then transferred to an ultra-low-temperature freezer, typically
at -70°C to -90°C. Duplicate vials of each microbial strain should be prepared to have one set of
cultures remain frozen at all times as part of a permanent microbial culture collection.
Revival
To recover microorganisms that have been frozen, a vial is removed from the freezer, opened, and a
small amount of frozen material is scraped from the surface with a sterile stick or inoculating nee‑
dle. After scraping, the material is inoculated into an appropriate microbial growth medium that is
incubated at an appropriate temperature and aerobic or anaerobic condition. The unused portion
of the frozen suspension should not be allowed to thaw or re-warm. Thawing can be minimized
through the use of glass beads to optimize culture resuscitation, or by keeping the vial in a bed of
dry ice when working with it.
Advantages
• Reliable, preserves genotypic and phenotypic characteristics
• Viability typically 1-3 years
• Amenable to maintaining and preserving large culture collections
• Does not require specialized skillset
• Not labor intensive
• Easy culture resuscitation when coupled with glass beads (see next section)
Disadvantages
• Initial cost of freezer
• Need appropriate back-ups and contingencies to ensure freezer does not fail
• May be less reliable for long term viability than ultra-freezing and lyophilization
10
Storage on Beads
This method involves low temperature storage of microbial suspensions in cryovials containing a
cryoprotectant and porous glass or plastic beads. By using this method, most microorganisms will
typically remain viable up to 1 year.
Basic Method
The microorganism to be stored should be grown on the surface of an appropriate non-selective
microbial growth agar Petri dish or slant by incubating for 18 to 24 hours. An isolation streak
should be performed as a purity check for possible microbial contaminants. A dense suspension is
prepared by adding a heavy loopful of microorganism to the cryoprotectant which is added to the
(sterile) cryovial containing the beads. Alternatively, a 1 ml aliquot of an appropriate sterile micro‑
bial growth broth containing a cryoprotectant may be added to a microbial growth agar Petri dish
and mixed to form a thick suspension. After forming this suspension, it is aseptically transferred
to sterile cryovials that contain beads. The cryovial is shaken to distribute the suspension among
the beads. After allowing appropriate time for the organism to bind to the bead (~2 – 5 min), any
additional cryoprotectant/microorganism suspension is aseptically removed using a pipette. The vial
is then ready to be placed in low temperature freezer (-20°C to -70°C).7,8
Revival
To recover a microorganism that is frozen to a bead, it is aseptically transferred from the storage vial
and placed onto microbial growth agar and is rubbed over the surface. Alternatively, the transferred
bead can be placed into a sterile container containing an appropriate microbial growth broth. The
inoculated microbial growth agar or broth is incubated at an appropriate temperature and aerobic
or anaerobic conditions.7,8
Advantages
This method has the same advantages as the traditional frozen suspension techniques. A few addi‑
tional advantages are:
Disadvantages
• Initial cost of freezer
• Need appropriate back-ups and contingencies to ensure freezer does not fail
• May be less reliable for long term viability than ultra-freezing and lyophilization
LONG-TERM METHODS
Ultra-freezing (Below -130°C)
Cryopreservation or ultra-freezing by using liquid nitrogen is a method that offers long-term stor‑
age of microorganisms to a laboratory. Ultra-freezing can preserve the original characteristics of a
microorganism and is simple to perform. Furthermore, storage in liquid nitrogen provides a stable
culture collection of critical sub-units that are easily accessible when needed or be preserved many
years, provided storage temperature is maintained below - 130°C.9,10
Preparation
Cells are grown to the late logarithmic stage by using a nutritive, nonselective microbial growth me‑
dia. After reaching logarithmic stage of the cell cycle, cells are suspended in a fresh microbial culture
medium that contains a cryoprotectant in order to be aseptically distributed into either sterile glass
or plastic ampoules. Mold cultures are harvested after they have sporulated. DMSO or 5 to 10%
glycerol is commonly used as a cryoprotectant for preserving bacteria and fungi because they lessen
the effects of internal ice crystal formation.9
Basic Method
A slow cooling rate of 1° to 10°C per minute until a temperature of -30°C is reached will help main‑
tain culture viability.11 This can be achieved by putting the vials in a controlled-rate freezing cham‑
ber or, more inexpensively, in a commercially available, insulated chamber placed in a mechanical
freezer at -70°C or colder for at least 24 hours.9
Microorganisms can be stored in nitrogen in either the liquid phase (-196°C) or in the vapor phase,
which is above the liquid. Storage of cultures in the vapor phase of liquid nitrogen has the advantage
in reducing the risk of having microbial contamination when compared to the use of submerged
tubes in liquid nitrogen. For liquid nitrogen vapor storage, it is important to note that the tempera‑
ture of the vials will rise further away from the surface of the liquid nitrogen.9
Revival
To revive a frozen culture after withdrawal from ultra-cold storage, place the ampule in a 37°C water
bath.9,10 When the frozen culture is thawed, the contents of the vial or ampoule should be imme‑
diately transferred aseptically to an appropriate microbial growth medium in order to prevent any
harmful effects from the cryoprotectant.
Special considerations
The use of liquid nitrogen requires safety precautions. Ampules that are stored in the liquid phase
can present the risk of explosion if liquid nitrogen penetrates an imperfect seal and expands rapidly
when warmed. Polypropylene screw-cap ampules reduce the hazard that glass ampules pose, as well
as eliminating several steps of preparation. A plastic face shield and protective gloves needs to be
worn while depositing or withdrawing microbial cultures from a liquid nitrogen containing storage
vessel. Failure to maintain a minimal level of nitrogen can result in the loss of an entire collection. To
prevent this, liquid nitrogen levels within the storage vessel will need to be monitored on a regular
10
Advantages
• Microorganisms are viable for up to 30 years provided the storage temperature is maintained
below -130°C.10
• Passages are kept to a minimum which helps prevent phenotypic drift.
Disadvantages
• Expertise and time are required.
• Freezer and supplies are expensive.
• Cost to run freezer is high.
• Frozen cultures can be harmed or ruined by thawing due to power outages. Frequent mon‑
itoring necessary.
• Safety equipment such as protective gloves and a face shield is required when placing or
removing cultures.
Freeze-drying (Lyophilization)
Freeze-drying has been widely used to preserve a broad range of bacterial and fungal species. It
involves the removal of water from a suspension of cells by a process called sublimation. During
sublimation, frozen liquid is converted directly into gas: there is no liquid phase. By removing water
from vegetative cells and spores, it halts cell metabolism which reduces the risk in having damage
due to prolonged exposure ice crystallization. This process can result in having a stable preparation
for a microbial culture that can be easily resuscitated.9
Preparation
To prepare for freeze-drying or lyophilization, vegetative microbial cells are grown on a nutritive and
non-selective microbial growth medium to the late logarithmic stage or early stationary stage of the
cell cycle.9 Cells are harvested and resuspended in a protective medium containing components such
as skim milk or sucrose.11 This medium will protect microbial cells from injury that could occur
during the freezing and drying. Recovery is best when the protective medium is inoculated heavily
so that it contains 106 to 1010 cells per ml.12 The medium is dispensed into vials for lyophilization.
Basic Method
Freeze-drying involves three steps. In the first step, the cell suspension is frozen slowly (for example,
-1°C per minute), allowing the formation of ice crystals which create channels from which the water
vapor can escape. In the second step that is called primary drying, ice crystals are sublimed from a
solid to a gaseous form by using a high efficiency vacuum pump. The water vapor travels to a con‑
denser, which is much cooler than the microorganism sample. This leaves only bound water in the
cells, which in the third step, called secondary drying, is removed with additional heat.13
Special considerations
There is not one freeze-drying protocol for all microorganisms. The process for each particular mi‑
croorganism should be empirically determined to provide for the greatest recovery of the original
population. Several factors in the process should be considered in reaching this goal including:
There is the potential for microbial contamination if microorganisms are freeze-dried without
the use of some type of protective barrier because microorganisms in the suspension can escape
from their vials or trays during processing. Some type of bacteriological filter should be used when
freeze-drying more than one strain at a time and equipment should be decontaminated after use.13
Freeze-drying could cause the loss of plasmids in some bacterial species that could result in changing
the characteristics of a microorganism. Microbial species that are sensitive to the freeze-drying tech‑
nique may lose some viability. Quality control testing is essential. New batches of strains should be
checked for purity, viability, and phenotypic, proteotypic, and/or genetic characteristics.
Safety glasses should be worn when opening flame-sealed ampoules containing the freeze- dried
material.5
Advantages
• After a culture has been freeze-dried or lyophilized, it can be stable for up to 30 years.
• Special storage conditions are not necessary.
Disadvantages
• A major disadvantage is the high initial capital cost for equipment.
• Expertise and time are required.
• There is not one method for all microorganisms because different species have different re‑
quirements.
IN HOUSE ISOLATES
Personal care product manufacturers strive to maintain clean and hygienic facilities so that they
may produce microbiologically safe products. CFR Title21 Part 211 Current Good Manufacturing
Practices for Finished Pharmaceuticals is a specific manufacturing guideline for personal care and
cosmetic manufacturers which are regarded as best practice.14 Although clean, personal care facilities
are not completely sterile, microorganisms are often still present in process water, raw materials, and
even finished goods. Difficult to sanitize areas in the manufacturing environment like pipes, tanks,
fill lines, air handling systems, and warehouses may present ideal sources for these microorganisms
to grow and adapt. Many times, in house isolates are detected and isolated during regular product
screening or hygiene audits.
In house isolates are useful in the conductance of preservative efficacy testing. The inclusion of in
house isolates may more adequately establish product robustness against the types of microorgan‑
isms that may be introduced during production and consumer usage. In comparison to reference
strains, environmental, raw material and product formulation isolates of a microbial species may
have developed an increased resistance to certain types of material such as preservatives15 or product
conditions such as high pH. Consequently, it is important for the microbiologist to use in house
isolates whenever appropriate during routine product testing and new product development.
In the case of these in house isolates, conventional methods of storage and maintenance may not be
adequate for them to retain their original genotype for exhibiting their phenotypic characteristics.
Spontaneous genetic reversion could occur if these microbial isolates are removed from either their
original environment for propagation on artificial microbial growth medium or if they are subjected
to physical stress. Occasionally, a recovered microbial isolate may not even survive minimal storage
on artificial microbial growth medium. Special attention should be given to the way that these re‑
covered microbial isolates are stored so that their original attributes are not lost and culture viability
is maintained. For those recovered microbial isolates obtained from raw materials or product for‑
mulations, a common strategy for maintaining these isolates is either a periodic subculturing into
the material from which they had been originally isolated or devising an artificial growth medium
to ensure retention of the desired culture trait. For example, Burkholderia cepacia, a common in
house isolate, may grow poorly or not at all on artificial growth medium.16,17 The isolate’s viability
may be better maintained by storage in the product it was isolated from or by utilizing a specialized
enrichment agar. Key traits which are unique to a recovered microbial isolate should be thoroughly
characterized and frequently monitored to provide an added measure of assurance of strain stability.
Deviation from the expected biological profile may indicate that the isolated organism no longer
retains its resistant characteristics.
CONCLUDING REMARKS
This guideline provides an overview of some commonly used techniques currently acknowledged
as satisfactory for the maintenance and storage of microbial cultures. There are many other less
common techniques, including those developed by companies for internal use, which may also be
acceptable. The objective for any maintenance and storage program is to maintain culture viability
and purity while ensuring the retention of desired culture characteristics. Microbial strains sourced
from culture collections should be maintained in a way that is consistent with the recommendations
of the supplier. It is the responsibility of the microbiologist to select and properly execute appro‑
priate methods for the organism(s) in question as well as maintain any applicable documentation
relating to the culture collection.
REFERENCES
1. Cross, L.J., Russell, J.E., and Desai, M. 2011. Examining the genetic variation of reference
microbial cultures used within food and environmental laboratories using fluorescent amplified
fragment length polymorphism analysis. FEMS Microbiology Letters 321:100–106.
2. ISO 11133. 2014. Microbiology of food, animal feed and water – Preparation, production,
storage and performance testing of culture media. www.iso.org
3. CLSI. 2015. M07- A10, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria
That Grow Aerobically; Approved Standard—Tenth Edition. Clinical Laboratory Standards
Institute, Wayne, PA.
4. United States Pharmacopeia and National Formulary. 2016. USP 39 NF 34 (2016) Chapter
<51> Antimicrobial Effectiveness Test. United States Pharmacopeia and National Formulary,
Rockville, MD, pp. 67-69.
5. Petti, C.A. and Carroll, K.C. 2011. “Procedures for the Storage of Microorganisms” In: Manual
of Clinical Microbiology 10th Edition (pp. 124-131). Versalovic, J., Carroll, K.C., Funke, G.,
Jorgensen, J. H., Landry, M.L., Warnock, D.W. (Eds.) ASM Press, Washington, DC.
6. Hubálek, Z. 2003. Protectants used in the cryopreservation of microorganisms. Cryobiology
46(3):205-229
7. Pro-Lab Diagnostics. 2016. Microbank™: Product instructions. Retrieved from
http://www.pro-lab.com/inserts/PL170.pdf
8. Saraiva Giampaglia, Carmen Maria, Artemir Oelho De Brito, Maria Conceicao Martins, Suely
Yoko Mizuka Ueki, Fabio OliveirLatrilh, Rosangela Siquira De Oliveira, Jonas Umeoka Yamauchi,
and Maria Alice De Silva Telles. 2009. “Maintenance of Mycobacterium tuberculosis on Glass
Beads.” Annals of Clinical & Laboratory Science 39.1: 51-54.
10
9. American Type Culture Collection® (2015) ATCC® Bacterial Culture Guide: Tips and
techniques for culturing bacteria and bacteriophages. Manassas, VA. https://www.atcc.org/~/
media/PDFs/Culture%20Guides/Previews/ATCC_Bacterial_Culture_Guide_Preview.ashx
10. De Paoli, P. 2005. Biobanking in microbiology: From sample collection to epidemiology,
diagnosis, and research. FEMS Microbiology Reviews 29: 897-910.
11. Malik, K.A. and Claus, D. 1987. Bacterial Culture Collections: Their Importance to
Biotechnology and Microbiology. Biotechnology and Genetic Engineering Reviews, 5:1,137-198.
12. Miyamoto-Shinohara, Y., Imaizumi, T., Sukenobe, J., Murakami, Y., Kawamura, S. and
Komatsu, Y. 2000. Survival Rate of Microbes after Freeze-Drying and Long-Term Storage,
Cryobiology 41, 251-255.
13. LABCONCO. 2010. A Guide to Freeze Drying for the Laboratory. http://www.labconco.
com/literature/brochures/freeze-dry-systems
14. U.S. Food & Drug Administration. 2015. CFR Code of Federal Regulations. Title 21,
Chapter 1, Part 211, Current Good Manufacturing Practices for Finished Pharmaceuticals.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=211
15. Geis, P.A., Krowka, J.F. 2013. The microbiology of personal care and cosmetic products.
SIMB NEWS, November/December 2013, V.63 N.6, pp.197-200. www.simbhq.org
16. Torbeck, L., Accasi, D., Guilfoyle, D.E., Friedman R.L., Hussong D. 2011. Burkholderia
cepacia: This Decision Is Overdue. PDA Journal of Pharmaceutical Science and Technology
September–October 2011, Vol. 65, No. 5, pp.535-543.
17. Barlasov, J., Sutton, S. Jakober, R. 2014. Recovery of Stressed (Acclimated) Burkholderia
cepacia Complex Organisms. American Pharmaceutical Review, April 2014, Vol. 17, No 3.
www.americanpharmaceuticalreview.com
ADDITIONAL INFORMATION
U.S. Food & Drug Administration (2016) Guidance for Industry and FDA Staff: Current Good
Manufacturing Practice Requirements for Combination Products. Draft Guidance.
http://www.fda.gov/RegulatoryInformation/Guidances/ucm126198.htm
U.S. Food & Drug Administration (2008)Good Manufacturing Practice (GMP) Guidelines/
Inspection Checklist.
http://www.fda.gov/Cosmetics/GuidanceRegulation/GuidanceDocuments/ucm2005190.htm
Gherna, R.L. 1994. Culture preservation. In Methods for General and Molecular Bacteriology (pp.
278-292). Gerhardt, P., Murray, R.G.E., Wood, W.A. and Krieg, N.R. (Eds.), American Society
for Microbiology, Washington, D.C.
Kumar, S., Kashyap, P.L., Singh, R. and Srivastava, A.K. 2013. Preservation and Maintenance of
Microbial Cultures. In Analyzing Microbes: Manual of Molecular Biology Techniques (pp. 135-152).
Arora D.K., Das S., and Sukumar, M. (Eds.) Springer, Berlin, Heidelberg.
Miyamoto-Shinohara, Y., Sukenobe, J., Imaizumi, T. and Nakahara, T. 2008. Survival of freeze-
dried bacteria, J. Gen. Appl. Microbiol. 54: 9-24.
Morgan, C.A., Herman, N., White, P.A. and Vesey, G. 2006. Preservation of micro-organisms by
drying; A review, Journal of Microbiological Methods, 66, 183-193.
Palková, Z. 2004. Multicellular microorganisms: laboratory versus nature. EMBO Rep. 2004
May 5(5): 470–476.
van Griethuysen A., van Loo, I., van Belkum, A., Vandenbroucke-Grauls, C., Wannet, W., van
Keulen, P. and Kluytmans, J. 2005. Loss of the mecA Gene during Storage of Methicillin-Resistant
Staphylococcus aureus Strains. American Society for Microbiology, J. Clin. Microbiol. 43.3:1361-
1365.
Raw Material
Microbial Content
11
MICROBIAL CONTENT
RAW MATERIAL
INTRODUCTION
In order to minimize the chance of contaminated finished product, it is necessary to control the
microbial content of personal care raw materials along with other physical and chemical attributes.
Personal care manufacturers should evaluate the microbiological quality of their raw materials and
establish appropriate specifications based on the best available scientific information.
Water and water supplies are addressed in the Personal Care Product Council’s “Microbiological
Quality for Process Water” guideline (Section 7). Water systems should be properly validated and
controlled. Quality specifications for water should be set, including alert and action levels.
GENERAL CONSIDERATIONS
When establishing acceptable levels for raw material microbial content, the following criteria should
be considered:
• Chemical composition.
• Physical nature.
• Origin and availability.
• Lot uniformity.
• Intended use of the product.
• Concentration of raw material used in the product.
• Manufacturing process.
• Raw material history.
• Storage conditions.
• Water activity.
Many synthetic raw materials currently used by the industry contain low microbial counts, due to
extremes in pH, low water content, or inherent antimicrobial properties. Others may be supplied as
aqueous dispersions or solutions, and may be susceptible to microbial proliferation. Therefore, it is
important to evaluate susceptible synthetic materials upon receipt to ensure that they have not been
contaminated during the manufacturing process, packaging, transportation and storage. When a
bioburden reducing treatment is implied with a raw material, the effectiveness of the process should
be evaluated and verified.
Naturally occurring raw materials are likely to contain a high level of microorganisms that may
pose a contamination risk to the finished product if not reduced or eliminated during processing.
The microbial content may vary depending upon the type and source of the raw material. It may be
necessary to treat such materials to reduce microbial levels before use or to purchase already treated
materials.
The criteria set by the manufacturer for the microbial content of a raw material should take into
MICROBIAL CONTENT
consideration the release criteria established for each finished product. For example, the absence of
Salmonella is significant if a raw material is used in an oral product. A raw material microbial con‑
RAW MATERIAL
tent specification is usually not greater than that for the finished product, especially when it is used
at greater than 1% in the formulation. A raw material with a microbial count greater than that set
for the finished product may be acceptable if its use does not compromise the safety and stability of
the formulation and its concentration in the finished product is low. When a bioburden is employed
with raw material, the effectiveness of the process should be evaluated and verified.
11
SPECIFIC CRITERIA
This guideline recognizes the importance of using raw materials of the highest quality in the man‑
ufacture of personal care products. Special conditions may allow or necessitate acceptance criteria
that vary from those recommended below. It is recommended that the minimum test portion be 1
g or 1 mL of sample.
The following are recommended guidelines:
• All synthetic and natural raw materials - not more than 102 CFU per g or mL
In addition to these recommended numerical guidelines, no raw material should have a microbial
content recognized as either harmful to the user or able to compromise integrity of the finished
product as recovered by standard plate count, specific pathogen test, or an equivalent automated
procedure.
GENERAL RECOMMENDATIONS
As personal care products and toiletries need not be manufactured from sterile raw materials, it is
important that raw materials are obtained from qualified suppliers and are handled, stored, and
used under conditions designed to deter microbial proliferation or subsequent contamination. The
Personal Care Products Council’s Quality Assurance Guidelines1 are a useful guide for the storage
and handling of raw materials as well as microbiological sampling techniques.2 Sampling techniques
are also described in Section 6 (Microbiological Sampling).
Validated microbiological analytical methods should permit the detection of microorganisms and
ensure the inactivation of the preservative. The presence of objectionable organisms can be deter‑
mined by identification of isolates using procedures such as described in “M-2 Examination for
11
and Identification of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida
albicans” (Section 19).
MICROBIAL CONTENT
RAW MATERIAL
If raw materials are found to have a microbial content greater than specified, an investigation to
identify and eliminate the source of the contamination can assist in implementing preventative
measures.2
It is recommended that a qualified microbiologist or independent microbiology laboratory be en‑
gaged to:
REFERENCES
1. Nikitakis, J.M. (ed.) 2014. Annex 4 – Raw Materials and Packaging Materials. In Personal Care
Products Council Quality Assurance Guidelines, Personal Care Products Council, Washington, DC
20036, pp. 31-34.
2. Nikitakis, J.M. (ed.) 2014. Annex 17 – Sampling. In Personal Care Products Council Quality
Assurance Guidelines, Personal Care Products Council, Washington, DC 20036, pp. 103-110.
Establishing Microbiological
Quality of Personal Care
Products
INTRODUCTION
Control over the microbial content of personal care products is consistent with the control of other
aspects of quality, and is necessary in order to ensure consumer safety and product integrity and
stability.
Because personal care products may be applied to bacteria-populated skin, microorganisms need
12
to be controlled, but not necessarily eliminated from these products. Therefore, it is appropriate
to assign rational limits to microbial content based on the best available information. Criteria such
QUALITY
MICROBIOLOGICAL
as the products intended use, route of administration, and target population should be taken into
account when establishing microbiological guidelines for safety and quality. The microbiological
quality guidelines presented here are intended to assist manufacturers in establishing best practices
including appropriate microbiological limits for their products that are susceptible to microbial
contamination. Guidance on microbiological quality for personal care products is available from the
Personal Care Products Council1 and Cosmetics Europe.2
It should be recognized that the application of microbial limits alone is not sufficient to guaran‑
tee the microbiological quality of the product. In addition, a microbiological quality management
process must also be implemented to ensure that the products produced by a manufacturer are in
compliance with their microbiological test specifications. This quality management process includes
appropriate product development to ensure consumer safety, supplier quality management, and
adherence to current Good Manufacturing Practices (GMP) in order to minimize the occurrence
of microbial contamination of finished products during manufacturing. Essential to the implemen‑
tation of effective microbiological quality management is the requirement for a microbiological
awareness education and training program for all levels of employees.
GENERAL CONSIDERATIONS
A. Product Development
Personal care product formulations that can either support the proliferation of microorganisms or
allow their survival in finished products should contain a preservative or preservative system that
will prevent the proliferation and/or survival of contaminating microorganisms that are introduced
during consumer use. The manufacturer has the responsibility for producing an effectively preserved
product. For product formulations that are susceptible to microbial growth and survival as a result
of contamination, preservation efficacy testing should be conducted during the development phase
of a product to ensure that they are adequately preserved.
The function of preservation is to protect consumers and to prevent product spoilage during normal
and reasonably foreseeable product use. Preservatives should not be used in lieu of current Good
Manufacturing Practices. Understanding the root causes of microbial contamination issues during
manufacturing is important. Instituting appropriate corrective measures will help to prevent their
recurrence and eliminating them during production will lead to control and prevention of microbial
contamination.
It must be emphasized that preservation systems cannot be chosen satisfactorily on theoretical
grounds and they require in situ determination of their efficacy by microbiological challenge tests or
other appropriate test systems during product development.
The formulator should develop product formulations that are adequately preserved to control
growth of microorganisms that are introduced into a product during normal consumer usage. If a
preservative is shown to be necessary, it should be selected at an early stage in the development of a
product and be considered an integral part of the formulation.
Water is essential for microbial growth. A preservative system should have solubility and partition
characteristics such that it is available at effective concentration in the aqueous phase of a multiphase
system.
MICROBIOLOGICAL
A preservative system should be effective against a broad spectrum of microorganisms and safe at the
concentration used. Combinations of preservatives can sometimes be more effective than individual
QUALITY
in a product formulation should be at levels necessary to allow for sufficient antimicrobial activity
to ensure adequate preservation. The preservative system should be compatible with other product
constituents and should be effective at the pH of the formulation. These determinations of com‑
patibility can be obtained by conducting microbial challenge testing during product development.
Lastly, it is important to ensure that critical processing parameters such as pH adjustments, heat
tolerance, and the proper order of addition for preservatives into a product formulation should be
properly documented in the directions for manufacturing. Following these directions is important
to prevent the accidental decomposition of the preservative system and to ensure that the preserva‑
tive system provides effective antimicrobial activity.
B. Raw Materials
Personal care products for use by the general public are not required to be manufactured using ster‑
ile raw materials or under aseptic processing conditions. Therefore, microorganisms found in the
general environment, in raw materials and in formulations components may be introduced into the
product during manufacture. It is important that raw materials and components be handled and
stored under conditions that are designed to deter the introduction of microbial contamination and
limit microbial proliferation.
Raw materials can contribute a significant level of microbial contamination to the finished product.
It is important to monitor and control them. The monitoring of raw materials should be appropriate
to their susceptibility to microbial contamination, as determined by a risk assessment. If practical,
suppliers of raw materials yielding the lowest population of microbial contamination should be
used. When a necessary raw material fails to have an acceptable level of microbial contamination,
the manufacturer might negotiate with the raw material supplier seeking a reduction of microbial
contamination and develop a specification to maintain the lower level.
Water is one of the major raw materials that are commonly used in most personal care product
formulations. Water can contain large numbers and many different types of microorganisms. These
microorganisms may present a distinct hazard to the microbiological quality and stability of the fin‑
ished products. Therefore, steps must be taken by the manufacturer to ensure that water used either
as a raw ingredient in a formulation or for processing such as cleaning and sanitization is regularly
monitored for microbial content. Appropriate steps should to be taken by the manufacturer when
either high microbial counts or the presence of undesirable microorganisms are found to be present
in water samples.
12
Current good manufacturing practices (GMP) are necessary to avoid accidental human or envi‑
ronmental microbial contamination during product manufacture. The manufacturing equipment
QUALITY
MICROBIOLOGICAL
should be designed for ease of cleaning and sanitizing, as well as for processing capability. It is
recommended that, wherever possible, the physical plant of the manufacturing facility be designed
and constructed to facilitate the manufacturing operations (compounding or processing, packaging,
storage, and quality assurance) in accordance with GMPs.
In order to comply with GMP, manufacturers of personal care products must define and follow spe‑
cific cleaning, sanitization, and control procedures. This process should include the establishment
of standard operating procedures to control microorganisms in susceptible raw materials, bulk and
finished products, as well as on personnel, equipment, and premises.
Adequate records should be maintained for all aspects of microbiological testing during the development
and manufacture of each product and for all control procedures used at the manufacturing facility. In
particular, documentation during the manufacture of products is an essential component of GMP.
• Any microorganisms present do not compromise either the aesthetic quality or long-term
stability of the product
• The packaging (including cap or closure) does not facilitate introduction of microorganisms
into the product during its anticipated life.
A sampling plan developed for formulations that are susceptible to microbial contamination during
the manufacturing process should be appropriate to the formulation and take into consideration the
manufacturing process history.
It is further recommended that a qualified microbiologist or independent microbiology laboratory
be engaged to develop validated microbiological procedures to analyze specific products and to pe‑
riodically examine manufacturing procedures and interpret assay data.
SPECIFIC CRITERIA
Acceptance criteria for the various classes of personal care products should be established when
necessary. For microbiologically susceptible products, conformance to the criteria is determined by
using a suitable technique, such as a plate count procedure (See References 3 & 4 and Section 18 –
Determination of the Microbial Content of Personal Care Products). A risk assessment of products
that are not considered microbiologically susceptible may either support a decision not to test some
MICROBIOLOGICAL
products or indicate reduced testing levels for others. An international standard such as ISO 29621
(Cosmetics – Microbiology – Guidelines for the risk assessment and identification of microbiologi‑
cally low-risk products)4 provides useful inputs to such a risk assessment.
QUALITY
A microbial content enumeration method for a particular product should be qualified for the type
of product being tested. The method must permit the detection at a minimum, or the growth of
any relevant microorganisms present. Furthermore, the test method used to quantify the microbial
12
content should adequately inactivate microbial growth inhibitors present in the product and permit
the detection of any relevant viable microorganisms that may be present in the product. It is recom‑
mended that the minimum test portion be 1 g or 1 ml of sample.
No product should have a microbial content that could be recognized as either harmful to the user
or able to compromise product aesthetics such as changes in viscosity, development of malodors,
and presence of visible microbial colonies. Specified organisms can be determined and identified
from colonies recovered on suitable microbial growth media. Alternative procedures can also be
used to detect the presence of specified organisms.
The conditions under which personal care products are manufactured, marketed, and used by the
consumer vary throughout the world. Alternative microbial limits, such as those set by compendia,
governmental bodies, or other recognized authorities, may be applicable in some cases. The appli‑
cation of specific criteria under this guideline should be decided by each national agency, whether
government or association. Where applicable, additional specific microbial content criteria for a
specific country, region, or other area may be necessary in order to comply with local regulatory
requirements.
Any microbial content exceeding acceptance criteria should be investigated to identify and eliminate
the source of the contamination. Preventive measures should then be implemented.
The references included with this document provide different methods and procedures that may be
used in order to make sure that personal care products are in conformance with the recommended
12
limits.
QUALITY
MICROBIOLOGICAL
REFERENCES
1. Nikitakis, J.M. ed. 2014. Personal Care Products Council Technical Guidelines – Quality Assurance
Guidelines, Personal Care Products Council, Washington, DC. www.personalcarecouncil.org
2. COLIPA. 1997. Guidelines on Microbial Quality Management (MQM). The European
Cosmetic Toiletry and Perfumery Association. www.cosmeticseurope.eu
3. ISO 2009. ISO 17516. Cosmetics – Microbiology – cosmetics Microbiology – Microbiological
Limits. www.iso.org.
4. ISO 2010. ISO 29621. Cosmetics – Microbiology – Guidelines for the risk assessment and
identification of microbiologically low-risk products. www.iso.org.
5. Japan Cosmetic Industry Association (JCIA). 2010. Technical Document 119: Methods of
Microbial Limits Test. www.jcia.org/n/en/jcia/d/
Determination of Preservation
Efficacy in Water-Miscible
Personal Care Products
INTRODUCTION
Many personal care products provide conditions that are conducive to microbial growth such as
water, nutrients, and favorable pH. Preservation efficacy testing (PET) is performed to assure that
each personal care product that is susceptible to microbial growth is not affected by the introduction
of microorganisms during normal or reasonably anticipated use by the consumer. However, some
personal care products, due to characteristics that create an environment hostile to microbial growth
and/or survival, are considered low microbiological risk1 (see also Section 14 - Microbiological Risk
Factor Assessment of Atypical Cosmetic Products and Reference #1). These products are not rou‑
tinely subject to preservative efficacy testing.
The design of preservation tests and subsequent interpretation of results is a complex process. The
technical personnel responsible for preservation testing should therefore, be professionally educated
and experienced in conducting challenge test procedures and evaluating the data generated (see Sec‑
tions 4 and 9 – Microbiology Staff Training and Microbial Validation and Documentation).
It is important to remember that microorganisms are ubiquitous and capable of adaptation. No
method can guarantee adequate microbiological control under all conditions. In addition, the im‑
portance of adhering to good manufacturing practices in the production of personal care products
13
cannot be overstated. Preservatives should not be used as a substitute for good manufacturing prac‑
tices.2
PRESERVATION EFFICACY
DETERMINATION OF
Personal care products constitute a wide and expanding variety of formulations and package config‑
urations that differ significantly from each other in their composition, intended use, and physical
characteristics. This guideline reflects current considerations and practices used within the personal
care industry in conducting preservation efficacy testing of water-miscible products. Other stan‑
dardized methods as well as those developed by the user may also be employed to assess preservation
efficacy of water-miscible personal care products.3,4 For guidance on testing atypical products, see
Section 16 - Microbiological Risk Factor Assessment of Atypical Cosmetic Products.
SCOPE
The purpose of this guideline is to provide guidance to those developing and performing PET of
water-miscible personal care products such as are described in Method M-3, A Method for Preserva‑
tion Testing of Water-Miscible Personal Care Products (Section18) and Method M-7, A Screening
Method for Preservation Testing of Water-Miscible Personal Care Products (Section 21).
GENERAL CONSIDERATIONS
The preservation efficacy test (PET) is an important tool in evaluating the robustness of a formula‑
tion to withstand microbial contamination during consumer use. Various factors can have an effect
on the performance of a preservative system in a formulation and on the interpretation of results
generated from these studies.1,5-7
The following factors may be considered when performing a preservation efficacy test and interpret‑
ing results:
PRODUCT TESTING
Microbial Content Test
It is recommended that the bioburden of the test sample(s) be determined by a microbial content
test, such as Method M-1 - Determination of the Microbial Content of Cosmetic Products (Section
18), prior to performing the preservation efficacy test. The purpose is to verify that the level and
type of microorganisms in the test sample will not interfere with the recovery of the test organisms
PRESERVATION EFFICACY
or interfere with the interpretation of the challenge test data. Furthermore, an initially high micro‑
bial bioburden in the test sample before inoculation with microorganisms could compromise the
DETERMINATION OF
preservation system.
Neutralization
Antimicrobial or preservative neutralizers are added to microbial plate count diluents and recovery
agars to inhibit or inactivate the antimicrobial properties or activity of the formulas being tested.8
Carryover of antimicrobial activity from the product formulation into the microbial plate count di‑
13
luent and recovery growth agar may partially or completely inhibit the growth of surviving challenge
test microorganisms.9
Antimicrobial or preservative neutralization may normally be accomplished by use of chemical
neutralizing agents, physical dilution, or a combination of both. Prior to the start of the neutral‑
ization step of the test, verification of the lack of neutralizer toxicity to each of the challenge test
microorganisms should be confirmed.10 Once this has been confirmed, this step does not need to
be repeated during routine neutralization studies of formulations using the same microbial count
diluent or recovery agar. If a new preservative neutralizing agent is added to the microbial count
diluent or recovery agar, verification of the lack of neutralizer toxicity to each of the challenge test
microorganisms should be re-confirmed.
Examples of chemicals and agents that may be used to neutralize the antimicrobial activity of pre‑
servatives are listed in Table 13-1.11 Verification of the antimicrobial or preservative neutralization
is generally performed by inoculating the product dilution and a microbial count diluent without
product (control) with a low level of challenge microorganisms to yield a final count of approx‑
imately 30 to 300 Colony-Forming Units (CFU)/milliliter (ml) for each challenge test microor‑
ganism in a product test dilution and diluent control. Enumeration of the microorganisms from
these dilutions is performed. Neutralization of the antimicrobial or preservative activity is verified if
microbial recoveries of both test and control dilutions are within 50% of each other. If one or more
challenge test microorganisms cannot be recovered, the use of a higher dilution and/or the investi‑
gation of additional chemical neutralizers may be considered.
Table 13-2 provides examples of the test counts, controls, and interpretation of results that may be
encountered when performing neutralization studies during preservative efficacy testing.
TEST PROCEDURE
Organisms
The organisms listed in Table 20-1 of Method M-3 (Section 20) and Table 24-1of Method M-7
(Section 24) are representative types of the microbial species that a formulation may encounter
during manufacture and use: Gram-positive cocci, Gram-negative fermentative bacilli, Gram-neg‑
ative non-fermentative bacilli, yeast and mold. It is recommended that at least one microorganism
from each group be included in the challenge test. Examples of other organism types, relevant to the
formulation, may include microbial isolates that have been recovered from raw materials, formula‑
13
tions returned from consumers or other sources (e.g., product in or after use studies). Either pure
or mixed microbial culture suspensions may be used to conduct challenge testing of formulations.
Decisions to use pure or mixed cultures may be influenced by the factors discussed below.
PRESERVATION EFFICACY
DETERMINATION OF
Inocula consisting of only pure microbial cultures will yield specific data on each test microorgan‑
ism employed in the challenge study. Mixed culture inocula may serve to simulate real world condi‑
tions during use. When conducting mixed culture challenge studies, it is recommended that closely
related types of microorganisms such as Gram-positive bacteria (e.g., cocci), Gram-negative fermen‑
tative bacilli, Gram-negative non-fermentative bacilli, and yeasts and molds be pooled into separate
distinct groups. Antagonism between different types of organisms may occur due to differences in
growth factors and nutritional requirements.12 A rapidly growing organism may impede the detec‑
tion of a more slowly growing organism. For example, Escherichia coli has a shorter generation time
and may obscure detection or growth of microorganisms such as Pseudomonas aeruginosa that have a
longer generation time. Competition for growth factors or production of inhibitory byproducts and
other factors may result in antagonism between different types of microorganisms.12,13
OTHER CONSIDERATIONS
Modified Formulations
When changes are made to the composition of a formulation that has already been challenge test‑
ed, a rapid screening test such as described in Method M-7 (Section 24) may be used to determine
whether the change has an adverse effect on the preservation adequacy of the formulation. The
decision to perform additional challenge testing for these types of formulations is dependent upon,
but not limited to the type of finished package used, pH changes to the formulation, the addition
of new or deletion of raw ingredients from the previously tested formulation, and the challenge test
data of the original tested formulation.
Scale-Up/Pilot Batches
Changes in processing conditions during scale-up from laboratory to production size batches may
alter the performance of the preservation system. Processing conditions (e.g., order of raw ingredi‑
PRESERVATION EFFICACY
ent addition, pH of a batch during processing, and temperature of a batch during processing) may
alter the antimicrobial activity or the physical stability of the preservative system in a formulation.
DETERMINATION OF
Therefore, preservation tests may be performed on scale-up batches to confirm the effectiveness of
the preservation system.
Product Stability
During product development, the stability of the preservation system in a formulation should be
considered. Challenge tests may be performed on either bulk material or product from a filled con‑
13
tainer that has been aged by using accelerated aging conditions such as holding at specific tempera‑
ture and/or humidity conditions or real time aging at ambient conditions. Accelerated aging may
cause a formulation to undergo chemical and physical changes more rapidly than would otherwise
occur during real time aging. A decrease in preservative effectiveness over a period of time may occur
due to a variety of factors. These factors include preservative degradation, partitioning, interaction
with other formula ingredients, and chemical reaction with or absorption into the packaging mate‑
rial. The PET may be used to assess the degree of preservative effectiveness after accelerated or real
time aging of a formulation has occurred. The preservative challenge test criteria for accelerated or
real time aged product may or may not differ from the challenge test criteria for fresh product.
RECOMMENDATIONS
Since many personal care products are used on a regular basis, an effective preservation system
should ensure the reduction of bacteria to a low and steadily decreasing level and fungi should re‑
main static or decrease over time, even after repeated use by the consumer. The following challenge
test criteria are the minimal recommendations for evaluating preservation system performance in
water- based product formulations:
• Vegetative Bacteria
There should be greater than or equal to 3 log (≥99.9%) reduction of vegetative bacteria
by aerobic plate count or quantitative spread plate methods within 7 days following each
challenge and no increase to the end of the test period.
• Yeast and Molds
There should be greater than or equal to 1 log (≥90%) reduction of yeasts and molds by
aerobic plate count or quantitative spread plate methods within 7 days following each chal‑
lenge and no increase for the duration of the test period.
• Spore‑Forming Bacteria
If spore-forming bacteria are included in the test, there should be bacteriostatic activity
against these microorganisms throughout the entire test period.
The above minimal challenge test criteria are suggested to aid manufacturers in evaluating the ad‑
equacy of preservation in personal care products. If a product does not meet these criteria, it is the
responsibility of the manufacturer to select the appropriate challenge test criteria that will ensure
product integrity. For example, single use packaging or use of pressurized delivery systems may be
factors that could be considered in selecting appropriate criteria. More stringent challenge test cri‑
13
teria may be considered where deemed appropriate.
PRESERVATION EFFICACY
DETERMINATION OF
Table 13-1
Table 13-2
Test Dilution
Control Count Test Dilution Count % Recovery Pass /Fail
13
PRESERVATION EFFICACY
DETERMINATION OF
REFERENCES:
1. ISO 2010. ISO 29621, Cosmetics – Microbiology – Guidelines for the risk assessment and
identification of microbiologically low-risk products. www.iso.org.
2. Nikitakis, J.M. 2014. Personal Care Products Council Quality Assurance Guidelines. The
Personal Care Products Council, Washington, DC.
3. United States Pharmacopeia. 2016. <51> Antimicrobial effectiveness testing. USP 39-NF31,
United States Pharmacopeia and the National Formulary. Rockville, MD, pp.67-69.
4. ISO 2012. ISO 11930, Cosmetics – Microbiology – Evaluation of the antimicrobial protection
of a cosmetic product. www.iso.org.
5. McCarty, T.J. 1984. Formulated factors affecting the activity of preservatives. In: Kabara, JJ,
Orth, DS, ed. Cosmetic and Drug Preservation, Principles and Practice. Marcel Dekker Inc., New
York, pp.359-402.
6. English, D.J. 2006. Factors in selecting and testing preservatives in product formulations. In:
Orth, D.S., Kabara, J.J., Denyer, S.P., and Tan, S.K., eds. Cosmetic and Drug Microbiology.
Informa Healthcare, New York, pp. 57-108.
7. Brannan, D.K. and Dille, J.C. 1990. Type of closure prevents microbial contamination of
cosmetics during consumer use. Appl. Environ. Microbiol. 56: 1476-1479.
8. Singer, S. 1987. The use of preservative neutralizers in diluents and plating media. Cosmetics
and Toiletries. 102(12): 55-60.
9. Sutton, S.W. 1996. Neutralizer evaluations as control experiments for antimicrobial efficacy
Test. In: J.M. Ascenzi ed. Handbook of Disinfectants and Antiseptics. Marcel Dekker, Inc., New
York. pp 43-61.
10. ASTM International. 2013. ASTM E1054-08 – Standard test methods for evaluation of
inactivators of antimicrobial agents. http://www.astm.org.
PRESERVATION EFFICACY
11. Anon. 2003. Disinfectants and Antiseptics. Pharmacopeial Forum Vol. 29 (3) May-June, 726-
DETERMINATION OF
735.
12. Fredrickson, A.G. and Stephanopoulos, G. 1981. Microbial Competition. Science: 213: 971-
979.
13. Neilands, JB. Microbial Iron Compounds. Ann. Rev. Biochem. 50: 715-731.
13
Preservation Efficacy
Testing of Eye-Area
Personal Care Products
INTRODUCTION
It is recognized that personal care products may be environments in which microorganisms can
adapt and then proliferate unless proper precautions are taken during formulation and manufacture.
The intended use of eye area personal care products makes it imperative that these products be pre‑
pared with preservative systems that remain effective.1 The alleged incidence of corneal ulceration
due to the periocular use of bacteria‑laden personal care2 has led the Food and Drug Administration
(FDA) to specifically address the adequate preservation of these eye area personal care products3
and the Cosmetic, Toiletries and Fragrance Association ( now called the Personal Care Products
Council) to recommend the same microbial limits as those indicated for baby products.4 Eye area
products are normally free of microbial contamination when purchased. However, some products
may contain organisms that are representative of human skin flora after use by the consumer.5 Mi‑
croorganisms may be introduced into the product from the environment or by the consumer, who
may, for example, add tap water to a product to make it less viscous.
In evaluating the adequacy of preservation of eye area personal care products, it is important to
point out that there is no substitute for judgment by knowledgeable microbiologists. It must also
be recognized that the addition of preservatives to personal care products is an adjunct to, but not a
substitute for, good manufacturing practices.
GENERAL CONSIDERATIONS
A. Developmental Formulations
Formulations that differ in at least one ingredient, e.g., binder or surfactant, should be tested
during the developmental stage using appropriate test microorganisms. If several preservative
systems are to be evaluated, each test formulation should be prepared concurrently from the same
microbiologically acceptable raw materials.
14
B. Pilot Batches
It may be desirable to perform a preservation test on individual pilot batches of product to ver‑
CARE PRODUCTS
TESTING OF EYE-AREA
ify the effectiveness of the preservative system. If feasible, these tests should be accompanied by
analytical determinations of preservative presence and concentration. Tests may be performed on
bulk material or on the filled samples.
C. Stability
Product should be evaluated for preservative stability in commercial packaging by testing after
storage that simulates warehouse, shipping and shelf‑life conditions.
RECOMMENDATIONS
Since eye area personal care products are usually applied daily, an effective preservation system will
help ensure a low level of microorganisms even after severe microbial insult acquired during product
use or misuse. There are many references recommending preservative efficacy in sterile ophthal‑
mics5,7,8,9,10,11 and several in aqueous eye personal care products.6,9 Given the daily use of eye area per‑
sonal care products, it is recommended that multiple challenges be made to fully ensure adequacy
of preservation.11 The following are recommended as minimal criteria for preservative performance.
A. Aqueous Liquid and Semi‑Liquid Eye personal care products
1. Vegetative Bacteria
There should be greater than 99.9% (3-log) reduction of vegetative bacteria by aerobic plate
count or quantitative spread plate methods within 7 days following each challenge and contin‑
ued reduction to a less‑than‑detectable level by the end of the test period.
2. Yeast and Molds
There should be greater than 90% (one log) reduction of yeasts and molds by aerobic plate
count or quantitative spread plate methods within 7 days following each challenge and contin‑
ued reduction for the duration of the test period.
3. Spore‑Forming Bacteria
There should be bacteriostatic activity against spore‑forming bacteria throughout the entire
test period.
B. Non‑Aqueous Eye Products
1. Vegetative Bacteria
There should be a 99.9% (3-log) or greater reduction of vegetative bacteria by aerobic plate
count or quantitative spread plate methods within 7 days following each challenge and contin‑
ued reduction to a less‑than‑detectable level by the end of the test period.
2. Yeasts and Molds
There should be at least a 90% (1-log) reduction of yeasts and molds by aerobic plate count or
quantitative spread plate methods within 7 days following each challenge and the level should
remain at or below that level for the duration of the test.
TESTING OF EYE-AREA
3. Spore‑Forming Bacteria
CARE PRODUCTS
There should be bacteriostatic activity against spore‑forming bacteria throughout the entire
test period.
These minimal criteria are suggested to aid manufacturers in evaluating the adequacy of preservation
of eye area personal care. Ultimately, it is the responsibility of the manufacturer to select appropriate
criteria that will ensure product integrity.
REFERENCES
1. Wilson, L.A., Kuehne, J.W., Hall, S.W. and Ahearn, D.G. 1971. “Microbial Contamination in
Ocular Personal Cares,” Am. J. Ophthal. 71(6):1298‑1302.
2. Wilson, L.A., and Ahearn, D.G. 1977. “Pseudomonas‑Induced Corneal Ulcers Associated with
Contaminated Eye Mascaras,” Am. J. Ophthal. 84:112‑119 (1977).
3. Madden, J.M., and Jackson, G.J. 1981.“Personal Care Preservation and Microbes: Viewpoint of
the Food and Drug Administration,” Personal Cares & Toiletries 96:75‑77.
4. “Microbiological Limits for Personal Cares and Toiletries” 2001. CTFA Microbiology Guidelines,
Personal Care, Toiletry and Fragrance Association, Washington, DC 20036 (November 2001).
5. Wilson, L.A., Julian, A.I., and Ahearn, D.G. 1975. “The Survival and Growth of
Microorganisms in Mascara During Use,” Am. J. Ophthal. 79(4):596‑601.
6. Tenenbaum, S. 1967. “Pseudomonads in Cosmetics,” J. of Soc. Cosmet. Chem. 18:797‑807.
7. Bean, H.S. 1972. “Preservatives for Pharmaceuticals,” J. of Soc. Cosmet. Chem. 23:703‑720.
8. British Pharm. 1980. Appendix XVIC A192, Vol. II.
9. CTPA Recommended Microbiological Limits and Guidelines to Microbiological Quality Control,
Appendix III (July 1983), Cosmetics, Toiletry & Perfumers Association - London W1M 9HD,
United Kingdom.
10. United States Pharmacopeia and the National Formulary. 2016. (USP39‑NF34), U.S.
Pharmacopeia, 1260 Twinbrook Parkway, Rockville, MD 20852.
11. Preservation Subcommittee of CTFA Microbiology Committee. 1981. “A Study of the Use of
Re‑challenge in Preservation Testing of Cosmetics,” CTFA Cosmet. J. 13:19‑22.
14
CARE PRODUCTS
TESTING OF EYE-AREA
Microbiological
Assessment of Product
Quality After Use
INTRODUCTION
Every personal care product manufacturer has a responsibility in establishing the microbiological
safety of its finished products. The establishment of microbiological safety for a personal care prod‑
uct is a 2-step process. The first step is to provide assurance to the consumer that each personal care
product is free from the numbers and types of objectionable microorganisms that could affect prod‑
uct quality and/or the health of the consumer. This first step in the microbiological safety process
is accomplished by following current Good Manufacturing Practices (GMPs) during the manufac‑
turing of each personal care product. In addition, each manufacturer should have the appropriate
microbial quality control checks on those raw materials and finished products that are susceptible
to microbial contamination. Additional information on GMPs for cosmetics can be found in the
Personal Care Product Council’s Quality Assurance Guidelines.1
The second step is to ensure that each personal care product not be affected by the introduction
of microorganisms during normal or reasonably anticipated use by the consumer. To prevent the
growth of microorganisms in or on a personal care product that are introduced during consumer
use, preservatives may be added to the formulation. For most typical personal care products (e.g.,
water miscible), microbial challenge testing (e.g., “M-3 Method for Preservation Efficacy Testing of
Water-Miscible Personal Care Products” (Section 20), “M-4, Method for Preservation Efficacy Test‑
ing of Eye-Area Personal Care Products” (Section 21), USP Antimicrobial Effectiveness Test,2 ISO
119303 or an in-house challenge test method) is performed to verify that the preservative system of
a formulation can prevent the growth of microorganisms.
In addition, the analysis of used test samples for microbial content from either a clinical or sensory
study may provide additional assurance in the adequacy of the preservative system. Furthermore,
there are atypical personal care products (e.g., anhydrous gels, waxed based sticks, loose or pressed
powders, etc.) for which the traditional preservative challenge test may not yield the appropriate
information regarding either the microbial integrity or susceptibility to contamination of the prod‑
uct by the consumer. For these type products, analysis of samples after an in-use study may be more
appropriate than a traditional challenge test.
ESTABLISHING A PROGRAM
In the development of an adequately preserved product, the nature of the product, directions for ap‑
plication, the microbial quality of the raw materials and the manufacturing process should be taken
into consideration. The microbiologist can exercise control over these factors. However, a personal
15
care product manufacturer does not have control of how a consumer will use a finished product.
In order to establish a program for evaluating the microbiological integrity or susceptibility to con‑
tamination of a personal care product during consumer use, it is necessary to generate information
relating to the way the product may be or should be used. This information can be obtained from
the product manager or through questionnaires, consumer letters, or by consumer market tests.
To determine how to structure an in-use study for a personal care product, the following informa‑
tion should be obtained: application, handling, length of use, and storage. This information will aid
the investigator in selecting the appropriate test panel members, defining usage instructions, and
defining a timetable. Study design should reflect actual product usage as closely as possible. If test
samples of a personal care formulation are going to be used in a clinical study for the establishment
of proposed product claims or to determine actual product safety, the study design should incorpo‑
rate all aspects of Good Clinical Practice.4 Special care should be exercised if this type of in-use study
involves finished products that are intended for use in either sensitive body areas, such as the eyes or
eye area, or by sensitive populations such as children or the elderly.
PANEL SELECTION
Selection of panel test members should be based on consumer habits and practices. Panel structure
must reflect this consumer usage information and should consider such factors as typical consumer
age, sex, geographical distribution, product usage patterns, etc. Panel size should be a function of
the degree of statistical sensitivity desired, with larger panels yielding increased sensitivity. An exact
size-versus-sensitivity determination may be made by consulting an appropriate sampling table.
After the panel structure has been determined, a request for participation should be forwarded to
potential panelists. It is recommended that this request be made to at least 20% more individuals
than are required to participate as a test panel member in order to allow for attrition and the initial
inability of some people to participate. The request for participation should include
No individual should be included on a test panel until this signed form is returned.
PRODUCT EVALUATION
Before anything is submitted for evaluation by a test panel, it should be confirmed that the formu‑
lation has been reviewed and approved for application and that microbial content testing of unused
test samples has been conducted to ensure that the product is microbiologically safe under the
prescribed conditions of use. In addition, the formulation being tested should have been evaluated
for safety and cleared for usage by the appropriate product safety department. Product identifica‑
tion should be recorded, including any pertinent history, product age, and lot or batch number. To
determine actual usage by a test panel member, it is recommended that each test sample should be
weighed prior to distribution and after it is returned.
When the test samples are distributed, a comprehensive set of use instructions should be prepared
and given to each test panel member. The instructions for using a test sample should include the
following:
The questionnaire should be designed to generate information that might be helpful in pinpoint‑
ing the reasons for an aberrant test result. It may provide the investigator or microbiologist with
information regarding the product’s ability to withstand either inappropriate or normal consumer
usage. A sample questionnaire is presented in Appendix I. If a test panelist uses a diary, the following
information should be recorded: time at which product was applied each day; amount of product
used at each application; and where the product was stored between applications.
When evaluating returned test samples, microbiological content testing should be conducted before
any other testing is performed. This is to ensure that recovered microbial contaminants from a test
sample were introduced during consumer usage and not from subsequent handling. The microbi‑
ological evaluation of the used product should be conducted within a reasonable time after the last
use of the product by test panelists (i.e., 7 days or less). Depending upon the number of individuals
that participate in a test panel, the microbiologist will have to decide whether to test all or a portion
of the returned samples for microbiological content. If a test panel consists of a low number of indi‑
viduals, it is recommended that each returned sample be analyzed for microbiological content. If the
test panel consists of a large number of individuals, all or a portion of the returned samples may be
15
analyzed. If a portion of the returned used test samples are analyzed, the number chosen should be
based upon some type of statistical sampling plan (e.g., the square root plus one). If aberrant micro‑
biological test results are obtained, the microbiologist has the option to analyze additional returned
test samples for confirmation of the result.
• Aseptically transfer the applicator to a container of sterile diluent or liquid culture medium.
After vigorously shaking, stomaching, or vortexing for a set period of time, perform an aer‑
obic plate count on an aliquot of the diluent or liquid culture medium.
• The applicator may be sampled using a direct contact method (see Microbial Content of
Product section on p. 166).
Alternative test methods to those described above may be used. Appropriate preservative neutral‑
izers, as required, should be incorporated into diluents, liquid or solid media. Whatever method is
chosen, it should be verified for recovery of microorganisms.
IDENTIFICATION OF ISOLATES
It is recommended that recovered microorganisms from test samples be identified. If multiple types
of microbial colonies are obtained, representative microbial colonies may be selected for identifica‑
tion.
INTERPRETATION OF RESULTS
For convenience, it is recommended that all test results be summarized. The interpretation of mi‑
crobiological in-use test results is largely a matter of in-house specifications. The extent to which
microorganism recoveries can be considered significant must be viewed in light of what the ultimate
effect would be on the consumer, the type of product (e.g., typical or atypical product formulation),
and how the product would typically be used by the consumer (e.g., eye versus lip).
Recovery of low levels of microorganisms may be of some significance, especially in water-based
products where the potential for proliferation may exist. Thus, the acceptance criteria for samples of
water-based products returned from in-use studies normally reflect the specification for end product
release. For these products, further investigation into recovery of low levels of microorganisms may
be warranted.
However, for products with low water activity, the potential for proliferation does not exist. For
these types of products, recovery of normal skin flora may be expected. Therefore, the acceptance
criteria for atypical products may be significantly different from those of water based products.
Higher microbial counts may be acceptable in atypical products used in areas of the body that con‑
tain higher microbial populations, and where there is less risk to the consumer. For example, 103 to
104 CFU/gram may be recovered in products applied to the lip area.
To ensure that the number of organisms recovered do not increase over time, either retest of initial
samples or of additional samples may be used to confirm stasis or reduction in recoverable levels of
microorganisms. If levels of microorganisms recovered do increase, then formulation and/or pack‑
age design should be reviewed. Any reported result that is aberrant may warrant further investiga‑
tion including performance of non-microbiological testing.
15
In-use studies of test samples cannot give a complete picture of how well a product will withstand
consumer handling and use. However, an in-use study for a proposed product may provide a margin
of added assurance to the manufacturer, as well as alerting them to potential problems that could
occur in the field. Regardless of the nature of the test data generated, consumer in-use studies can
provide meaningful information in how a product may behave during repeated microbiological
insult during consumer usage.
Appendix I
Product: _________________________________________________________________________
Panelist: _________________________________________________________________________
2. When did you apply the product (e.g., after bath/shower, after housework, before
retiring, etc.)?
3. Did you use the product on areas other than the hands? If so, where?
5. Did you experience any adverse reactions (e.g., a rash)? If so, please explain.
REFERENCES
1. Nikitakis, J. M. (Ed.) 2014. Personal Care Product Council Quality Assurance Guidelines,
Personal Care Product Council, Washington, D.C.
2. United States Pharmacopeia and the National Formulary. 2016 (USP39-NF34), <51>
15
ADDITIONAL INFORMATION
Brannan, D.K., Dille, J.C., Kaufman, D.J., 1987 “Correlation of In-Vitro Challenge Testing with
Consumer Use Testing for Personal Care Products,” Applied and Environmental Microbiology,
58:1827-1832
Brannan, D.K., Dille, J.C., 1990 “Type of Closure Prevents Microbial Contamination of Personal
Cares During Consumer Use,” Applied and Environmental Microbiology, 56 :1476-1479
Farrington, J.K., Martz, E.L., Wells, S.J., Ennis, C.C., Holder, J., Levchcuk, J.W., Avis, K.E.,
Hoffman, P.S., Hitchins, A.D., Madden, J.M., 1994.“Ability of Laboratory Methods to Predict
In-Use Efficacy of Antimicrobial Preservatives in an Experimental Personal Care,” Applied and
Environmental Microbiology, 60 :4553-4558
Larson, E.L., Gomez-Duarte, D., Lee, L.V., Della-Latta, P., Kain, D.J., Keswick, B.H., 2003.
“Microbial flora of hands of homemakers,” Am.J. Infect. Control, 31 :72-79.
Lindstrom, S.M., Hawthorne, J.D., 1986. “Validating the Microbiological Integrity of Personal
Care Products through Consumer-Use Testing,” J. Soc. Cosmet. Chem. 37:481-428.
Passaro, D.J., Waring, L., Armstrong, R., Bolding, F., Borvier, B., Rosenberg, J., Reingold, A.W.,
McQuitty, M., Philpott, S.M., Jarvis, W.R., Werner, S.B., Tompkins, L.S., Vugia, D.J. 1997.
“Postoperative Serratia marcescens Wound Infections Traced to an Out-of-Hospital Source,”
J. Infect. Diseases, 175:992-995.
Trick, W.E., Vernon, M.O., Hayes, R.A., Nathan, C., Rice, T.W., Peterson, B.J., Segreti,
J., Welbel, S.F., Solomon, S.L., Weinstein, R.A., 2002. Impact of Ring Wearing on Hand
Contamination and Comparison of Hand Hygiene Agents in a Hospital, Clinical and Infectious
Diseases, 36:1383-1390.
Wilson, L.A., Julian, A.I., and Ahearn, D.G. 1975. The Survival and Growth of Microorganisms
in Mascara During Use, Am. J. Ophthal. 79:596-601
16
ATYPICAL PRODUCTS
ASSESSMENT OF
INTRODUCTION
Every personal care product manufacturer has a dual responsibility relative to the microbiological
quality of its products. The first is to ensure that the product, as purchased, is free from the numbers
and types of microorganisms that could affect product quality and consumer health. The second is
to ensure that microorganisms introduced during normal product use will not adversely affect the
quality or safety of the product.
During product development, the microbiologist may use several tools to evaluate the ability of a
product to prevent the growth of microorganisms introduced during product use. The challenge
test, which involves introducing a known quantity of microorganisms into a formula and monitor‑
ing the rate of kill over time, is frequently used.* A second method of evaluating product quality
during consumer use is by evaluating the product after a use test that simulates “real life” situa‑
tions.** Finally, the microbiologist may perform a microbiological risk assessment of the product.
The risk assessment process is based on a number of factors generally accepted as important in
evaluating the spoilage potential of a product. It is intended to guide the microbiologist and for‑
mulator in determining what level of testing is necessary to assure the quality of the product during
manufacturing and consumer use.
This guideline serves as an aid to the personal care microbiologist in assessing the microbiological
quality of formulations for which the normally recommended method of challenge testing, de‑
veloped for water based formulations, may not yield appropriate information. These include an‑
hydrous formulations, formulations with low water content, or those products where water is the
internal phase.
This guideline also serves as a tool to aid the microbiologist in recommending ways of reducing
product susceptibility to microbial growth. Certain personal care products, depending on their
composition and presentation (packaging), may have negligible potential for microbial prolifera‑
tion during use. Microbial contamination of a personal care product during use is a function of
the physico-chemical characteristics of the product and the way in which it is packaged (i.e., its
presentation). The guideline “ISO 29621 Cosmetics — Microbiology — Guidelines for the risk
* For examples, see “M-3 Method for Preservation Efficacy Testing of Water-Miscible Personal Care Products” (Section 20)
and “M-4 Method for the Preservation Efficacy Testing of Eye Area Personal Care Products” (Section 21). For guidance
on the use of these methods, see “Determination of Preservation Efficacy in Water-Miscible Personal Care Products”
(Section 13) and “Preservation Efficacy Testing of Eye-Area Personal Care Products” (Section 14).
** For guidance, see “Microbiological Assessment of Product Quality after Use” (Section 15).
PRODUCT TYPES
Common examples of atypical products are listed below. In each example, water is not readily avail‑
able to provide an environment that supports growth of microorganisms. Water in the product may
ATYPICAL PRODUCTS
be surrounded by oil or silicone as the external phase, with the water being present as small droplets
and influenced by other water-soluble formula ingredients. Also, the water activity may be too low
ASSESSMENT OF
to support growth, and in some cases, the product might be totally anhydrous.2
• Lip balms
• Pomades
• Ointments
• Powders
• Cream to powder make-up
In addition to products with low water activity, products with the physico-chemical characteristics
below may not allow the proliferation of harmful microorganisms:
Products with an alcohol content equal to or greater than 20% (vol/vol)2
Products with a pH of less than 3 or greater than 10.3-6
PRODUCT SUSCEPTIBILITY
Atypical products may contain raw ingredients that do not support the growth of microbial contam‑
inants and therefore may prevent microorganisms from proliferating when the product is subjected
to normal consumer use. In these types of products, organisms may survive, but cannot reproduce.
This may be due to low water activity or low water activity in combination with pH and/or an‑
tagonistic formula ingredients that are water soluble. Water droplet size may also be critical in the
water phase. If water activity reading is low in a product formulation or if the formula is anhydrous,
studies have shown that microorganisms will not proliferate. In fact, this is the basis for the use of
water activity as an assessment tool in determining the risk for microbiological proliferation for food
products, like cereals.7,8
In some atypical products, microbial survival may occur on the outside of the product without ever
permeating and spreading through the product. This observation is also due to the low “free water”
content.
Because most atypical products will not support microbial proliferation, the method of product
delivery may be the vector for transferring microbial contamination from the product back to the
consumer.
16
A number of factors need to be evaluated when performing a microbial risk assessment to determine
what type of testing or preservative system may be needed for a particular formulation. Listed below
ATYPICAL PRODUCTS
ASSESSMENT OF
are several factors that need to be considered in determining a products potential risk of microbial
contamination during consumer usage.
Water Activity
The metabolism and reproduction of microorganisms demands the presence of water in an available
form. The most useful measurement of water availability in a product formulation is water activity
(aw). Water activity is defined as the ratio of the water vapor pressure of the product to that of pure
water at the same temperature: 7
aw = p/Po = (n2/(n1 + n2))
where,
When a solution becomes more concentrated, vapor pressure decreases, and the water activity falls
from a maximum of 1.00 (aw) for pure water. As the water activity level falls below the optimum
value for each microorganism, the length of the lag phase in the microbial growth cycle will increase
toward infinity unless rehydration occurs.
Listed below are examples of the minimum water activity levels required for growth of selected mi‑
croorganisms.8,9,11
The above water activity values should be considered as reference points since microbial growth may
occur at lower values depending on differences in temperature or nutrient content of the product
formulation. Even though water activity values are important in assisting in the risk analysis for
microbial contamination, water activity should never be used as the sole indicator in determining
whether product testing is necessary for a particular product formulation.
Formula Review
ATYPICAL PRODUCTS
Every formula contains raw materials that have an impact on the susceptibility of the formula to
microbiological contamination. Raw materials can be classified as susceptible, hostile, or neutral to
ASSESSMENT OF
microbial growth, and their concentration will affect the susceptibility of the formulation to micro‑
bial contamination.***
It is recommended that a microbiologist review formulas to determine their potential susceptibility
to microbial contamination. If a formulation tends to absorb moisture, samples of these types of
atypical products should be microbiologically evaluated (including aw) after being exposed to high
16
humidity conditions (i.e., 50-75% for about 3 weeks or until equilibrium is demonstrated).
Anhydrous products may contain binders or other hygroscopic materials that are able to absorb
moisture. In addition, consideration of water on the surface of products may occur under high hu‑
midity conditions. Consumers may introduce water during normal use or during misuse.
The physical product form will affect whether microbial contaminants will be introduced at the
product surface or be mixed throughout the product during consumer use.
Factors to be taken into consideration are:
Site of Application
The risk assessment needs vary, depending upon the body area for product application. The site of a
product’s application is an important risk factor in determining the level and type of microbiological
testing that would be required for a personal care product. For example, an eye area product presents
a much greater potential risk of microbiological contamination to the consumer than a product that
is applied to other areas of the body. Lip products, under normal conditions, generally come into
contact with higher numbers of microorganisms which are part of the normal microflora present in
the consumer’s lip area, but do not pose a health risk.
*** For examples, see “Raw Material Microbial Content” (Section 11)
Some points to consider when determining the risk in relation to site of application for a product
formulation include:
• Is the site on the body to which the formulation is to be applied to an area where microbial
levels are high (lip) or low (eye)?
• Is the product applied under moist (higher risk) or dry (lower risk) conditions?
• What is the mode of application (brush, sponge, or finger)?
16
• How frequently is the product used?
ATYPICAL PRODUCTS
ASSESSMENT OF
Applicators and the Mode of Application
The mode of application plays a large role in determining the risk factor of a product. Even though
the product may not support growth, the method of delivery may be a vector of microbial bacterial
contamination.
Applicators could provide an environment that might be suitable for microbial proliferation. For
example, porous sponge applicators may be a concern due to their ability to absorb moisture and re‑
tain sebum and dirt from the skin. With the presence of water, sebum, and dirt from the skin, there
may be enough water and nutrients present in a used applicator to allow for microbial proliferation.
In those applicators that are to be used in conjunction with a wet/dry product, the incorporation
of an antimicrobial agent may be considered to prevent microbial proliferation. The preservatives
system of a product must not be expected to inhibit microbial growth in or on a product applicator
Some typical questions that need to be asked before microbiological testing is conducted on appli‑
cators are as follows:
• Are applicators such as puffs, brushes, or pads used with the products?
• Could these applicators act as a breeding ground for microorganisms or a vector for micro‑
bial contamination of the product and/or consumer?
• Does the product and component come in direct contact with the consumer (lips, eyes, fingers)?
• Do these applicators contain an anti-microbial agent?
• Is the applicator stored in direct contact with the product?
• Are there directions given on how to store or clean applicators between uses?
When evaluating and determining the risk factor for microbiological contamination in product
applicators, the following additional factors are to be considered:
• Type of applicator
• Type of material used
• Treated or not treated with an antimicrobial agent.
• The efficacy of a treated applicator should be tested via a zone of inhibition test or other
appropriate method.10,11
• Wet/dry application of product
Packaging
The type of packaging used for a finished product is a critical risk factor in determining the overall
potential for microbial contamination during consumer usage. The use of packaging can provide
additional protection by restricting direct access to the product.
The following factors are among those taken into consideration when assessing product risk with
regards to packaging:
Confirmation of the microbial integrity of the applicator and finished product can be determined
from conducting an in-use study.
Manufacturing Process
Certain aspects of the manufacturing process (e.g., high temperature) may affect the microbiological
contamination susceptibility for a personal care product. It is useful for both the microbiologist and
personal care chemist to review the manufacturing process to determine the potential risk of micro‑
bial contamination to the formulation.
Factors to be considered:
• Are there processing factors that could affect the efficacy of the preservative system?
• What is the temperature of the manufacturing process?
• What is the microbial content of the raw materials?
• Are hostile raw materials used to make the product?
• What is the order of addition of the raw materials?
PRODUCT TESTING
General
After evaluating the above factors, the microbiologist can determine what level and type of microbi‑
ological testing is necessary. If it is determined that microbiological testing is necessary, the follow‑
ing information should be taken into account to select the most appropriate test method.
Challenge Tests
General Considerations
The recommended preservative challenge test methods that are used for determining the preserva‑
tive adequacy of aqueous based products may not be suitable for evaluating certain atypical product
formulations. When testing and assessing preservative challenge test data for atypical products, the
following factors are important points to consider:
16
• A test in which an aqueous based inoculum is introduced into an anhydrous sample may
change the physical dynamics of the product and, therefore, may not predict its microbial
ATYPICAL PRODUCTS
ASSESSMENT OF
stability.
• Most preservatives are water-soluble. In emulsions, preservatives are used in the water phase
because contaminating microorganisms require water to proliferate.
• For an emulsion in which the external phase is water immiscible and an aqueous challenge
inoculum is used, the water-soluble preservatives will be unable to penetrate the water im‑
miscible phase. In these cases, the preservatives will be unavailable to either inhibit prolifer‑
ation or have cidal activity against each of the challenge microorganisms.
The recovery procedure for determining the microbial counts from inoculated challenge
samples of an atypical product may need to be modified from those that are commonly used
ASSESSMENT OF
in aqueous based challenge test methods. For example, water-in-oil emulsions and anhy‑
drous products are not readily miscible with water. It has been demonstrated that 1.0-gram
aliquots of an anhydrous product solubilizer in a 1.0-gram aliquot of sorbitan monostearate
(Tween 80) and this mixture were dispersed further by increasing the volume with an aque‑
ous diluent to make a 1:10 dilution.14
16
In Use Studies
General
In addition to or in place of a product challenge test, an in use study may provide sufficient data to
conduct a risk assessment on some products. An in-use study may be used to evaluate the microbi‑
ological integrity of a product during consumer use. The study design should reflect actual product
use as closely as possible. For further information, refer to “Microbiological Assessment of Product
Quality after Use.” (Section 15)
Testing
When samples are returned from an in-use study, an aerobic plate count must be conducted before
any other tests are performed in order to ensure that any microbial contaminants recovered were
introduced by the panelists and did not arise from subsequent handling in the laboratory. Useful
microbial content information may be obtained by a similar evaluation of the components (such as
applicators) that come into direct contact with the product during use.
Microbiological analysis of these samples can be conducted by using either standard in-house meth‑
ods or the PCPC, “M-1 Determination of the Microbial Content of Personal Care Products” (Sec‑
tion 18) and “M-2 Examination for Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa,
and Candida albicans” (Section 19). It is recommended that microbiological evaluation take place
within 7 days after the last consumer use.
Criteria
16
The pass/fail criteria for in-use return samples normally reflect the microbiological test specifications
that are used for quality control end product release. The pass/fail criteria for atypical products or
ATYPICAL PRODUCTS
ASSESSMENT OF
for water-based products may vary significantly depending on the product type and area of use. For
example, it may be acceptable that products that have been used in the lip area may contain a higher
microbial level than products used in the eye when evaluated after use.
To ensure that the number of microorganisms recovered after usage does not increase over time,
these types of atypical products should be tested at a prescribed time interval. If microbial counts
do increase over time, the formulation and/or package design should be reviewed to determine what
steps could be taken to prevent them from increasing.
REFERENCES
1. ISO 2010. ISO 29621 Cosmetics — Microbiology — Guidelines for the risk assessment and
identification of microbiologically low-risk products. Geneva, Switzeland. www.iso.org
2. Yablonski, J.I. and Mancuso, S.E. 2002. “Preservation of Atypical Cosmetic Product Systems,”
Cosmetics and Toiletries, 117 :31-40.
3. Ali, Y. et al. 2001. “Alcohol” in S.S. Block, Disinfection, Sterilization, and Preservation, Fifth
Edition, pp. 229-253.
4. Brannan, D.K. 1997. Cosmetic Microbiology, CRC Press, New York, pp. 47-50.
5. Kabara, J.J. (ed.). 1984. Food grade chemicals in a systems approach to cosmetic preservation,”
In: Cosmetic and Drug Preservation: Principles and Practice, Marcel Dekker, New York, p. 391.
6. Kabara, J.J., and Orth, D.S. 1996. Preservative-Free and Self-Preserving Cosmetics and Drugs,
Marcel Dekker, New York, p. 245-246.
7. Silliker, J.H., et al., Eds. 1980. International Commission on Microbiological Specifications for
Food. Microbial Ecology of Foods, Vol. 1, Academic Press, Orlando, FL, pp. 76-91.
8. Food Microbiology Fundamentals and Frontiers (ed Michael P. Doyle, Larry R. Beuchat, and
Thomas J. Montville); ASM Press, 1997, ISBN 1-55581-117-5.
9. Jay, J.M. (ed.) 2000. Modern Food Microbiology, Sixth Edition, Aspen Publishers, Gaithersburg,
MD, pp. 38-44, especially p. 42.
10. Brannen, D.K. (ed.) 1997. Cosmetic Microbiology, CRC Press, Boca Raton, FL, pp. 47-50.
Determination of Preservation
Efficacy in Nonwoven Substrate
Personal Care Products
INTRODUCTION
Nonwoven substrate personal care products, commonly called wipes, constitute a wide and expand‑
ing variety of items that differ significantly from other types of personal care products in their com‑
position, intended use, and physical characteristics.1 The nonwoven matrix or substrate is composed
of fibers or filaments that are bonded together mechanically, thermally, or chemically and is used for
the delivery of cosmetics or other product systems.
17
In view of the differences between wipes and other types of personal care products, the standard
IN NONWOVEN SUBSTRATE
PRESERVATION EFFICACY
preservation efficacy tests for aqueous-based (See Section 20: M-3 A Method for Preservation Effica‑
cy Testing of Water-Miscible Personal Care Products) or atypical (See Section 23: M-6 Method for
Preservation Testing of Atypical Personal Care Products) personal care products are not suitable for
testing these product forms. The two major test method differences have to do with the procedure
for inoculum introduction and the procedure for the recovery of introduced microorganisms. It is
recommended that, when developing preservation efficacy methods and testing protocols, the cos‑
metic microbiologist be aware of the factors listed below under “General Considerations” and how
they may affect the reliability of the test method under development.
This document is intended to be used in conjunction with “M-5 Methods for Preservation Testing
of Nonwoven Substrate Personal Care Products” (Section 22).
GENERAL CONSIDERATIONS
A. Components
A nonwoven personal care product is composed of the following components:
Any change to the composition or nature of any of these components may affect the overall pres‑
ervation efficacy of the final product and may require retesting.
1. Substrate
The nature and composition of substrates can have a decided effect upon preservative-substrate
interaction as well as subsequent preservative system performance. A substrate2,3 is a nonwoven
web of long and short fibers held together by some means of bonding other than weaving.
Fibers can be natural or synthetic. The substrate functions as the carrier for a variety of prod‑
uct-specific add-ons. Generally, substrates are composed of any one or a combination of vari‑
ous fiber types including natural materials such as cellulose or wood pulp or synthetic materials
such as rayon or viscose, polyester and polypropylene polymer extrusions or bicomponent ma‑
terials. Bonding technologies include mechanical entanglement, chemical or adhesive binding,
thermal melting and hydrogen bonding.
Binders can significantly affect the preservative system.4,5 For example, anionic binders, com‑
monly used in some substrates, have the potential to inactivate or seriously disrupt most cat‑
ionic preservative systems. Alternatively, binders may contain preservatives which may result
in a more robust product.
Other substrate issues that can affect preservation efficacy may include the fiber type and
composition, the web forming process, the web bonding process, the proportion of pulp to
binder, the composition and ionic nature of the chemical binding agent, and the presence and
IN NONWOVEN SUBSTRATE
PRESERVATION EFFICACY
nature of substrate finishes or coatings. Depending on the nature and degree of reactivity of
fiber surfaces, preservatives may become chemically or physically bound and their antimicro‑
bial activity may be reduced. This may also be the case with certain finishes, coatings and other
substrate surface treatments that can react with preservatives.
2. Add-Ons
An add-on is the formulation applied to a nonwoven substrate. The add-on can be of varied
composition and may be in the form of a liquid, lotion, emulsion, powder, cream, ointment,
oil or other material. Although preservation efficacy demonstrated for the add-on may provide
17
useful information, it may not be predictive of the preservation efficacy of the final nonwoven
substrate product. Substrate and packaging may also influence preservation efficacy. The ratio
of the weight of the liquor to the weight of the substrate is a critical factor in the performance
of the preservative. Ratios can vary from 5:1 to 1:1 depending on product. The lower the ratio,
the more preservative required, especially against mold. If the liquor ratio is changed, then a
new test is required.
3. Packaging
The packaging size and type, e.g., tubs, canisters, soft packages, single pack, etc., should be tak‑
en into consideration in developing the most appropriate protocol for the preservation efficacy
testing of the final product. How the product changes over time may be dependent on the type
of package chosen, e.g., evaporation of the add-on through the package or adsorption of the
add-on to the package can occur, potentially affecting preservative stability.
of inoculations in the test method. The length of the test should be representative of packaging
design. The selection of challenge organisms ideally reflects the final use of the product. For exam‑
ple, challenge organisms for baby wipes (coliforms) may differ from those for an eye area product
(Pseudomonads), (See Section 16 – Microbiological Risk Factor Assessment of Atypical Personal
Care Products).
End use and delivery of the product may determine acceptance criteria. For example, there may
be different acceptance criteria for single pack versus multi pack products.
C. Preservative Stability
It is recommended that preservative stability be evaluated in the finished product packaging be‑
cause of possible interactions of preservative, add-on, substrate, and package. The stability of the
preservative system in the add-on does not necessarily reflect its stability in the finished product.
It is recommended that accelerated aging studies on finished wipe products be confirmed with
real time studies. See the Personal Care Products Council Stability Testing Guidelines6 for more
detail.
17
PRODUCT TESTING
IN NONWOVEN SUBSTRATE
PRESERVATION EFFICACY
A. Preliminary Considerations
Due to the unique nature of non-woven products, molds are organisms of particular concern due
to their ability to degrade cellulose fibers and the exposure of the large surface area of the wipe
to the environment during manufacture and use. A high microbial load may reduce preservative
activity or cause preservative failure in the final product.
A sedimentation study7 to determine fluid migration through a vertical stack of wipes may be
useful information for some test protocols, for instance if the inoculum is delivered by filter car‑
rier. This data is useful in determining the distribution, or degree of sedimentation, of the add-on
within packages of saturated wipe products packaged in stacks.
A period of time for equilibration of the add-on and the substrate before testing is recommended.
This allows time for total saturation of the add-on and distribution of the preservative. An ana‑
lytical approach to the determination of equilibration may be considered. For example, if one is
conducting the sedimentation study for fluid distribution, an analytical evaluation of preservative
distribution (either by direct measurement of the preservative or by measuring a surrogate analyte
which would mimic preservative migration) can be done in parallel.
It is recommended that all aspects of product testing, such as organism recovery, neutralization,
inoculation, etc, be verified (See Section 9: Microbial Validation and Documentation) for meth‑
od suitability.
B. Organisms
Organism strains recognized by United States Pharmacopeia (USP)8 and/or used in the industry
for preservation efficacy testing are recommended. (See Section 10: Maintenance and Preserva‑
tion of Test Organisms and Section 22: M-5 Methods for Preservation Testing of Nonwoven
Substrate Personal Care Products – Table 22.1- Suggested Challenge Organisms) Additional ref‑
erence strains and/or organisms appropriate to the product, including spores, may be used where
deemed necessary.
Pure or mixed culture inocula may be used. However, if different microorganisms are pooled,
antagonism among microbes may occur or it may be difficult to differentiate between types of
survivors.(See Section 20 M-3- A Method for Preservation Efficacy Testing of Water-Miscible
Personal Care Products - 5.2.1 )
Some products may not require a full preservation efficacy test. For example, dry wipes, as defined
by water activity measurement, may require limited or alternative testing.
C. Inoculation Procedures
IN NONWOVEN SUBSTRATE
The choice of inoculation site, inoculum volume, and distribution of the inoculum onto the
PRESERVATION EFFICACY
product should be determined with the anticipated consumer use and packaging of the product
in mind. The procedure used should be representative of product use.
There are several aspects to consider when choosing an inoculation procedure:
1. Packaging
Although testing in the final product packaging is preferred, there are situations where it is
impractical or impossible to do so. In these cases, testing outside of the final package is an ac‑
ceptable alternative. If the same product is delivered in different packaging, i.e., tubs, canisters,
17
D. R ecovery Procedures
1. Neutralization Verification
It is recommended that neutralization studies be conducted with all challenge organisms used
in the test. See ASTM 1054-08 for details.9
2. Recovery Verification
The nonwoven substrate material is likely to entrap some microorganisms resulting in a less
than complete recovery of the inoculum. The level of recovery may change from product to
product, depending on the combination of substrate and add-on. In most cases, mechanical or
other action, is necessary to release microorganisms from the substrate (See Section 22: M-5
Methods for Preservation Efficacy Testing of Nonwoven substrate Personal Care Products).
Addition of a surfactant and / or multiple extractions from the same sample may be necessary
to optimize recovery. It is recommended that the interpretation of results take into account the
established recovery efficiency which is based on a time zero count.
17
RECOMMENDATIONS
It is recommended that a risk assessment be used to establish acceptance criteria for a specific prod‑
IN NONWOVEN SUBSTRATE
PRESERVATION EFFICACY
uct (See Section 16 – Microbiological Risk Factor Assessment of Atypical Cosmetic Products). The
risk assessment should reflect the final product and its intended use and may take into consideration
many factors including, but not limited to, the following:
Whatever the product, an effective preservative system for a personal care wipe should prevent pro‑
liferation of introduced microorganisms. The following criteria may be used as guidelines, but may
be modified based upon the method used and the risk assessment.
Vegetative Bacteria
There should be greater than 99.9% (3 log) reduction of vegetative bacteria by aerobic plate count,
quantitative spread plate or spiral plate methods within 14 days following each challenge and no
increase for the duration of the test period.
Spore-Forming Bacteria
If spore-forming bacteria are used in challenge testing, there should be bacteriostatic activity against
spore-forming bacteria throughout the entire test period.
REFERENCES
1. Lochhead, Robert Y. 2006. Emerging Technologies for Cosmetic and Personal Care Wipes.
Cosmetics and Toiletries 121: 47-52.
2. See the INDA (International Nonwovens & Disposables Association) website at www.inda.org
IN NONWOVEN SUBSTRATE
388.
6. Nikitakis, J.M. (ed.) 2014. Guideline for Industry: The Stability Testing of Cosmetic Products,
Personal Care Products Council, Washington, DC, 2010.
7. Cremieux, A., S. Cupferman, and C. Lens. 2005. Method for the Evaluation of the Efficacy on
Antimicrobial Preservatives in Cosmetic Wet Wipes, International Journal of Cosmetic Science, 27:
223-236.
8. United States Pharmacopeia and the National Formulary (USP 39 – NF34). 2016.
Antimicrobial Effectiveness Testing,” U.S. Pharmacopeia, 1260 Twinbrook Parkway, Rockville,
MD, 2499-2500.
9. ASTM 1054-08, 2016. “Standard Test Methods for Evaluation of Antimicrobial Agents,”
Annual Book of ASTM Standards, Volume 11.05, ASTM.
M-1
Determination of the
Microbial Content Of
Personal Care Products
1 Scope
1.1 This section is an acceptable plate count procedure for determining the microbial content of
personal care products. Microbial content testing may be performed on raw materials, bulk
products, in-process materials, and finished goods.
2. Applicable Documents
2.1 “M-2 Examination for and Indentification of Staphylococcus aureus, Escherichia coli and Pseu-
domonas aeruginosa).” (Section 19)
2.2 Establishing Microbiological Quality of Personal Care Products (Section 12)
2.3 Raw Materials Microbial Content (Section 11)
2.4 Microbial Validation and Documentation (Section 9)
18
3. Suggested Materials
* It must be demonstrated that the test method adequately inactivates antimicrobial substances present in the product. It is
recommended that a neutralizer be present in the diluent or agar or both.1
3.2.1 Autoclave
3.2.2 Sterile Petri dishes, 15 × 100 mm
3.2.3 20 mL, 10 mL, and 1.0 mL sterile syringes and/or pipettes, spatulas and other
sampling devices
3.2.4 Water bath capable of maintaining a temperature range of 45°-50°C
3.2.5 Microbiological incubators at 20°-25°C and 30°-34°C
18
* It must be demonstrated that the test method adequately inactivates antimicrobial substances pres‑
ent in the product. It is recommended that a neutralizer be present in the diluent or agar or both.1
18
(2) In a refrigerator to prevent growth.
A diagram of this dilution and plating scheme is shown in Figure 18-1
4.7 Testing in duplicate may be performed for increased accuracy. Wide disparity between du‑
plicate tests may invalidate results.
4.8 To ensure comparable results between different types of microorganisms (bacteria, yeasts,
and molds), plates should be incubated and read at times consistent between separate tests.
4.9 Include a laboratory control using apparatus, dilution blank (without product), media and
appropriate incubation. Concurrent contamination on test and control plates invalidates the
test. Find and eliminate the source of contamination. Repeat both control and product tests.
4.10 Count the colonies. If there is difficulty in distinguishing colonies from material, compare to
the refrigerated plates, or examine the colonies under a stereo microscope. (With experience,
the refrigerated plates can be eliminated from the procedure.)
4.10.1 General Counting Rules: if the number of colonies appears to exceed 250 CFU,
the plate may be sectioned for an estimated count. For plates where colonies are
too numerous and unable to be clearly distinguished, the plate may be marked as
“Too Numerous to Count” (TNTC).
4.11 The number of colony forming units (CFU) per mL or g is the colony count multiplied by
the appropriate dilution factor (10 or 100).
4.12 Neutralization of antimicrobial activity should be evaluated for each product tested.Car‑
ryover of antimicrobial activity from the product formulation into the plate count diluent
and recovery growth agar may occur. This may inhibit the growth of surviving challenge test
microorganisms, resulting in a false negative microbial count. To avoid a false negative result,
neutralization of the antimicrobial properties of the formulation must take place in the plate
count diluent and/or the recovery growth agar. Antimicrobial neutralization may normally
be accomplished by use of chemical neutralizing agents, physical dilution, or a combination
of both. Verification of neutralization is generally performed by inoculating the product di‑
lution with a low level of challenge microorganisms and performing the enumeration meth‑
od. Side-by-side dilutions with and without a product formulation are made. Enumeration
THE MICROBIAL CONTENT
bial recoveries are similar. If one or more challenge microorganisms cannot be recovered, the
use of a higher dilution and/or the investigation of additional chemical neutralizers may be
considered.1-3
4.13 Morphologically suspect colonies can be further identified by the methods described in
“M-2 Examination for and Identification of Staphylococcus aureus, Escherichia coli, Pseudo-
monas aeruginosa, and Candida albicans (Section 19).”
18
REFERENCES
1. ASTM International 2013. ASTM E1054-08 Standard Practices for Evaluating Inactivators of
Antimicrobial Agents. ASTM International, West Conshohocken, PA.
2. U.S. Pharmacopeia & National Formulary. 2016. USP 39- NF 34. <61> “Microbial Limit
Tests.” U.S. Pharmacopeia, Rockville, MD. pp. 83-88
3. U.S. Pharmacopeia & National Formulary. 2016. USP 39- NF 34. <1227> Validation of
Microbial Recovery from Pharmacopeal Articles.” U.S. Pharmacopeia, Rockville, MD. pp. 684-
686.
18
THE MICROBIAL CONTENT
M-1 DETERMINATION OF
1.0 mL
0.1 mL
FIGURE
Figure
18-‐2
18-2. AEROBIC
Aerobic
Plate
Count
PLATE COUNT
Using
Separate
USING SEPARATE AGARS
Agars
Step
1:
1:10
Dilution
of
the
Product
1.0 mL
0.1 mL
18
Bacteria
30
-‐35°C
>
2
days
Bacteria
Bacteria
Bacteria
Control
Refrigerated
Plates
Control
Fungal
Fungal
Control
Refrigerated
Plates
Control
M‑2
Examination for and
Identification of Staphylococcus
aureus, Escherichia coli,
Pseudomonas aeruginosa, and
Candida albicans
INTRODUCTION
For cosmetics and other personal care products, the identification of Staphylococcus aureus, Esche-
richia coli, Pseudomonas aeruginosa, and Candida albicans may be relevant because they may affect
product integrity and consumer safety. The methods described here represent current industry prac‑
tices for identification of these microorganisms. The identification of other microorganisms, such as
Burkholderia and Enterobacter species, may also be of interest.
1. Scope
1.1 The following document gives general guidelines for identifying Staphylococcus aureus, Esch-
erichia coli, Pseudomonas aeruginosa, and Candida albicans that may have been isolated from
raw materials and personal care products using M-1 (See Guidelines - M-1) or other enu‑
meration or detection methods. Alternative methods (e.g., ISO Cosmetic Microbiology
Standards (see Additional Information), biochemical and/or genotypic procedures) may be
substituted for these methods.
2. Suggested Materials:
2.1 General, Selective, and Differential Microbial Growth Media
19
Table 19-1 summarizes suitable media that may be used for presumptive identification of
these specified microorganisms. Procedures for use of these media in the identification of in‑
dividual types of microorganisms will be described in the following sections. Confirmation
MICROORGANISMS
M‑2 IDENTIFICATION OF
2.2 Reagents
2.2.1 Cytochrome Oxidase Test. Use filter paper impregnated with 1% tetraethyl
phenylenediamine dihydrochloride (Kovacs’ oxidase reagent)
2.2.2 Materials for Coagulase Test. Mammalian plasma, preferably rabbit or horse, with
or without suitable additives.1
2.2.3 Materials for Latex Agglutination Test. Kits are available from numerous commer‑
cial sources. The exact composition of materials and reagents may vary by manu‑
facturer.
2.2.4 Gram Stain Kit containing:
2.2.4.1 Gram Crystal Violet Solution
2.2.4.2 Gram Iodine Solution
2.2.4.3 Gram Decolorizer Solution
2.2.4.4 Gram Safranin Solution
Kits are available from numerous commercial sources. The exact composition of
reagents may vary by manufacturer. Follow the manufacturer’s procedure for stain‑
ing.
2.3 Equipment
2.3.1 Water baths at 37°C, 42°C and 45.5°C
2.3.2 Ultraviolet light (488 nanometers)
2.3.3 Compound light microscope with 1000X magnification, oil immersion lens
2.3.4 Microbiological incubator(s) at temperature(s) appropriate for specific test(s)
3. Procedure
3.1 The following procedures should be performed only with isolated colonies. If microbial
growth is observed on Petri dishes from enumeration or detection procedures, representative
colonies should be streaked for isolation onto non-selective agar. Incubate plates at tempera‑
ture used in enumeration or detection procedure. Before use in presumptive identification
testing, it is recommended that batches of selective/differential agars should be tested for
their microbial growth promotion ability and appearance of the medium or colonies using
the microbial strains that have been recommended by the manufacturer. It is recommend‑
ed that positive and negative control test microorganisms be used in conjunction with the
unknown microbial isolate to verify the accuracy of biochemical tests. Schematic diagrams
M‑2 IDENTIFICATION OF
for the identification of Staphylococcus aureus, Escherichia coli, Pseudomonas aeurginosa and
Candida albicans are shown in Figures 19-1 through 19-5.
MICROORGANISMS
3.3.2 Coagulase
3.3.2.1 After 24 hours, transfer characteristic colonies (see Table 19-1) from the
surface of the medium to individual tubes each containing 0.5 mL of
coagulase test plasma. Simultaneously assay coagulase positive and nega‑
tive cultures. Incubate at 35.0 ± 2.0°C, examining the tubes for clots at 3
hours and at subsequent intervals up to 24 hours. If commercial kits are
used, manufacturers’ instructions should be followed. While most S. au-
reus are coagulase positive, the latex agglutination test should be used for
confirmation of Gram-positive, catalase-positive cocci.4,5 If the reactions
of the controls are not correct, the assay results are invalid.
3.3.2.2 For a positive and negative Coagulase test control, a known ATCC cul‑
ture of Staphylococcus aureus and Staphylococcus epidermidis should be
used when an unknown Gram-positive coccus is tested.
3.3.3 Latex Agglutination Test
3.3.3.1 A 18-24 hour Gram positive cocci isolate that is catalase positive on a
general purpose media should be used to perform the test.
3.3.3.2 Because of the availability of numerous commercial latex agglutination
test kits, see manufacturer directions in how to perform the test.
3.3.3.3 For positive and negative latex agglutination test controls, known ATCC
culture of Staphylococcus aureus and Staphylococcus epidermidis should be
used when an unknown Gram-positive, catalase positive coccus is tested
3.3.4 Selective/Differential Media
As an alternative to the above biochemical tests, Catalase-positive, Gram-positive
cocci isolates may be streaked onto one of the following selective/differential agars
(see Table 1) to gain further information for the presumptive identification of an
isolate as Staphylococcus aureus:
3.3.4.1 Vogel-Johnson Agar (VJA) – the presence of black microbial colonies
surrounded by a yellow zone.2
3.3.4.2 Mannitol Salt Agar (MSA) – the presence of yellow microbial colonies
with yellow zones.2
3.3.4.3 Baird Parker Agar (BPA) – the presence of black, shiny microbial colo‑
nies surrounded by clear zones.2
3.3.5 If desired, confirmatory identification of an isolate as Staphylococcus aureus may be
accomplished using a commercially available identification kit for Gram-positive
cocci.
M‑2 IDENTIFICATION OF
MICROORGANISMS
Add a few drops of Kovacs’ oxidase reagent to a strip of filter paper. Smear a loopful
of an 18 – 24 hour culture grown on non-selective media onto the reagent soaked
filter paper using a platinum or plastic loop. (Do not use a nichrome wire loop, as
it may cause a false positive.) A dark purple-black color that develops within 15
seconds is a positive reaction.2,3
Known ATCC cultures of Escherichia coli and Pseudomonas aeruginosa should be
used as positive and negative control microorganisms for the Cytochrome Oxidase
Test when a unknown Gram-negative bacillus is tested.
3.5.2 Selective/Differential Media
Streak isolates onto Cetrimide or Pseudomonas Isolation Agar (PIA) plates and
incubate at 35.0 ± 2.0°C for 24 hours.
3.5.2.1 Note: After incubation, Pseudomonas aeruginosa colonies will appear as
yellow-green to blue microbial colonies on Cetrimide Agar and green to
blue-green microbial colonies on Pseudomonas Isolation Agar.2
3.5.3 If desired, confirmatory identification of an isolate as Pseudomonas aeruginosa may
be accomplished using a commercially available biochemical identification kit for
Gram-negative bacilli.
3.6 Test for Candida. albicans 6,7
The main elements for presumptive identification are yeasts which produce chlamydospores
on Corn Meal Agar and exhibit characteristic growth on selective and differential media. On
general purpose media, growth appears as white to beige creamy convex colonies.
3.6.1 Gram-positive, short ovoid or elongated cells, sometimes with buds should be
tested to determine the presence of Candida albicans. (Figure 19-4).
3.6.2.1 Chlamydospore production on Corn Meal Agar with 1% Polysorbate
806
3.6.2.1.1 Remove a small portion of the yeast colony with an inoculat‑
ing wire and streak-inoculate the surface of the medium across
the center of the plate. Place a sterile coverglass over the inoc‑
ulum streak. Incubate at 25.0 ± 2.5°C for up to 3 days.
3.6.2.1.2 Inspect plates daily by removing the dish lid and examine the
growth through the coverglass under the microscope with
magnification of 100 to 400X.
3.6.2.1.3 Candida albicans produces large, highly refractile, thick-walled
chlamydospore which may be seen terminally or on short lat‑
eral branches.2
3.6.2.2 Chromogenic Agar
3.6.2.2.1 Candida albicans Chromogenic agar is a specialized microbial
M‑2 IDENTIFICATION OF
19
MICROORGANISMS
M‑2 IDENTIFICATION OF
Table 19-1
Other media may be substituted providing that their equivalence has been demonstrated.
M‑2 IDENTIFICATION OF
MICROORGANISMS
REFERENCES
1. United States Pharmacopeia. 2016. <62> Microbial Examination of Nonsterile Products: Tests
for Specified Microorganisms. United States Pharmacopeia and the National Formulary. USP394-
NF34. Rockville, MD., 75-80.
2. Difco & BBL Manual. 2009. 2nd Edition. Divison of Becton Dickinson and Company, Sparks,
Maryland.
3. Tille, P.M. 2013. Bailey & Scott’s Diagnostic Microbiology, 13th Edition. Mosby, New York, New
York.
4. Essers, L., and Radebold, K., 1980. Rapid and Reliable Identification of Staphylococcus aureus
by a Latex Agglutination Test. J. Clin. Microbiol. 12: pp 641-643.
5. Roberts, J.I.S., and Gaston, M.A. 1987. Protein A and Coagulase Expression in Epidemic and
Non-epidemic Staphylococcus aureus. J. Clin. Pathol. 40: pp 837-840.
6. Kelly, J.P. and Fungiello, F. 1959. Candida albicans: A Study of Media Designed to Promote
Chlamydospore Production. J. Lab. & Clin.. Med., 53, pp 807-809.
7. Murray, P.R., Baron, E.J., Jorgensen, J.H., Landry, M.L., Pfaller, M.A. 2015. Manual of Clinical
Microbiology 11th Edition, Volume 1; ASM Press.
ADDITIONAL INFORMATION
European Pharmacopeia 8th Edition, 2014. <2.6.13> Microbiological Examination of Non-sterile
products (Test for Specified Micro-organisms, Council of Europe, Strasbourg, France.
US Food and Drug Administration. 2016 Bacteriological Analytical Manual, http://www.fda.gov/
Food/FoodScienceResearch/LaboratoryMethods/ucm2006949.htm.
ISO 18415, Cosmetics - Microbiology — Detection of Specified and Non-specified
Microorganisms
ISO 18416 Cosmetics- Microbiology – Detection of Candida albicans
ISO 21148 Cosmetics – Microbiology General Instructions for Microbiological Examination
ISO 21150 Cosmetics – Microbiology - Detection of Escherichia coli
ISO 22717 Cosmetics – Microbiology - Detection of Pseudomonas aeruginosa
ISO 22718 Cosmetics – Microbiology - Detection of Staphylococcus aureus
19
MICROORGANISMS
M‑2 IDENTIFICATION OF
Recovered
Microbial Isolate
SECTION 19
Gram-positive bacilli
isolate Gram-positive cocci Gram-negative bacilli Yeast isolate
isolate isolate
Negative Positive
AUREUS, ESCHERICHIA COLI, PSEUDOMONAS AERUGINOSA AND
AUREUS
Gram-positive cocci
isolate
Biochemical
Identification Path Presumptive Identification
Path
Cytochrome Oxidase
Negative , Gram-
SECTION 19
Biochemical Presumptive
Identification Path Identification Path
AERUGINOSA
Biochemical Presumptive
Identification Path Identification Path
Gram-Stain
SECTION 19
M-3
A Method for Preservation
Efficacy Testing of Water
Miscible Personal Care Products
1. Scope
1.1 This is an acceptable procedure for determining the preservative efficacy of water-miscible
personal care product formulations.1-5
1.2 Aseptic techniques and sterile materials must be employed.
2. Applicable Documents
2.1 “Determination of Preservation Efficacy in Water-Miscible Personal Care Products” (Section 13).
3. Materials
3.1 Selection of Challenge Microorganisms
The microbial strains listed in Table 20-1 may be considered for use in developing preserva‑
tion efficacy data for Personal Care products.
Either pure or mixed microbial culture suspensions may be used to challenge test formula‑
tions. Inocula consisting of only pure microbial cultures will yield specific data on each test
microorganism employed in the challenge study. When conducting mixed culture challenge
studies, it is recommended that closely related types of microorganisms such as Gram-posi‑
tive bacteria, Gram-negative bacteria, and yeasts and molds be pooled separately.
3.2 Maintenance of Challenge Microorganisms
Refer to Section 10 (Maintenance and Preservation of Test Organisms), ATCC culture
maintenance recommendations, available on their website (www.atcc.org), and to other
sources.6-8
Storage of other organisms relevant to the product in the original product or incorporation
of product into maintenance medium is often the only way to retain its unique characteris‑
tics. This method is especially appropriate where the isolate is subsequently inoculated into
a similar material.
• Eugon Agar
• Letheen Agar
• Microbial Content Agar
• Modified Letheen Agar
• Plate Count Agar
• Soybean Casein Digest Agar Medium (Tryptic Soy Agar)
• Microbial Content Agar with Tween
Addition of neutralizers may be necessary to demonstrate adequate preservative
neutralization. Other suitable agars and neutralizing agents may be used.
If the above agars do not support the growth of fungi, one of the following agars
may be considered:
• Malt Agar
• Malt Extract Agar
• Mycological Agar
• Potato Dextrose Agar
• Sabouraud Dextrose Agar
Other suitable agars and neutralizing agents may be used.
4. Preliminary Tests
4.1 Preservative Neutralization
Carryover of antimicrobial activity from the product formulation into the plate count dilu‑
ent and recovery growth agar may occur. This may inhibit the growth of surviving challenge
test microorganisms, resulting in a false negative microbial count. To avoid a false negative
result, neutralization of the antimicrobial properties of the formulation must take place in
the plate count diluent and/or the recovery growth agar.
Antimicrobial neutralization may normally be accomplished by use of chemical neutralizing
agents, physical dilution, or a combination of both.
Verification of neutralization is generally performed by inoculating the product dilution
with a low level of challenge microorganisms and performing the enumeration method Side-
by-side dilutions with and without a product formulation are made. Enumeration of the
microorganisms from these dilutions is performed. Neutralization is verified if microbial
recoveries are similar. If one or more challenge microorganisms cannot be recovered, the
use of a higher dilution and/or the investigation of additional chemical neutralizers may be
considered.9,10
demonstrated (See Section 4.1 on page 211 and References 9 and 10).
5. Inoculation Procedures
5.1 Preparation of Inocula
Freshly prepared cultures should be used for inoculating test samples.
In general, culture conditions in Table 20-2 should be considered when preparing the inoc‑
ula. Refer to the ATCC website (www.atcc.org) for optimal growth media and conditions
for specific microorganisms. Inclusion of cellulose degrading molds may necessitate longer
incubation periods and require a paper source for growth.
5.1.1 Preparation of Initial Bacteria and Yeast Suspensions
Broth cultures or cultures grown on solid agar media are acceptable for use. For
reference strains such as the ATCC strains, no more than five transfers from the
stock culture are recommended.12 Broth cultures should be centrifuged and then
re-suspended in the chosen suspending fluid. (See 3.3.1) Microbial growth on a
solid medium is transferred to the chosen suspending fluid.
5.1.2 Preparation of Initial Mold Suspensions
The mold inoculum is prepared by washing the sporulating agar culture with the
chosen suspending fluid (See 3.3.1) and filtering the spore suspension through
sterile gauze or glass wool. Sterile glass beads can be used as an aid in the dispersion
of spores in the suspending fluid.
5.1.3 Preparation of Bacterial Spore Suspensions
If spore-forming bacteria are to be included in the test, the inocula may be pre‑
pared as indicated in the AOAC Sporicidal Test.3 Some strains are commercially
available as prepared spore suspensions.
5.1.4 Preparation of Challenge Inocula
5.1.4.1 Inoculum levels
The recommended inoculation levels for challenge testing are:
• 1x106 Colony-Forming Units (CFU) of bacteria pergram of product
• 1x105 CFU of yeast per gram of product
• 1x105 CFU of mold spores per gram of product
The inoculum level for the challenge microorganisms should be verified
by standard microbiological techniques such as pour plate methods.
Sample size will in part determine the minimum detectable level. A sample sizeo‑
fatleastonegramoronemilliliterofproductforthequantitativepourplatemethodis rec‑
ommended. Aseptic techniques must be employed.
5.3.2.1 Quantitative pour plate method
20
Serial dilutions are prepared from the aliquot recovered from the chal‑
lenged sample unit. Each serial dilution is thoroughly mixed, and an ali‑
quot is transferred to a Petri dish. Melted agar maintained at 44-48°C is
added to the Petri dish, and the dish is rotated to uniformly disperse the
product dilution. The agar plates are allowed to solidify, then inverted
and incubated under conditions appropriate for the test microorganisms
(see Table 20-2).
After incubation, the number of microbial colonies is counted, and the
resulting figure is multiplied by the appropriate dilution factor to obtain
the number of microorganisms per sample unit.
5.3.2.2 Quantitative spread plate method
The quantitative spread plate method is performed in a manner similar
to the pour plate method; however, an aliquot of each dilution is trans‑
ferred directly onto the surface of solidified microbial growth agar. The
sample aliquot is then evenly spread over the agar surface. The agar plates
are allowed to dry, then inverted and incubated under conditions appro‑
priate for the test microorganisms (see Table 20-2).
After incubation, the number of microbial colonies is counted, and the
resulting figure is multiplied by the appropriate dilution factor to obtain
the number of microorganisms per sample unit.
5.2.3.3 Quantitative Spiral Plate Method.
The quantitative spiral plate method is performed in a similar manner
to spread plate method; however, an aliquot of the test solution is trans‑
ferred to a spiral plate machine and it is diluted onto an agar plate in
a spiral pattern. The agar plates are allowed to dry, then inverted and
incubated under conditions appropriate for the test organisms.
6. Other Considerations
6.1 Length of Test Procedure
It is recommended that preservation tests be carried out for a minimum of 28 days. In some
cases, numbers of challenge microorganisms may be reduced below detectable levels during
the early stages of the test only to adapt to the preservative system and later proliferate. A
final judgment of preservative adequacy should not be made until all the data are obtained.
6.2 Rechallenge
Consideration may be given to rechallenge. A rechallenge is useful for determining if a
formulation is marginally preserved and identifying which types of microorganisms may be
potential problems for that particular formulation.
Table 20-1
Table 20-2
REFERENCES
1. AOAC International 2007. AOAC 998.10-2009, Efficacy of preservation of non-eye area water-
miscible cosmetic and toiletry formulations. AOAC International, Rockville, MD
2. ASTM International 2012. ASTM E640-06 (2012) Standard Test Method for Preservatives in
20
M-4
Method for Preservation
Efficacy Testing of Eye Area
21
Personal Care Products
2. Applicable Documents
2.1 “Preservation Efficacy Testing of Eye Area Personal Care Products” (Section 14).
3. Materials
3.1 Selection of Challenge Microorganisms
The types of microorganisms shown in Table 21-1 should be given consideration in develop‑
ing preservation data. Additional microorganisms may also be included in the test procedure
if preservation problems may be encountered with such microorganisms.
3.2 Maintenance of Challenge Microorganisms
See also Section 10 (Maintenance and Preservation of Test Organisms) and Reference 3.
Table 21-2 shows conditions recommended for culture maintenance. Alternatively, cultures
may be freeze-dried, frozen or grown on a slant and overlaid with sterile mineral oil. Al‑
though initially more time-consuming, these methods eliminate the necessity of frequent
transfers and help ensure better culture stability. The viability of cultures must be checked
regularly.
Other isolates may present unique maintenance problems. Storage in the original product or
in corporation of product in the maintenance medium may be necessary to retain viability
and continued resistance. This method is especially appropriate where the isolate is subse‑
quently inoculated into a similar product.
The following diluents have been found suitable for preservation studies:
M-4 EFFICACY TESTING
• Letheen Broth
• Thioglycolate Broth
• TAT Broth
• Dey/Engley (D-E) Neutralizing Broth
Other diluents may also be used
21
4. Procedure
4.1 Aseptic technique should be practiced, and all test materials and media should be sterile.
21
4.2 Aqueous Liquid and Semi-liquid Eye Products
ed:
• 1x106 CFU of bacteria per gram of product
• 1x105 CFU of yeast per gram of product
• 1x105 CFU of mold spores per gram of product
Other levels may be used as needed
After inoculation, all products should be thoroughly mixed manually or
mechanically to uniformly distribute the challenge microorganisms. The
volume of the inoculum should not alter the character of the product
being challenged. Challenged formulations should then be incubated at
controlled room temperature under appropriate conditions of humidity
for the duration of the test.
4.2.4 Sampling the challenged product
4.2.4.1 Sampling intervals
Challenged formulations should be sampled for viable micro‑
organisms at selected time intervals after inoculations. The fre‑
quency of sampling should follow a set pattern to facilitate
future comparison of results. Sampling is recommended im‑
mediately after inoculation (0 hour) and at 1-3, 7, 14, 21 and
28 days. When rechallenged, sampling should be once a week
thereafter for at least 3 weeks.
4.2.4.2 Sampling methods
The inoculated product should be thoroughly mixed just pri‑
or to sampling to ensure that the sample is representative. In
some cases, the inoculum can thrive in “pockets” of growth in
21
• Capping and shaking vigorously by hand
21
should be used. The containers should not react with the product.
Inoculum
Inoculum
An oil or emulsified aqueous inoculum is suggested. It may be applied as
a liquid or a spray and mixed as in “Mixing” above.
Pan, cake or stick samples
Procedure
OF EYE AREA PRODUCTS
For pans, cakes or sticks that are surface inoculated, see 4.3.3.3.
M-4 EFFICACY TESTING
Table 21-1
Table 21-2
21
Yeasts Trypticase Soy Agar Refrigeration 4-8°C Biweekly or Monthly
Potato Dextrose Agar
Mycophil (Mycological) Agar
Table 21-3
ADDITIONAL INFORMATION
Bean, H.S. 1972. “Preservatives for Pharmaceuticals.” Journal of the Society of Cosmetic
Chemistry 23:703-720. 1972.
Tenenbaum, S. 1967. “Pseudomonads in Cosmetics.” Journal of the Society of Cosmetic
Chemistry 18:797-807.
Wilson, L.A., Kuehne, J.W., Hall, S.W. and Ahearn, D.G. 1971. “Microbial Contamination in
OF EYE AREA PRODUCTS
M-4 EFFICACY TESTING
REFERENCES
1. ASTM International. 2012. ASTM E640-06 (2012) Standard Test Method for Preservatives in
Water-Containing Cosmetics. ASTM International, West Consohocken, PA.
2. AOAC International. 2007. AOAC 998.10-2009, Efficacy of preservation of non-eye area
21
M-5
Methods for Preservation
Testing of Nonwoven Substrate
Personal Care Products
1. Scope
1.1 These methods cover a variety of procedures currently used within the personal care products
industry to evaluate preservative efficacy of different types of nonwoven substrate, wipe, or
towelette products.
22
These methods apply to nonwoven substrate personal care products that contain an aque‑
ous-based add-on solution. For nonwoven personal care products containing non-aqueous
NONWOVEN SUBSTRATE
M-5 TESTING OF
add-on materials or concentrates, it is important that critical consideration be given to
the typical use of the finished product and risk assessment and testing be completed as
detailed in “Microbiological Risk Factor Assessment of Atypical Personal Care Products”
(Section 16).
It is recommended that the method chosen reflect consideration of the manufacturing pro‑
cess, the type of packaging used, and the end use of the product.
1.2 Aseptic techniques and sterile materials must be employed.
2. Applicable Documents
2.1 “Determination of Preservative Adequacy in Nonwoven Substrate Products” (Section 17).
3. Materials
3.1 Selection of Challenge Microorganisms
The microbial strains listed in Table 22-1 may be considered for use in developing preserva‑
tion data of nonwoven substrate, wipe, or towelette products.
3.2 Maintenance of Challenge Microorganisms
See Section 10 (Maintenance and Preservation of Test Organisms)
• Phosphate Buffer, pH 7
• Soybean Casein Digest Medium (Tryptic Soy Broth)
• Trypticase Azolectin™ Tween™ (TAT) Broth
• Saline-Tween-Lecithin Diluent
Other suitable diluents may be used.
The addition of neutralizers may be necessary to demonstrate adequate preserva‑
tive neutralization (See 4.2).
3.3.3 Recovery Agars
Many factors affect organism viability. Therefore, it is important for the agar to
provide optimum nutritional support for the recovery of the challenge organisms.
The following have been found suitable for preservation studies:
• Eugon Agar
• Letheen Agar
22
Other suitable agars may be used. The addition of neutralizers may be necessary to
demonstrate adequate preservative neutralization.
NONWOVEN SUBSTRATE
M-5 TESTING OF
4. Preliminary Tests
4.1 Initial Count
It is recommended that all formulations be examined for microbial content prior to initia‑
tion of preservation studies.
4.2 Neutralization of Antimicrobial Activity
Carryover of antimicrobial activity from the product formulation into the plate count dilu‑
ent and recovery growth agar may occur. This may inhibit the growth of surviving challenge
test microorganisms resulting in a false negative microbial count. To avoid a false negative
result, neutralization of the antimicrobial properties of the formulation must take place in
the plate count diluent and/or the recovery growth agar.
Antimicrobial neutralization may normally be accomplished by the use of chemical neutral‑
izing agents, physical dilution, or a combination of both.
Verification of neutralization is generally performed by inoculating the product dilution
with a low level of challenge microorganisms and performing the enumeration method (See
Section 6.2). Side-by-side dilutions with and without a product formulation are made. Enu‑
meration of the microorganisms from these dilutions is performed. Neutralization is verified
if microbial recoveries are within 1 log. If one or more challenge microorganisms cannot be
recovered, the use of a higher dilution and/or the investigation of additional chemical neu‑
tralizers may be considered. Refer to ASTM E1054-081 or USP2 for additional details.
In some cases, low recovery of organisms may be due to poor recovery efficacy rather than
failure to neutralize the preservative system.
PCPC MICROBIOLOGY GUIDELINES | 229
SECTION 22 M-5 PRESERVATION TESTING OF NONWOVEN SUBSTRATE PRODUCTS
5. Inoculation Procedures
5.1 Preparation of Inocula
Freshly prepared cultures should be used for inoculating test samples. In general, culture
conditions in Table 22-2 should be considered when preparing the inocula. Refer to the
ATCC Web site (www.atcc.org) for optimal growth media and conditions for specific micro‑
organisms. Inclusion of cellulose degrading molds may necessitate longer incubation periods
and require a paper source for growth.
5.1.1 Preparation of Initial Bacteria and Yeast Suspensions
NONWOVEN SUBSTRATE
Either broth cultures or cultures grown on solid agar media are acceptable for use.
For reference strains such as the ATCC strains, no more than five transfers from
the stock culture are recommended.3 Broth cultures should be centrifuged and
M-5 TESTING OF
then re-suspended in the chosen suspending fluid (See 3.3.1). Microbial growth
on a solid medium is transferred to the chosen suspending fluid.
5.1.2 Preparation of Initial Mold Suspensions
The mold inoculum is prepared by washing the sporulating agar culture with the
chosen suspending fluid (See 3.3.1) and filtering the spore suspension through
22
sterile gauze or glass wool. Sterile glass beads can be used as an aid in the dispersion
of spores in the suspending fluid.
5.1.3 Preparation of Bacterial Spore Suspensions
If spore-forming bacteria are to be included in the test, the inocula may be pre‑
pared as indicated in the AOAC Sporicidal Test.4 Some strains are commercially
available as prepared spore suspensions.
5.1.4 Preparation of Challenge Inocula
5.1.4.1 Inoculum Levels
The recommended inoculation levels for challenge testing are:
• 1x106 Colony-Forming Units (CFU) of bacteria per sampling unit
of product
• 1x105 CFU of yeast per sampling unit of product
• 1x105 CFU of mold spores per sampling unit of product
22
The number of viable microorganisms on dried carriers must be equivalent
to the recommended levels. If necessary, the volume of filtered culture sus‑
NONWOVEN SUBSTRATE
M-5 TESTING OF
pension may be increased to take into account mortality due to desiccation.
5.2 Sample Preparation
In addition to the quantity required for the test, it is recommended that extra sample units
be prepared in the event they are needed. An unpreserved control should be included if pos‑
sible. If product rechallenge is desired, sufficient sample units must be prepared prior to the
start of the test. The sample reporting unit used depends on the inoculation and sampling
method chosen. If applicable, determine and record the weight and/or the average area of
the nonwoven substrate product sample, e.g., 1 g or 1 cm2.
If possible, preservative challenge testing should be conducted on product in the final pack‑
age to ensure compatibility with the preservative system and to represent the marketed prod‑
uct. Where the product does not lend itself to testing in the container/package, other ap‑
proaches may be employed, as detailed below in Section 5.2.4.
5.2.1 Tubs
Aseptically open packages and inoculate the product as received according to the
inoculation procedure (Section 5.3). Reseal the packages and follow the sampling
procedure under Section 6.1.
5.2.2 Soft Packages
Aseptically open packages, and inoculate the product as received according to
the inoculation procedure (Section 5.3). Some inoculation techniques may allow
for the aseptic introduction of the inocula directly into the package. Reseal the
packages and follow the sampling procedure (Under “Sampling the Challenged
Product” in Section 6.1 below).
5.2.3 Canisters
Aseptically open canister, remove the roll, and inoculate the top sheets of the prod‑
uct according to an appropriate inoculation procedure (Section 5.3). Reinsert the
roll into the canister. Seal the canisters and follow the sampling procedure (Section
6.1).
5.2.4 Transferred Samples
Aseptically open packages and transfer an appropriate number of nonwoven sub‑
strate units to sterile, resealable containers for inoculation. Follow the inoculation
procedure (Section 5.3). Seal the containers and follow the sampling procedure
(Section 6.1).
5.3 Methods for Inoculation
Inoculation of nonwoven substrates can be accomplished in a variety of ways. Methods for
inoculating product are described below. In each case, verification of microorganism recov‑
ery (described below) is an important component of the method verification.
5.3.1 A specific volume of an inoculum suspension is delivered by pipette using a point
delivery over the sample unit in a predetermined pattern. (For example, place 0.1
NONWOVEN SUBSTRATE
ml in five different areas of the substrate such as the four corners and the center.)
After inoculation, the package is sealed. This inoculation method can be used to
M-5 TESTING OF
5.3.6 Dried inocula on membrane filter carriers are placed between two substrate layers
in the package. Placement of the filter may be determined by conducting a sedi‑
mentation study. After inoculation, the package is resealed.
5.4 Storage of Inoculated Samples
Challenged formulations can be stored at controlled or ambient temperature undercondi‑
tions of humidity considered appropriate for the final product packaging for the duration of
the test.
6. Recovery Procedures
6.1 Sampling the Challenged Product
6.1.1 Sampling Intervals
Challenged formulations should be sampled for viable microorganisms at selected
time intervals after inoculations. The frequency of sampling should follow a set
pattern to facilitate future comparison of test results between different product
formulations or samples, for example, weekly up to 28 days after inoculation.
22
6.1.2 Sampling Sites
NONWOVEN SUBSTRATE
M-5 TESTING OF
The method of sampling chosen will depend upon several factors including the
method of inoculation. Below are several sampling methods that may be used.
6.1.2.1 For most inoculation methods, the top nonwoven substrate in the stack
or the outer most nonwoven substrate in the roll may be sampled from a
product package.
6.1.2.2 For a product challenge method where multiple nonwoven substrates
in a product package are inoculated, the inoculated substrate units per
package should be sampled at the appropriate time.
6.1.2.3 For a product challenge method where an inoculated nonwoven sub‑
strate is aseptically transferred to a secondary package (See “Transferred
Samples” in Section 5.3), one product package per sampling interval
may be sampled.
6.1.2.4 For a product challenge method where the inoculum is evenly distribut‑
ed across the nonwoven substrate, a uniform cross section (e.g., 1 g) of
the substrate may be sampled at each sampling interval.
6.1.2.5 For a product challenge method using dried inocula, a membrane filter
carrier is sampled at each interval. Additionally, one or two substrates
above and one or two below the filter may be sampled separately at each
sampling interval to evaluate migration of organisms through the sam‑
ple.
Serial dilutions are prepared from the aliquot recovered from the challenged sam‑
ple unit. Each serial dilution is thoroughly mixed and an aliquot is transferred to
a Petri dish. Melted agar maintained at 44-48°C is added to the Petri dish, and
the dish is rotated to uniformly disperse the product dilution. The agar plates are
allowed to solidify, then inverted and incubated under conditions appropriate for
the test microorganisms (see Table 22-2).
22
After incubation, the number of microbial colonies is counted and the resulting
figure is multiplied by the appropriate dilution factor to obtain the number of
microorganisms per sample unit.
6.2.2 Quantitative Spread Plate Method
The quantitative spread plate method is performed in a manner similar to the pour
plate method; however, an aliquot of each dilution is transferred directly onto the
surface of solidified microbial growth agar. The sample aliquot is then evenly spread
over the agar surface. The agar plates are allowed to dry, then inverted and incubated
under conditions appropriate for the test microorganisms (see Table 22-2).
After incubation, the number of microbial colonies is counted, and the resulting
figure is multiplied by the appropriate dilution factor to obtain the number of
microorganisms per sample unit.
7. Reporting
Calculate and report the percent reduction of inoculum counts per substrate, per gram of prod‑
uct, or per unit area for each organism or organism pool.
Table 22-1
22
Fermentative Gram- Klebsiella pneumoniae (10031) Select at least one
Negative Bacilli Enterobacter cloacae (13047)
NONWOVEN SUBSTRATE
M-5 TESTING OF
Escherichia coli (8739)*
Enterobacter gergoviae (33028)
Non-Fermentative Pseudomonas aeruginosa (9027)* Select at least one
Gram-Negative Bacilli Burkholderia cepacia (25416)
Pseudomonas fluorescens (13525)
Pseudomonas putida (31483)
Yeasts Candida albicans (10231)* Select at least one
Candida parapsilosis (22019)
Molds Aspergillus brasiliensis (16404)* Select at least one
Chaetomium globosum (6205)**
Trichoderma reesei (13631)**
Cladosporium oxysporum (76499)**
Penicillium species
Spore-Forming Bacilli Bacillus subtilis (6051) Optional
Other In-house isolates Optional
*Staphylococcus aureus (6538), Escherichia coli (8739), Pseudomonas aeruginosa (9027), Candida albicans
(10231), and Aspergillus brasiliensis (16404) are specified in the United States Pharmacopeia (USP) Antimicrobial
Effectiveness Testing Method.5
**Inclusion of cellulose degrading molds may require longer incubation periods and require a paper source for
growth.
Table 22-2
REFERENCES
M-5 TESTING OF
1. ASTM International. 2013. ASTM E1054-08 Standard Practices for Evaluating Inactivators of
Antimicrobial Agents. ASTM International, West Conshohocken, PA.
2. U.S. Parmacopeia & National Formulary. 2016. USP 39- NF 34. <1227> Validation of
Microbial Recovery from Pharmacopeal Articles. USP-NF, Rockville, MD,pp. 684-686.
3. Reichgott, M. 2003. “Reference Strains: How Many Passages Are Too Many?,” ATCC
22
M-6
A Method for Preservation
Testing of Atypical Personal
Care Products
1. Scope
1.1 This general method reflects a variety of approaches currently used within the cosmetics
industry and serves as an acceptable procedure for determining the preservative efficacy of
atypical personal care products, such as oils, powders, or other formulations that have low
water content and/or are not miscible with water. The recommended preservative challenge
test methods used for determining the preservative efficacy of aqueous-based products (See
References 1–3 and Section 20) may not be suitable for evaluating certain atypical prod‑
uct formulations. When testing and assessing preservative challenge test data for atypical
products, the following factors are important points to consider (See “Microbiological Risk
Factor Assessment of Atypical Personal Care Products” in Section 16):
• A test in which an aqueous-based inoculum is introduced into an hydrous product may
change the physical dynamics of the product and, therefore may not predict its microbial
stability.
• Most preservatives are water soluble. In emulsions, preservatives are used in the water
phase because contaminating microorganisms require water to proliferate.
23
• For an emulsion in which the external phase is water immiscible (emulsions in which
ATYPICAL PRODUCTS
M-6 TESTING OF
water is not the external or continuous phase) and an aqueous challenge inoculum is
used, the water-soluble preservatives may not be able to migrate into the aqueous phase.
In these cases, the preservatives may not be available to inhibit proliferation or have cidal
activity against each of the challenge microorganisms.
1.2 Aseptic techniques and sterile materials must be employed.
2. Applicable Documents
2.1 “Microbiological Risk Factor Assessment of Atypical Personal Care Products” (Section 16).
2.2 “Determination of Preservative Adequacy in Personal Care Product Formulations” (See
Section 13).
3. Materials
3.1 Selection of Challenge Microorganisms.
The microbial strains listed in Table 23-1 may be considered for use in developing preserva‑
tion data for personal care products.
Either pure or mixed microbial culture suspensions may be used to challenge test formula‑
tions. Inocula consisting of only pure microbial cultures will yield specific data on each test
microorganism employed in the challenge study. When conducting mixed culture challenge
studies, it is recommended that separate pools of closely related types of microorganisms such
as Gram-positive bacteria, Gram-negative bacteria, and yeasts and molds be maintained.
3.2 Maintenance of Challenge Microorganisms
Refer to Section 10 (Maintenance and Preservation of Test Organisms), the ATCC cul‑
ture maintenance recommendations, available on their website (www.atcc.org), and to other
sources.4,5
3.3 Test Media
3.3.1 Inocula Suspending Fluids
Suspending fluids are used to prepare the bacterial and fungal suspensions for in‑
oculating the test product. The following may be used:
• Phosphate Buffer (pH 7.0)
• 0.85% Sodium Chloride Solution (Normal Saline)
• Sodium Chloride Peptone Solution (1% peptone in normal saline)
Other suitable fluids may be used. The addition of 0.05% – 0.1% polysorbate 80
or other surfactant to the suspending fluid is recommended to aid in dispersion of
mold spores.
3.3.2 Microbial Plate Count Diluents
ATYPICAL PRODUCTS
Plating diluents serve to disperse the sample and dilute it to levels that permit re‑
M-6 TESTING OF
23
• Mycological Agar
ATYPICAL PRODUCTS
M-6 TESTING OF
• Potato Dextrose Agar
• Sabouraud Dextrose Agar
Other suitable agars may be used.
4. Preliminary Tests
4.1 Preservative Neutralization
Carryover of antimicrobial activity from the product formulation into the plate count dilu‑
ent and recovery growth agar may occur. This may inhibit the growth of surviving challenge
test microorganisms resulting in a false negative microbial count. To avoid a false negative
result, neutralization of the antimicrobial properties of the formulation must take place in
the plate count diluent and/or the recovery growth agar.
5. Inocula Preparation
5.1 Preparation of Inocula
Freshly prepared cultures should be used for inoculating test samples.
In general, culture conditions in Table 23-2 should be considered when preparing the inocula.
5.1.1 Preparation of Initial Bacteria and Yeast Suspensions
Either broth cultures or cultures grown on solid agar media are acceptable for use.
For reference strains such as the ATCC strains, no more than five transfers from
the stock culture are recommended.7
5.1.1.1 Aqueous Inoculum
Broth cultures should be centrifuged and then re-suspended in the cho‑
ATYPICAL PRODUCTS
sen suspending fluid. (See Section 20) Microbial growth on a solid me‑
M-6 TESTING OF
23
per gram or milliliter may be used instead of the inoculum concentration
of 105 to 106 CFU per gram or milliliter that is recommended in the
aqueous based challenge test methods.
ATYPICAL PRODUCTS
M-6 TESTING OF
Note: By reducing the inoculum size, it is easier to measure stasis or
quantify an increase in the microbial count.
A minimum sample size of 20 grams should be prepared for each challenge micro‑
organism or pool of microorganisms.
M-6 TESTING OF
For wet dry pressed powders, up to 5% water may first be added to the product,
prior to inoculation.
6.1.4 Mixing
A glass rod, tongue depressor, or mechanical mixer may be necessary to uniformly
23
disperse test microorganisms. Inoculated product that has collected on the mixing
device or on the container’s inner surfaces or edges must be worked back into the
sample to prevent excessive loss of product (See Section 20).
23
6.4 Storage of Inoculated Samples
Inoculated samples should be stored under ambient conditions
ATYPICAL PRODUCTS
M-6 TESTING OF
6.5 Sampling the Challenged Product
6.5.1 Sampling interval
Challenged formulations should be sampled for viable microorganisms at selected
time intervals after inoculations. The frequency of sampling should follow a set
pattern to facilitate future comparison of test results between different product
formulations. Sampling intervals should be based on microbial contamination risk
as demonstrated by product water activities and other microbiological related at‑
tributes.
• Water in oil and/or silicone emulsions
Three sampling points, such as 7, 14, 28 days
Sample size will in part determine the minimum detectable level. A sample size of
at least one gram or one milliliter of product for the quantitative pour plate meth‑
od is recommended. Aseptic techniques must be employed.
6.5.2.1 Quantitative pour plate method
Serial dilutions are prepared from the aliquot recovered from the challenged sam‑
ple unit. Each serial dilution is thoroughly mixed, and an aliquot is transferred to
a Petri dish. Melted agar maintained at 45-48°C is added to the Petri dish, and
the dish is rotated to uniformly disperse the product dilution. The agar plates are
allowed to solidify, then inverted and incubated under conditions appropriate for
the test microorganisms (see Table 23-3).
After incubation, the number of microbial colonies is counted, and the resulting
figure is multiplied by the appropriate dilution factor to obtain the number of
CFU per gram or milliliter of sample.
6.5.2.2 Quantitative spread plate method
The quantitative spread plate method is performed in a manner similar to the pour
plate method; however, an aliquot of each dilution is transferred directly onto
the surface of solidified microbial growth agar. The sample aliquot is then evenly
spread over the agar surface. The agar plates are allowed to dry, then inverted and
incubated under conditions appropriate for the test microorganisms (see Table 23-
2).
After incubation, the number of microbial colonies is counted, and the resulting
figure is multiplied by the appropriate dilution factor to obtain the number of
CFU per gram or milliliter of sample.
6.5.2.3 Quantitative Spiral Plate Method.
The quantitative spiral plate method is performed in a similar manner to spread
23
plate method; however, an aliquot of the test solution is transferred to a spiral plate
machine and it is diluted onto an agar plate in a spiral pattern. The agar plates are
ATYPICAL PRODUCTS
M-6 TESTING OF
allowed to dry, then inverted and incubated under conditions appropriate for the
test organisms.
Table 23-1
Table 23-2
Other Media
Table 23-2
ADDITIONAL INFORMATION
Bean, H.S. 1972. “Preservatives for Pharmaceuticals.” J. of Soc. Cosmet. Chem. 23:703-720.
Tenenbaum, S. 1967. “Pseudomonads in Cosmetics.” J. of Soc. Cosmet. Chem. 18:797-807.
Wilson, L.A., Kuehne, J.W., Hall, S.W., and Ahearn, D.G. 1971. “Microbial Contamination in
Ocular Cosmetics,” American Journal of Ophthalmology 71(6):1298-1302.
Yablonski, J.I. and Mancuso, S.E. 2002. “Preservation of Atypical Cosmetic Systems.” Cosmetics &
Toiletries 2: 41.
REFERENCES
1. ASTM International 2012. ASTM E640-06 (2012) Standard Test Method for Preservatives in
23
Water-Containing Cosmetics. ASTM International, West Consohocken, PA.
ATYPICAL PRODUCTS
M-6 TESTING OF
2. AOAC International 2007. AOAC 998.10-2009, Efficacy of preservation of non-eye area water-
miscible cosmetic and toiletry formulations. AOAC International, Rockville, MD
3. ISO 2012. ISO 11930 Cosmetics — Microbiology — Evaluation of the antimicrobial
protection of a cosmetic product. ISO. Geneva, Switzerland. www.iso.org
4. Brown, M.R. and Gilbert, P. (Eds.) 1995. Microbiological Quality Assurance: A Guide Towards
Relevance and Reproducibility of Inocula, CRC Press, Boca Raton, FL.
5. Kirsop, B.E. and Doyle, A. (Editors) 1991. Maintenance of Microorganisms and Cultured Cells,
Second Edition, Academic Press, New York, NY.
6. ASTM International 2013. ASTM E1054-08 Standard Practices for Evaluating Inactivators of
Antimicrobial Agents. ASTM International, West Conshohocken, PA.
7. Reichgott, M. 2003. “Reference Strains: How Many Passages Are Too Many?,” ATCC Connection
23, available at: https://www.atcc.org/~/media/PDFs/Technical%20Bulletins/tb06.ashx
8. AOAC International. 2013. AOAC Method 966.04 Sporicidal Activity of Disinfectants. AOAC
International, Rockville, MD
9. U.S. Parmacopeia & National Formulary. 2016. USP 39 - NF 34. <51> Antimicrobial
Effectiveness Testing, USP-NF, Rockville, MD, pp. 67-69.
ATYPICAL PRODUCTS
M-6 TESTING OF
23
M-7
A Screening Method for
Preservation Testing of Water-
Miscible Personal Care Products
Scope
1. Introduction
1.1 This procedure allows a more rapid determination of preservation efficacy in water-miscible
personal care products in comparison to traditional methods. This procedure is intended to
be used as a screening test during product development to quickly differentiate between pre‑
servative systems that may be capable of providing adequate preservation and those which
have insufficient anti-microbial activity to protect the product. It is not intended to provide
the definitive information on the adequacy of preservation of the final formulation. This
information is obtained through standard tests, such as those described in Methods M-3
(Section 20), M-5 (Section 22), and M-6 (Section 23).
This procedure may also be used to more quickly qualify products to which minor formula‑
tion changes have been made. However, to assure that the product is adequately preserved,
more stringent criteria for the elimination of microorganisms over the course of the test than
those used in conventional tests should be adopted.
1.2 Aseptic techniques and sterile materials must be employed.
2. Applicable Documents
2.1 “Determination of Preservative Efficacy in Water-Miscible Personal Care Products” (Section
13).
3. Materials
3.1 Selection of Challenge Microorganisms
24
The microbial strains listed in Table 24-1 may be considered for use in developing preserva‑
tion data for personal care products.
MISCIBLE PRODUCTS
M-7 SCREENING WATER-
4. Preliminary Tests
4.1 Preservative Neutralization
Carryover of antimicrobial activity from the product formulation into the plate count dilu‑
ent and recovery growth agar may occur. This may inhibit the growth of surviving challenge
test microorganisms resulting in a false negative microbial count. To avoid a false negative
result, neutralization of the antimicrobial properties of the formulation must take place in
the plate count diluent and/or the recovery growth agar.
Antimicrobial neutralization may normally be accomplished by use of chemical neutralizing
agents, physical dilution, or a combination of both.
24
a low level of challenge microorganisms and performing the enumeration method Side-by-side
dilutions with and without a product formulation are made. Enumeration of the microor‑
ganisms from these dilutions is performed. Neutralization is verified if microbial recoveries
are similar. If one or more challenge microorganisms cannot be recovered, the use of a higher
dilution and/or the investigation of additional chemical neutralizers may be considered.
4.2 Microbial Content Test
It is recommended that that a microbial content test (See Section 18) be performed on the
test sample prior to performing the preservative efficacy test. Verification of neutralization of
the antimicrobial properties of the test sample should be demonstrated (See Section 4.1) at
the same time as the microbial content test.
5. Inoculation Procedures
5.1 Preparation of Inocula
Freshly prepared cultures should be used for inoculating test samples.
In general, culture conditions in Table 24-2 should be considered when preparing the in‑
ocula. Refer to the ATCC website1 for optimal growth media and conditions for specific
microorganisms.
5.1.1 Preparation of Initial Bacteria and Yeast Suspensions
Either broth cultures or cultures grown on solid agar media are acceptable for use.
For reference strains such as the ATCC strains, no more than five transfers from
the stock culture are recommended.7 Broth cultures should be centrifuged and
then re-suspended in the chosen suspending fluid. Microbial growth on a solid
medium is transferred to the chosen suspending fluid.
5.1.2 Preparation of Initial Mold Suspensions
The mold inoculum is prepared by washing the sporulating agar culture with the
chosen suspending fluid (See Section 3.3.1 above) and filtering the spore suspen‑
sion through sterile gauze or glass wool. Sterile glass beads can be used as an aid in
the dispersion of spores in the suspending fluid.
5.1.3 Preparation of Bacterial Spore Suspensions
If spore-forming bacteria are to be included in the test, the inocula may be pre‑
pared as indicated in the AOAC Sporicidal Test.8 Some strains are commercially
available as prepared spore suspensions.
5.1.4 Preparation of Challenge Inocula
5.1.4.1 Inoculum levels
The recommended inoculation levels for challenge testing are:
M-7 SCREENING WATER-
of product
• 1-5×105 CFU of yeast per gram of product
• 1-5×105 CFU of mold spores per gram unit of product
• Mixing in a stomacher
• Gentle mixing in a tissue grinder
Sample size will in part determine the minimum detectable level. A sample size of
at least one gram or one milliliter of product for the quantitative pour plate meth‑
od is recommended.
5.3.2.1 Quantitative pour plate method
Serial dilutions are prepared from the aliquot recovered from the chal‑
lenged sample unit. Each serial dilution is thoroughly mixed, and an ali‑
quot is transferred to a Petri dish. Melted agar maintained at 45-48°C is
added to the Petri dish, and the dish is rotated to uniformly disperse the
product dilution. The agar plates are allowed to solidify, then inverted
and incubated under conditions appropriate for the test microorganisms
(see Table 24-2).
After incubation, the number of microbial colonies is counted, and the
resulting figure is multiplied by the appropriate dilution factor to obtain
the number of microorganisms per gram.
5.3.2.2 Quantitative spread plate method
The quantitative spread plate method is performed in a manner simi‑
lar to the pour plate method. However, an aliquot of each dilution is
transferred directly onto the surface of solidified microbial growth agar.
The sample aliquot is then evenly spread over the agar surface. The agar
plates are allowed to dry, then inverted and incubated under conditions
appropriate for the test microorganisms (see Table 24-2).
After incubation, the number of microbial colonies is counted, and the
resulting figure is multiplied by the appropriate dilution factor to obtain
the number of microorganisms per gram.
5.2.3.3 Quantitative Spiral Plate Method.
The quantitative spiral plate method is performed in a similar manner
to spread plate method; however, an aliquot of the test solution is trans‑
ferred to a spiral plate machine and it is diluted onto an agar plate in
a spiral pattern. The agar plates are allowed to dry, then inverted and
incubated under conditions appropriate for the test organisms.
M-7 SCREENING WATER-
MISCIBLE PRODUCTS
Table 24-1
Table 24-2
Table 24-3
REFERENCES
1. ASTM International. 2013. ASTM E1054-08 Standard Practices for Evaluating Inactivators of
Antimicrobial Agents. ASTM International, West Conshohocken, PA.
2. ASTM International. 2012. ASTM E640-06 (2012) Standard Test Method for Preservatives in
Water-Containing Cosmetics. ASTM International, West Consohocken, PA.
3. AOAC International. 2007. AOAC 998.10-2009, Efficacy of preservation of non-eye area
water-miscible cosmetic and toiletry formulations. AOAC International, Rockville, MD
4. ISO 2012. ISO 11930 Cosmetics — Microbiology — Evaluation of the antimicrobial
protection of a cosmetic product. ISO. Geneva, Switzerland. www.iso.org
5. Brown, M.R. and Gilbert, P. (Eds.) 1995. Microbiological Quality Assurance: A Guide Towards
Relevance and Reproducibility of Inocula, CRC Press, Boca Raton, FL.
6. Kirsop, B.E. and Doyle, A. (Editors) 1991. Maintenance of Microorganisms and Cultured Cells,
Second Edition, Academic Press, New York, NY.
7. Reichgott, M. 2003. “Reference Strains: How Many Passages Are Too Many?,” ATCC
Connection 23, available at: https://www.atcc.org/~/media/PDFs/Technical%20Bulletins/tb06.
ashx
8. AOAC International. 2013. AOAC Method 966.04 Sporicidal Activity of Disinfectants. AOAC
International, Rockville, MD
9. U.S. Pharmacopeia & National Formulary. 2016. USP 39 - NF 34. <51> Antimicrobial
Effectiveness Testing, USP-NF, Rockville, MD, pp. 67-69.
M-7 SCREENING WATER-
MISCIBLE PRODUCTS
Glossary
A Anaerobic
able to grow in the absence of oxygen.
Action Level
level or range that, when exceeded, indicates Anhydrous
that a process has deviated from its normal op‑ without water.
erating condition, and that requires corrective
action to be taken to bring the process back into Antimicrobial
its normal operating condition. a chemical agent, either produced by a micro‑
organism or by synthetic means, that is capable
Adaptation of killing or suppressing the growth of micro‑
a change or changes in an organism or popu‑ organisms.Antimicrobial Preservative Efficacy
lation of organisms, through which the organ‑ Test. See Preservation Test.
ism(s) become more suited to the prevailing en‑
vironmental conditions. Antiseptic
a substance for use on living tissue that either
Add-on destroys or inhibits the growth of microorgan‑
in a non-woven substrate based product, the isms.
formulation added to the substrate, e.g., a lo‑
tion, solution, emulsion, oil, or other material. Aqueous
containing water.
Aerobic
requiring oxygen for growth. Aseptic
free of microorganisms that are capable of caus‑
Agar ing infection or contamination.
a gelatinous colloidal extract from algae consist‑
ing of agarose and agaropectin that is used in Aseptic Technique
microbial growth media to make it a semi‑solid precautionary measures taken in microbiologi‑
at room temperature. cal work to prevent the contamination by extra‑
neous microorganisms.
Air Sampling
a technique by which the quantity of viable mi‑ Atypical Product
croorganisms or particulate matter present in a a product in which water is not readily avail‑
voume of air is determined or isolated. able to provide an environment that supports
growth of microorganisms, a product in which
Alert Level the water activity is too low to support growth,
a level or range that, when exceeded, warns that or a product having other physico‑chemical
24
a process may have deviated from its normal op‑ characteristics that do not allow growth of mi‑
erating condition. croorganisms.
MISCIBLEGLOSSARY
M-7 SCREENING WATER-
Ambient Air
environmental or room air.
PRODUCTS
B C
Bactericide CFU
a chemical or physical agent that destroys viable See Colony-forming Unit
bacteria.
Calibration
Bacteriostat the set of operations and conditions that estab‑
an agent that inhibits the growth of bacteria. lishes the relationship between values produced
by a measuring instrument or system, or val‑
Bacterium (pl. bacteria) ues obtained from a material measure, and the
a single‑celled, prokaryotic microorganism that corresponding values from a known reference
multiplies by cell division. standard.
up to final packaging but has not been placed in Gram‑negative, nonspore‑forming bacteria of
MISCIBLEGLOSSARY
the final package. intestinal origin that ferment lactose with gas
M-7 SCREENING
formation.
Culture Maintenance
a process that keeps a microorganism alive, un‑
Distillation
MISCIBLEGLOSSARY
M-7 SCREENING WATER-
Documentation Fungicide
records containing all relevant information or‑ a chemical or physical agent that kills fungi.
ganized in an orderly and easily understood for‑
mat, usually applied to a process, method, or Fungistat
equipment usage. an agent that inhibits the growth of fungi.
Fungus
E a saprophytic, symbiotic, or parasitic, hetero‑
trophic, eukaryotic microorganism, i.e., a yeast
Enteric Organisms
or mold
microorganisms associated with the intestinal
tract.
G
Eucaryotic
a type of cell that has a well‑defined nuclear Genotype
membrane. genetic material contained in the entire comple‑
ment of alleles (chromosomes).
Growth Phase
PRODUCTS
Formalin
M-7 SCREENING
membrane.
Installation Qualification (IQ)
MISCIBLEGLOSSARY
M-7 SCREENING WATER-
Microbial Content O
the number of viable microorganisms present in
a specific volume or quantity of material. Objectionable Organism
an organism that can be harmful to the user
Microbial Proliferation Rate based upon the nature of the product, its in‑
reproduction rate of microorganisms. tended use and its potential hazard, or is able
to compromise the physical integrity or appear‑
Microbiological Limits ance of the product.
maximum microbial content and specific mi‑
crobial type restrictions established for raw ma‑ Operational Qualification (OQ)
terials or finished products. a list of critical components, operating ranges,
as defined by the specification, and actual per‑
Microbiological Specification formance for a piece of equipment.
a statement of microbial content limits.
Ozone
Mold a highly reactive allotropic triatomic form of
filamentous fungus. oxygen used in disinfection and deodorization.
Pathogen
N a disease‑causing organism.
Natural Raw Materials
substances of plant, animal, or mineral origin Peroxygen Compounds
that may be minimally processed before use. chemical compounds that contain the bivalent
group O‑O and are used as sanitizing agents.
Negative Control
a sample in a test series without the test agent Personal Care Product
used as a standard of comparison in judging ex‑ Articles including cosmetics, as defined by the
perimental effects. U.S. food and Drug Administration, as well as
some products such as suncreens that are clas‑
Neutralizing Agent sified as srugs by the agency. See: http://www.
a chemical substance added to a medium to in‑ fda.gov/ForIndustry/FDABasicsforIndustry/
ucm238796.htm
WATER-
Pipeline Pig
M-7 SCREENING
Preservative Failure
R
deterioration in the effectiveness of the preser‑ Raw Material
vative system in a product that allows for micro‑ any ingredient used in the manufacture of a
bial growth or survival. product.
S Shelf Life
a period of time during which a raw material
Sample
or finished product may be stored and remain
one or more representative portions or items se‑
suitable for use.
lected from a set to obtain information about
that set.
Species
one kind of microorganism; a subdivision of a
Sampling
genus.
operations relating to the taking and prepara‑
tion of samples.
Specification
clear and accurate description of the essential
Sampling Devices
technical requirements for items, materials, or
tools and equipment used to aseptically sample
services; in the microbiology laboratory, often
materials, surfaces, or an environment.
refers to a statement of microbial limits.
Sampling Personnel
Spore
individuals trained in proper sampling tech‑
a highly resistant form of a microorganism, e.g.,
niques to prevent extraneous microbial contam‑
mold or bacilli.
ination.
Spread Plate
Sanitary
a plate count method in which a small volume
hygienic.
of test material is dispersed, by means of a sterile
spreader, over the entire surface of a solid agar
Sanitary Manufacturing Practice
medium in a Petri dish.
guidelines to maintain clean and sanitary condi‑
tions within the manufacturing environment.
Stabile Product
a finished product that maintains acceptable
Sanitization
characteristics over a specified time and under
the process utilized to reduce viable microor‑
defined environmental conditions.
ganisms on a surface to an acceptable level;
surfaces must be clean for the sanitization pro‑
Standard Operating Procedures
cedure to be effective.
written procedures detailing how to operate
equipment or execute a process.
Sanitizer
a chemical agent used for sanitization of clean
Sterile
surfaces.
free from viable microorganisms and spores.
WATER-
Selective medium
Sterilization
PRODUCTS
Swab
a wad of absorbent material usually wound
V
around or attached to the end of a small stick Validation
or applicator and used for removing material or substantiation and verification that a specific
microorganisms from a surface area. See also process or test method consistently does what it
Transport Swab. is intended to do.
T Vectors
carriers of microorganisms.
24
Taxonomy
the classification of organisms, based on mutual
similarities. Vegetative Bacteria
MISCIBLEGLOSSARY
M-7 SCREENING WATER-
Viable
capable of living. Y
Yeast
W a single‑cell fungus that reproduces primarily by
budding.
Waste
any material or product that its holder intends
for disposal.
WATER-
PRODUCTS
MISCIBLEGLOSSARY
M-7 SCREENING